A Novel Process for the Production of Clinical Dextran. by Kim, Doman
Louisiana State University
LSU Digital Commons
LSU Historical Dissertations and Theses Graduate School
1992
A Novel Process for the Production of Clinical
Dextran.
Doman Kim
Louisiana State University and Agricultural & Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact
gradetd@lsu.edu.
Recommended Citation
Kim, Doman, "A Novel Process for the Production of Clinical Dextran." (1992). LSU Historical Dissertations and Theses. 5443.
https://digitalcommons.lsu.edu/gradschool_disstheses/5443
INFORMATION TO USERS 
This manuscript has been reproduced from the microfilm master. UMI 
films the text directly from the original or copy submitted. Thus, some 
thesis and dissertation copies are in typewriter face, while others may 
be from any type of computer printer. 
The quality of this reproduction is dependent upon the quality of the 
copy submitted. Broken or indistinct print, colored or poor quality 
illustrations and photographs, print bleedthrough, substandard margins, 
and improper alignment can adversely affect reproduction. 
In the unlikely event that the author did not send UMI a complete 
manuscript and there are missing pages, these will be noted. Also, if 
unauthorized copyright material had to be removed, a note will indicate 
the deletion. 
Oversize materials (e.g., maps, drawings, charts) are reproduced by 
sectioning the original, beginning at the upper left-hand corner and 
continuing from left to right in equal sections with small overlaps. Each 
original is also photographed in one exposure and is included in 
reduced form at the back of the book. 
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6" x 9" black and white 
photographic prints are available for any photographs or illustrations 
appearing in this copy for an additional charge. Contact UMI directly 
to order. 
University Microfilms International 
A Bell & Howell Information Company 
300 North Zeeb Road. Ann Arbor. Ml 48106-1346 USA 
313/761-4700 800/521-0600 

Order Number 9316974 
A novel process for the production of clinical dextran 
Kim, Doman, Ph.D. 
The Louisiana State University and Agricultural and Mechanical Col., 1992 
U  M I  
300 N. ZeebRd. 
Ann Arbor, MI 48106 

A NOVEL PROCESS FOR THE PRODUCTION OF CLINICAL DEXTRAN 
A Dissertation 
Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the 
requirements for the degree of 
Doctor of Philosophy 
in 
The Department of Microbiology 
by 
Doman Kim 
B.Sc., Seoul National University, 1985 
M.Sc., Seoul National University, 1987 
M.Sc., Louisiana State University, 1990 
December 1992 
ACKNOWLEDGEMENTS 
I am deeply indebted to Dr. D. F. Day for his advice, encouragement, 
and fruitful discussions throughout this work, and also for his kind help in the 
preparation of this dissertation. 
Sincere appreciation is extended to Dr. M.D. Socolofsky, Dr. E.C. 
Achberger, Dr. R.C. Gayda, Dr. E.S. Younathan and Dr. R.J. Gale for 
valuable discussions, suggestions on all aspects of this study and for 
reviewing this manuscript and advice and constructive criticism in the 
preparation of this dissertation. Also I would like to thank to Dr. M. Saska 
(Audubon Sugar Inst., LSU) for use his HPLC and valuable suggestions; to 
Dr. L. Day for her both moral and intellectural support; to Ms. D. Sarkar 
(Audubon Sugar Inst., LSU) for her various help and suggestions during this 
study; to Dr. N. Patel (Chemdex Inc., FL) for his fruitful discussion and supply 
of standard materials; to Dr. S. Clarke (Audubon Sugar Inst., LSU) for helpful 
discussion in this work; to Ms. C. Henk for her assistant in Electron 
Microscope study; to Mr. M. Brou (Audubon Sugar Inst., LSU) for his 
technical help running fermentor. 
I would also like to thank to my lab colleges, R. Ashby and J. Lee for 
valuable discussion; to my friends S.H. Kim (Biochemistry, LSU), H.H. Baek 
(Food Science, LSU), D. Y. Kim (Vet School, LSU) and H. J. Kim 
(Biochemistry, LSU) for their helpful discussions and suggestions during this 
work. 
Appreciation is extended to the Audubon Sugar Institute for providing 
funds and facilities to complete this research. 
I dedicate this work to my wife, Myung-Suk, my son, Gha-Hyun, my 
daughter, Nah-Yun, and my families. Their love, patience and understanding 
have made this work possible. 
iii 
TABLE OF CONTENTS 
Page 
ACKNOWLEDGEMENTS ii 
TABLE OF CONTENTS iv 
LIST OF TABLES viii 
LIST OF FIGURES x 
ABSTRACT xiii 
INTRODUCTION 1 
REVIEW OF LITERATURE 3 
I. Dextran and its uses 3 
(1) Dextran as blood volume extenders and 
blood substitutes 3 
(2) Dextran derivatives 4 
II. Dextransucrase 6 
(1) Dextransucrase production 7 
(2) Purification and characterization of 
dextransucrase 8 
(3) Mechanism of action 14 
III. Dextran production 19 
(1) Batch culture 19 
(2) Cell free fermentation 21 
(3) Immobilization of dextransucrase 22 
IV. Commercial processes for producing 
low molecular weight dextrans 23 
iv 
Page 
(1) Dextran depolymerization 24 
(2) Dextran fractionation 27 
V. Dextranases 30 
VI. Electron microscopy of dextran.. 31 
VII. Mixed culture 32 
MATERIALS AND METHODS 35 
I. Organisms and growth conditions 35 
II. Selection of ATCC 74054 35 
III. Enzyme production and purification 36 
IV. Enzyme assays 38 
V. Enzyme characterizations 39 
VI. Dextran size and quantity determination 40 
VII. Dextranase addition effect on dextransucrase activity 41 
VIII. Optimization of mixed culture fermentation 42 
IX. Viscosity comparisons of products 43 
X. Maltose and dextranase addition effects on 
Leuconostoc fermentations 44 
XI. Exogenous dextran addition 44 
XII. Dextran hydrolysis 44 
XIII. Dextran precipitation from cultures 45 
XIV. Residual dextranase activity in the dextran 
preparation 46 
XV. Activated charcoal filtration 46 




I. Studies on a constitutive dextranase mutant 48 
(1) Mutant isolation 48 
(2) Mutant characterization 52 
(3) Dextranase characterization 52 
(4) Amylase production 59 
II. Dextransucrase 64 
(1) Growth and dextransucrase production by 
L. mesenteroides in high sucrose 64 
(2) Effect of dextranase on dextransucrase 
activity 64 
III. Optimization of mixed culture fermentation 67 
(1) Media requirements - yeast extract and CaCfe 67 
(2) Effect of pH on the production of clinical dextran 72 
(3) Effect of temperature on the production 
of clinical dextran 75 
(4) Sucrose concentrations 75 
IV. Mixed culture fermentation 81 
V. Product characterization 97 
(1) Viscosity comparisons of products 97 
(2) A comparison of clinical dextran yield as a function 
of sucrose concentration in mixed culture 103 
VI. Mechanism of clinical dextran formation 103 
(1) Maltose and dextran addition 103 
vi 
Page 
(2) Effect of dextranase on dextran size in 
L. mesenteroides pure culture 115 
VII. Product recovery 123 
(1) Alcohol precipitation 123 
(2) Salt effects on solvent precipitation 123 
VIII. Protein (residual dextranase) removal 127 
IX. Identification of HMW (high molecular weight) dextran 





LIST OF TABLES 
Page 
Table 1. Growth and dextranase production by Lipomvces 51 
Table 2. Hydrolysis products of ATCC 74054 dextranases 61 
Table 3. Dextranase and amylase production by ATCC 
74054 on sucrose, starch or dextran 63 
Table 4. Dextranase activation effect on dextransucrase activity 66 
Table 5. Effects of yeast extract on dextran yield 69 
Table 6. Effect of CaCl2 on the production of dextransucrase and 
dextranase in mixed culture 71 
Table 7. Temperature effect on the cell growth in mixed 
culture 77 
Table 8. The effect of discontinuous and single sucrose 
addition on dextran productivity 78 
Table 9. Effect of the final sucrose concentration on final 
L mesenteroides and L starkevi cell numbers 82 
Table 10. Viscosity comparisons of products 102 
Table 11. Dextran yields with pure and mixed culture 104 
Table 12. Effect of maltose addition on dextran size 
distribution 109 
Table 13. Effect of dextran addition on L. mesenteroides 
pure culture fermentations 114 
Table 14. Effect of dextranase addition on L. mesenteroides 
pure culture 117 
Table 15. Comparison of dextran recoveries by ethanol 
or isopropanol precipitation 125 
Table 16. Effect of salts on dextran precipitation by ethanol 126 
Table 17. Effect of salts on dextran precipitation by 
methanol, ethanol or isopropanol 128 
viii 
Page 
Table 18. Effect of NaCI or MgS04 addition on dextran 
recovery 129 
Table 19. Effect of residual dextranase activity on dextran 
prepared from mixed culture 130 
Table 20. Dextranase removal using activated charcoal 132 
Table 21. Hydrolysis of mixed culture dextran with acid or 
dextranase 134 
ix 
LIST OF FIGURES 
Page 
Figure 1. Mechanisms proposed for the synthesis of dextran 
by Leuconostoc mesenteroides ATCC 10830F 
dextransucrase (A) and the acceptor reactions (B) 16 
Figure 2. Fractionation scheme used on dextran 
hydrolysates 28 
Figure 3. Phenotype of L. starkevi ATCC 12659 and 
a dextranase mutant on blue dextran agar plates 49 
Figure 4. Growth of ATCC 74054 on glucose and fructose 
media 53 
Figure 5. Sugar consumption by ATCC 74054 on mixed 
carbon sources 54 
Figure 6. Growth of ATCC 74054 at various sucrose 
concentrations 55 
Figure 7. Dextranase production by ATCC 74054 at 
various sucrose concentrations 56 
Figure 8. Optimum pH's for dextranases produced on 
different carbon sources 57 
Figure 9. Optimum temperature for dextranases produced on different 
carbon sources 58 
Figure 10. Temperature stability of dextranases produced 
on different carbon sources 60 
Figure 11. Growth, dextranase and amylase, production 
by ATCC 74054 on sucrose 62 
Figure 12. Growth and dextransucrase production of 
L mesenteroides at 15 and 30 % sucrose 65 
Figure 13. Phase-contrast micrograph of mixed culture broth 68 
Figure 14. Comparison of activity of dextransucrase and 
dextranase at various pH's in mixed culture 73 
Figure 15. Effect of pH on dextran productivity 74 
X 
Page 
Figure 16. Effect of fermentation temperature on dextran yields 76 
Figure 17. Clinical dextran productivity as a function of 
sucrose concentration 80 
Figure 18. Dextransucrase production as a function of sucrose 
concentration 83 
Figure 19. SEM micrographs of L. mesenteroides ATCC 10830 84 
Figure 20. SEM micrographs of L. starkevi ATCC 74054 
culture 87 
Figure 21. GPC chromatograms of dextrans from a 30 % sucrose mixed 
culture fermentation 89 
Figure 22. Dextran distribution with time 91 
Figure 23. SEM micrographs of L. starkevi and 
L. mesenteroides in mixed culture 92 
Figure 24. SEM micrographs of pure and mixed culture 95 
Figure 25. Cumulative dextran molecular weight distributions.. 98 
Figure 26. SEM micrographs of L. starkevi and 
L. mesenteroides in mixed culture 99 
Figure 27. Sugar changes during mixed culture fermentation 101 
Figure 28. Thin layer chromatogram of supernatants from mixed 
culture and pure culture fermentations 106 
Figure 29. Cumulative dextran molecular weight distribution after 
the addition of maltose 108 
Figure 30. Effect of maltose addition on dextransucrase activity 
in the L. mesenteroides pure culture 110 
Figure 31. Acid and enzyme hydrolysates of dextrans 112 
Figure 32. Cumulative dextran molecular weight distributions after 
the addition of exogenous dextrans 116 
Figure 33. Effect of dextranase addition on dextransucrase 
activity in the L. mesenteroides pure culture 118 
xi 
Page 
Figure 34. Effect of dextranase addition on fermentations 
containing no residual sucrose 120 
Figure 35. Effect of dextranase addition on fermentations 
containing residual sucrose 121 
Figure 36. Change in amount of sucrose and isomaltooligosacharide 
with time 122 
Figure 37. The precipitation pattern of mixed culture 
dextrans by isopropanol 124 
xii 
ABSTRACT 
A new process for the production of a clinical (or controlled size) 
dextrans was developed. This process is simpler, cheaper and more 
economical than traditional methods. It involves the use of a mixed culture 
fermentation with a dextranase producing strain (Lipomvces starkevi ATCC 
74054) and a dextransucrase producing strain (Leuconostoc mesenteroides 
ATCC 10830). The new process produced 84 % (w/w) of the theoretical yield 
of clinical dextrans with an average polydispersity between 1.2 and 1.5. The 
mechanism for clinical dextran formation is a competitive production of 
acceptors from newly formed dextran molecules by dextranase. The 
acceptors compete for the existing glucosyl portion of sucrose, resulting in 
higher levels of small size dextran molecules. The maintenance of a proper 
balance of dextransucrase to dextranase is essential for the functioning of 
this process. 
x i i i  
INTRODUCTION 
Dextran is the collective term given to that group of bacterial 
polysaccharides composed of chains of D-glucose units connected by a 1,6 
linkages. Low molecular weight dextrans have their largest application in the 
pharmaceutical industry. Various molecular weights and weight distributions 
have been used as blood plasma extenders (dextran 70, average molecular 
weight 70,000) and blood flow improvers (dextran 40, average molecular 
weight 40,000). Dextran, circulating in the blood system is rapidly removed 
by the kidneys if it is below an appropriate threshold size but slowly by 
metabolic pathways if it is above a threshold molecular weight. Good 
anticoagulant activity with low toxicity has been obtained with the dextran 
derivative, dextran sulfate, of molecular weight 7,300 with 1.9 sulfate groups 
per glucose residues (150). Dextran sulfate is also reported to inhibit some 
virus infections. It can interfere with the initial adsorption of the virus to 
susceptible cells (150, 176). Its action is molecular weight dependent. LMW 
(low molecular weight) dextran sulfate specifically interacts with the major 
envelope glycoprotein of HIV-1, inhibiting its ability to bind to CD 4 cells 
(115, 121). In addition, cross-linked dextran, mercaptodextran, and iron-
dextran have been used for various applications. The demand of dextran 
derivatives has increased dramatically. The important factor for any dextran 
derivative is its size. 
Commercially, dextran is produced by whole culture fermentation. 
Leuconostoc mesenteroides ATCC 10830 (F) is grown in a medium 
containing sucrose along with other required nutrients. It produces a native 
dextran with a molecular mass of about 5 x 108daltons. This is unsuitable 
for blood plasma substitutes. Relatively low molecular weight dextrans (a 
1 
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few hundred to a million) are produced by controlled acid hydrolysis of 
native dextran, followed by organic solvent fractionation. The process has 
drawbacks. Since it is multi-step, the yields are relatively low due to losses 
during acid hydrolysis and repeated fractionations and it has inherent high 
viscosity because of the high molecular weight polymers. There have been 
many studies on improving clinical dextran production with purified 
dextransucrase (139, 148). A popular idea for making clinical dextran with 
this enzyme has been to use maltose as an acceptor (148). However, this 
process requires enzyme production and an enzyme purification step. An 
enzymatic hydrolysis method for clinical dextran production has been 
patented (129, 130). There is, however, no practical method to recover the 
dextranase for re-utilization. Thus, for over 40 years, a whole culture 
fermentation process, followed by de-polymerizations and fractionations has 
been used for clinical dextran production. 
This study reports on the production of a new, simpler, and industrially 
practical method for producing clinical dextrans. 
REVIEW OF LITERATURE 
I. Dextran and its uses 
Dextran is the collective term given to that group of bacterial 
polysaccharides composed of chains of D-glucose units connected by a 1,6 
linkages. Their structures (degree of branching), molecular weights and 
other properties are specific to the organisms that produce them. Dextran is 
synthesized only from sucrose. It is produced by bacteria of the family 
Lactobacillaceae and specially the genera Lactobacillus (37, 43, 56, 66, 90, 
100), Leuconostoc (74. 97, 146), and Streptococcus (36, 56, 57, 70, 175). 
The commercial world market for this polymer is several billion kilograms a 
year. 
(1) Dextran as blood volume extenders and blood substitutes 
Low molecular weight dextran (M.W. of 70,000 ± 25,000) is used as 
an agent for restoring blood volume (63, 64, 151). Macromolecular and 
colloidal materials have been shown for many years to act like natural blood 
colloids (171). Early on, Swedish workers (63, 64) developed the use of 
dextran for maintaining blood volume. Alpha 1,4 glucosidic bonds are 
rapidly cleaved by human enzymes, whereas a 1,6 bonds are cleaved more 
slowly. Obviously, polymers with a high proportion of a 1,4 bonds will rapidly 
degrade to low molecular weight oligomers losing their properties as blood 
volume expanders (153). 
The possibility of dextran - hemoglobin solutions as a blood 
substitute, serving at once the dual functions of plasma expension and 
oxygen delivery, has been considered (145, 177). The removal of 
erythrocyte stroma effectively detoxified such solutions (177). Stroma-free 
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hemoglobin can be sterilized by filtration, easily stored, and used in 
transfusions without blood-group typing, its physiological properties have 
been widely examined. However, due to its relatively small size, the 
hemoglobin infused into the circulation is rapidly eliminated through the 
kidneys and by other metabolic routes. To develop usable procedures that 
can increase the effective size of the hemoglobin molecule and slow down 
its disappearance from the circulation, a complex between soluble dextran 
and human hemoglobin has been synthesized by alkylation or dialdehyde 
method (177). Both soluble dextran - hemoglobin complexes could bind and 
release oxygen reversibly. They found that the complex obtained by the 
alkylation method was excreted by the kidneys and cleared from the 
circulation more slowly than free hemoglobin. 
(2) Dextran derivatives 
Dextran esters and ethers have been produced having a diverse 
range of properties. The properties depend upon the type and the degree of 
substitution as well as the molecular size of the dextran. Dextran derivatives 
are used in the photographic industry. Patents have been issued (29) on 
improved film emulsions incorporating dextrans which use less silver without 
any loss of fineness of grain. 
a. Cross-linked dextrans - The most widely used dextran derivative is 
the cross-linked dextran known as Sephadex™ (Pharmacia Fine Chemicals, 
Ltd., Uppsala, Sweden). It is manufactured by the reaction of an alkaline 
dextran solution with epichlorohydrin, producing cross-linked dextrans. 
Cross-linked dextran matrices have a wide variety of uses including solid 
5 
supports for affinity chromatography and bases for ion-exchange molecular 
sieves. 
b. Dextran sulfate - Sulfated esters of dextran are prepared by mixing 
chlorosulfonic acid in pyridine at -10°C, raising the temperature to 60°C and 
adding dry, finely powered dextran. Dextran sulfate is an anticoagulant with 
properties similar to, although less effective than, heparin. Anticoagulant 
activity increases sharply when sulfate substitution uses from 1.0 to 1.3 
sulfate groups per glucose residue (150). High molecular weight dextran 
sulfate is toxic because it precipitates fibrinogen producing embolisms (153). 
Toxicity is greatly reduced in dextran sulfates with molecular weights of less 
than 20,000. The approximate size of heparin is 17,000. Good anticoagulant 
activity with low toxicity has been obtained from a dextran sulfates of 7,300 
M.W. and 1.9 sulfate groups per glucose residue (150). Dextran sulfate also 
interacts with p-lipoproteins and has found application in the determination 
of serum cholesterol (150). 
Dextran sulfate is reported to inhibit some virus infections. It can 
interfere with the initial adsorption of the virus to susceptible cells (176). 
LMW (low molecular weight) dextran sulfate (MW approximately 8,000 
containing 17 to 20 % sulfate) specifically interacts with the major envelope 
glycoprotein of HIV-1, inhibiting its ability to bind to CD 4 cells (115, 121). 
HMW (high molecular weight) dextran sulfate 500 (MW 500,000) is 
commonly used as a reticuloendotherial blocker. Lipopolysaccharide 
induced tumour necrosis factor production in sera is enhanced when mice 
are pretreated with dextran sulfate 500. The size of the dextran sulfate is 
important (80). Dextran sulfate also has an affinity for the nucleic acids and 
is a potent inhibitor of ribonuclease (144). 
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c. Mercaptodextran - Mercaptodextran is synthesized by thiolating 
dextran with N-acetyl homocysteine thiolactone. The thiol groups of 
mercaptodextran are stable toward autooxidation. Mercaptodextran has a 
higher affinity for heavy metal ions, specifically, mercuric, and cupuric ions 
than other thiols or chelating agents. This affinity for heavy metal ions, 
combined with low toxicity make dextran sulfate useful in treating acute, 
heavy metal poisoning and in the environmental clean up of heavy-metal 
contamination (76). 
d. Iron-dextran - when LMW dextran is treated with water-soluble, 
weakly electrolytic Iron (III) salts at 40 ° - 115 °C at pH 11.5 is produced a 
complex containing from 5 to 30 % (by weight) of iron (27). These complexes 
are used in the treatment of iron deficiency anemia in both human and 
veterinary medicines. Iron dextran contain 20 % (w/v) Fe (4). 
e. Other dextrans - Many other dextran derivatives such as 
carbonates, triacetates, phosphates, nitrates, benzyl and hydroxyalkyi ethers 
have been synthesized. Their uses range from tableting and encapsulating 
agents (9) to emulsifying and thickening agents (181), high viscosity gums 
(182), explosives (118, 128), soil conditioners (131, 191), well drilling (136), 
etc. 
II. Dextransucrase 
Dextransucrase (sucrose 1, 6-a-D-glucan 6-a-glucosyltranferase, EC 
2.4.1.5) is an extracellular enzyme secreted by species of Leuconostoc and 
Streptococcus. It polymerizes the glucosyl moieties of sucrose to form 
dextran (119). The reaction is represented by the following equation; 
nCi2H220ii —> (C6HioC>5)n + nCeH^Oe. 
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L. mesenteroides dextransucrase - Dextransucrase from 
mesenteroides 10830 (B-512) F is an industrially important enzyme due to 
its ability to synthesize dextran. Studies of its mechanism have added both 
theoretical and practical aspects to understanding the mechanisms of 
glucan synthesis and glucosyl transfer reactions with acceptors. This 
enzyme constructs dextrans, containing 95 % a 1,6 bonds and 5 % a 1,3 
bonds in the form of branches using sucrose as an a-D-glucosyl donor for 
the synthesis of D-glucans. 
(1) Dextransucrase production 
Many researchers have proposed multi-step processes using purified 
dextransucrase to produce clinical dextrans. The hydrolysis of sucrose 
provides the energy required for the condensation of D-glucopyranosyl 
units, allowing in vitro dextran synthesis. Dextransucrase produced by 
Leuconostoc sp. on low level of sucrose. The inoculation rate is generally 1 
or 2 % (v/v), large inocula accelerate the rate of fermentation but decrease 
the yields of dextransucrase (184). High sucrose levels induce higher 
enzyme production. However, even with 3 to 5 % sucrose, the culture 
produces so much dextran as to render the cell removal difficult. Two 
percent sucrose is accepted as the optimal level for the production of 
dextransucrase by Leuconostoc sp. At this concentration of sucrose dextran 
formation is little, suggesting that the sucrose is being used completely as an 
energy source (126). Dextransucrase is not produced when 
mesenteroides is grown on glucose or maltose (106). 
Monsan and Lopez (122) and Schneider et al. (162) reported 
dextransucrase activities, in broth, of 178 DSU/ml and 300 DSU/ml, 
respectively. One dextransucrase unit (DSU) is the amount of enzyme which 
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will convert 1 mg sucrose to dextran in 1 hr liberating 0.52 mg fructose at a 
pH 5.2 and a temperature of 25 °C. Variation of sugar type, i.e. maltose, 
glucose and fructose instead of sucrose (24, 126), and sucrose 
concentrations (4, 184) to increase dextransucrase yields have been 
attempted. Fed-batch fermentation under pH (5, 25) and temperature control 
with optimized aeration (105, 162) have had limited success. 
Using continuous culture Lawford et al. (106) produced approximately 
0.75 lU/ml dextransucrase with a dilution rate of 0.53 hr1 and Paul (139) 
obtained 3.4 U/ml/hr with a dilution rate of 0.4 hr1. One unit (U) of 
dextranase was defined as the amount of enzyme which liberates 1 ^mole of 
isomaltose equivalents. Pennell and Barker (142) produced approximately 
5 U/ml/hr of dextransucrase in an unaerated continuous fermentations. The 
effect of yeast extract quality, sucrose concentration and agitation rate in 
continuous culture have been studied for their effect on dextransucrase 
production. Under sucrose limited growth, Lawford et al. (106) found 
dextransucrase activity in the supernatant increases with dilution rate only 
after a critical concentration of inducer (sucrose) in the chemostat is 
reached. Paul et al. (138) obtained 3 fold higher enzyme productivity with 
continuous culture than with fed-batch culture. 
(2) Purification and characterization of dextransucrase 
a .  L .  m e s e n t e r o i d e s  dextransucrase - L. mesenteroides 
dextransucrase is purified from the culture broth of sucrose fermentation. It is 
purified by a sequence including dextranase treatment, DEAE-cellulose 
chromatography, affinity chromatography on Sephadex G-200, and 
chromatography on DEAE-Tris-acyl M (119). It has a pH optimum of 5.0 - 5.5, 
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and a Km of 12 - 16 mM. Robyt and Walseth (159) found that B-512F 
dextransucrase was a mannoglycoprotein. Enzyme preparation composed 
of two major proteins with molecular weights of 158,000 and 177,000. The 
177,000 form predominates in fresh preparations, whereas the 158,000 form 
increases at the expense of the 177,000 form during storage. A B-512F 
mutant (B-512FM) produces a single dextransucrase of molecular weight 
158,000 (52). Kobayashi et al. (86) reported different sizes for 
dextransucrase. They obtained relatively small amounts of apparently 
homogenous dextransucrase from B-512F that had a molecular weight of 
64,000. This is the lowest molecular weight reported for this dextransucrase. 
Their preparation had very low dextran synthesizing activity but a high 
sucrose hydrolyzing activity. Kobayashi and Matsuda (87) reported the 
presence of multiple forms of the extracellular dextransucrase from B-512F. 
Dextransucrase aggregates were a mixture of two, i.e., oligomers of a 65K 
protomer and their charge isomers. Since the highly aggregated form 
showed a higher activity for dextran synthesis than the dissociated forms, 
they suggested that endogenous dextran acts as a source of primer that 
stabilizes the enzyme molecule. They also suggested that the occurrence of 
oligomeric forms of the enzyme might play an important role in the control of 
dextran synthesis in vivo. 
Paul reported the purification of a dextransucrase using phase 
partition (140). The molecular weight of the monomeric active enzyme was 
estimated to be 65,000. The molecular weights of the aggregated enzymes 
were 130,000 and 195,000. The isoelectric point of the dextran free protein 
was 4.0. Enzyme activity was stimulated by dextrans addition and the Km 
value decreased with increasing dextran concentration (85). 
Dextransucrase will polymerize the D-glucosyl groups from a-D-
glucopyranosyl a-L-sorbofuranoside (114), 0-p-D-galactopyranosyl-1,4-p-
D-fructofuranosyl  a -D-glucopyranoside ( lactosucrose) (2),  p-ni t rophenyl  a-
D-glucopyranoside (3), and a-D-glucopyranosyl fluoride (4). These 
substrates differ from sucrose only in the leaving group. All have an a-D-
glucosidic linkages of energy similar to, or higher than, that of sucrose (17). 
The a-glucosyl moiety, which is important for binding and subsequent 
polymerization, is unchanged. Kobayashi et al. (89) studied the substrate 
binding sites of Leuconostoc dextransucrase by inhibition kinetics. They 
proposed a mechanism, in which the donor (sucrose) and acceptor (dextran) 
bind to distinct, separate sites on the enzyme. They reported that D-fructose 
and maltose were inhibitors of dextransucrase. Miller and Robyt (120), using 
radiation inactivation to measure the minimal enzyme unit required for 
activity, reported that L. mesenteroides B-512F dextransucrase has two 
nucleophilic sites. They are located on the same peptide, rather than on 
different subunits in a dimer. Peptide association is not required for dextran 
synthesis. Fu and Robyt (50) proposed that two imidazolium groups of 
histidine are in the active site. They donate protons to the leaving, D-
fructosyl  moiet ies.  The resul t ing imidazole groups faci l i tate the format ion of  a 
1,6 glycosidic linkages by abstracting protons from the C6-OH, becoming 
reprotonated for the next series of reactions. Using a series of a-1-
fluorosugars Grier and Mayer changed the configurations of specific 
hydroxyl groups of the glucosyl moiety to examine substrate specificity (61). 
Analogs of a-D-glucopyranosyl fluoride were found to be inhibitors of 
dextransucrase but did not act as glucosyl donors. Epimerizations at C2, C3, 
and C4 produced competitive inhibitors. Four and 6-deoxy-glucopyranosyl 
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fluoride were competitive inhibitors. It is likely that hydroxyl groups are 
important for the binding of substrate to the active site via hydrogen-bond 
formation. New substrates may be found for dextransucrase if the hydroxyls 
on the glucose ring can be replaced with other groups that can participate in 
hydrogen bonding. Michiels (117) tested a-D-glucopyranosyl fluoride at 
positions 2, 3, or 5 as substrates and inhibitors of dextransucrase. They 
found C2 and C3 hydroxyl groups are important for the proper binding of a-
D-glucopyranosyl fluoride to the dextransucrase active site and that the C3-
hydroxyl probably acts as a hydrogen-bond donor. 
b. Streptococcus dextransucrase - Dextransucrase produced by fL 
sanguis is a constitutive extracellular enzyme. It can be purified from the 
culture fluids of late log or early stationary phase cells grown on glucose or 
other simple carbon sources. The organism also produces a protease that 
cleaves the proto dextransucrase, producing a fully active form with a 
molecular weight of 156,000. After proteolysis, the aggregate and oligomeric 
forms of the enzymes are hybrids of the proto and proteolyzed monomers 
(59). This enzyme has a pH optimum between 6.0 and 6.5, and an 
isoelectric point of 5.15. The Km for sucrose in the presence and absence of 
acceptors (dextran T-10) is 5.09 and 0.93 mM, respectively. The 
glucopyranosyl configuration is necessary for donor activity (61, 79). 
Acceptor substrate specificity is extremely broad. It ranges from simple 
alcohols, such as ethanol, to glucose oligosaccharides and dextran. While 
dextran is the probably the best acceptor for this enzyme, the 
oligosaccharides are the most widely investigated (117). Fructose also 
serves as an acceptor. However, it generates two types of products. Over a 
short reaction time (10 - 15 seconds) it forms sucrose by an isotope 
exchange reaction (112) and over 3 hrs reaction time (117) leucrose (5-O-a-
D-glucopyranosyl-D-fructopyranose) and maltulose (4-O-a-glucosyl-D-
fructose) are the major products. The active site numbers and branch 
formation mechanisms are similar to L. mesenteroides dextransucrase (31, 
157). 
Some Streptococci produce soluble polymers whereas others yield 
insoluble ones. The terms GTF (S) and GTF (I) have been used to designate 
the enzymes responsible for the formation of soluble and insoluble polymers 
(28). Since solubility is related to the proportion of a 1,6 bonds, those 
enzymes that form soluble polysaccharides are more specifically designated 
as dextransucrases. The reactions catalyzed by glucosyltransferases may 
play an important role in the formation of dental caries. Four kinds of 
glucosyltransferases (GTase) have been purified from S. mutans serotype g. 
(67, 68, 116, 165, 195, 197). They are two primer independent GTase's and 
two primer dependent GTase's. One of the primer dependent GTase's 
produces highly branched, water soluble glucans (165) and the other is 
water insoluble glucans (67, 116). The two primer independent GTases 
produce water soluble glucans and supply the primers for both primer 
dependent GTase's (68, 116). One of the primer independent GTase's is a 
donor for the branching enzyme (195, 197). Kobs (91) reported the presence 
in S. sanguis dextransucrase of a catalytic domain that contains two non-
equivalent sites. One site confers the ability to bind to acceptor molecules 
such as dextran, with high affinity. The other site is responsible for the 
formation of the glucosyl-enzyme intermediate by sucrose hydrolysis. They 
suggested that two acceptors binding sites exist on dextransucrase (92). 
c. Dextransucrase properties - Willemot et al. (190) observed that the 
dextran in the dextran-enzyme complex has activating and stabilizing effects 
on activity. They suggested that a local concentration of dextran in the 
microenvironment of the enzyme is important. Kobayashi and coworkers 
(86) reported that the addition of exogenous dextran stimulated the sucrase 
activity (sucrose cleavage) 1.3 fold, and transferase activity (dextran 
synthesis) 9.6 fold. Kobayashi et al. (88) reported that, in contrast to dextran, 
low-molecular weight sugars did not stimulate the transferase. In fact, 
glucose, fructose and maltose inhibited transferase activity. D-Fructose and 
maltose were competitive inhibitors of the transferase reaction with Ki value 
of 44.8 mM and 5.4 mM, respectively. Maltose and isomaltose are 
competitive inhibitors of Streptococcus GTF-S. However, nigerose had no 
effect on GTF-S activity. The Ki values for these inhibitors are 0.8, 2.5, and 
15 mM, respectively. Kobayashi and coworkers reported that 0.075 % 
fructose or 0.15 % maltose in sucrose solutions inhibited dextransucrase 
activity (89). 
Dextransucrase is inactivated by EDTA and the enzyme activity can 
be recovered by the addition of alkaline earth metal ions (72). It is probable 
that the enzyme occurs as a calcium-enzyme. Dextransucrase thermal and 
pH stability increase upon addition of 0.1 mM Ca** ion (72). Optimal pH for 
dextransucrase production is ranged from 6.5 to 7.0 and the optimal pH for 
dextransucrase activity is 5.0 to 5.2. Dextransucrase activity is most stable in 
the same pH's. Over pH 5.8, dextransucrase activity decreased to less than 
25 % of the original activity after 1 hour. Upon the addition of Ca4-* ion, the 
dextransucrase is stable over a pH range of 5.0 to 6.0 (5). 
(3) Mechanism of action 
a. Dextransucrase reaction mechanism - The mode of action of 
dextransucrase has been the subject of argument for 40 years. When 
dextransucrase was discovered (1941), Cori and Cori (30) were working on 
the synthesis of glycogen. This polysaccharide molecule is built by the 
addition of glucose, from a-glucose-1 phosphate, to the growing chain's 
non-reducing end. Similar mechanisms were postulated for dextran 
formation, until it was found that phosphorylated sugars were not involved in 
dextran synthesis. 
Two mechanisms have since been proposed for the dextransucrase 
reaction. Either the enzyme remains in combination with the growing 
polymer chain (170), therefore a single chain mechanism operates, or the 
enzyme separates from the growing chain. The single chain mechanism was 
supported by those workers who failed to detect oligosaccharides or low 
molecular weight dextran (5) in pure cultures of L. mesenteroides. There 
were also controversies about the start of polymerization and the need for 
primers. Germain et al. (54) reported that S. mutans dextransucrase activity 
from glucose grown cultures was partially primer dependent. They reported 
that the non-reducing ends of dextran were substrates and served as the 
necessary primers for new dextran synthesis (55). They hypothesized that 
equal concentrations of dextrans of different molecular sizes would have 
equal concentrations of non-reducing ends and different concentrations of 
reducing ends. Depending on the site for priming, the non-reducing end or 
reducing end, the activation would be identical or different with the dextran 
size. They found that activation was identical for different sized dextrans. The 
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activation was also identical for a dextran that had been modified at the 
reducing end. Germain's explanation is, however, at odds with Robyts'. 
Ebert and Schenk (46), and Robyt and Corrigan (154) proposed a 
mechanism for growth from the reducing end. Robyt and Corrigan used 
dextran modified at the non-reducing ends and found dextransucrase 
activation. Because the non-reducing ends of the modified dextrans were 
not available for reaction, they concluded reducing end growth. To study the 
primer requirement Robyt and Walseth (158) prepared charged 
dextransucrase by incubating the enzyme with sucrose. They separated the 
charged enzyme from the resulting fructose and un-reacted sucrose on Bio-
Gel P-6 (BGP). This enzyme was then incubated with 14C-glucose, 14C-
fructose, or 14C-maltose all labeled at the reducing end. They found each of 
the labeled acceptors produced two labeled products. Reduction and acid-
hydrolysis of the labeled products showed that all three of the acceptors 
were incorporated into the products at the reducing end. The reaction 
occurred in the absence of sucrose. They concluded that primers were not 
necessary to initiate polymer growth (Figure 1). The termination step is not 
completely understood, but evidence suggests that dextransucrase bound 
saccharides are released slowly (39, 112). Ebert and Schenk (46), and 
Robyt (152) tried to explain chain termination using insertion theory, that is 
the bond between the enzyme and the growing chain is broken in such a 
way that it cannot be reformed. This breakage occurs by interference of an 
acceptor. Their mechanism for dextran branch formation is also explained by 
this insertion mechanism (152). The C3-OH of an acceptor dextran makes a 
nucleophilic attack onto the C1 of the reducing end of the dextranosyl- or 
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Figure 1. Mechanisms proposed for the synthesis of dextran by 
Leuconostoc mesenteroides ATCC 10830F dextransucrase (A) 
and the acceptor reactions (B) (150). 
(A) Xi and X2 represent nucleophiles at the active site; 
represents sucrose;open circle is glucose; open triangle is 
fructose; O - 0 indicates glucose residues joined by a-1, 6-
glucosidic linkages. 
(B) (a) is the reaction of isomaltose displacing the glucosyl and 
dextranosyl groups from the enzyme to give respectively 
isomaltose and dextran terminated at the reducing end by 
isomaltose; (b) is the reaction with acceptor-dextran to give a 
single glucose unit; open circle or closed circle is glucose; — 
is an a-1, 6- glucosidic linkage and arrow is an a-1, 3 branch 
linkage. The solid symbols represent 14C-labeled units. 
Slashed closed circle indicated reducing end glucosyl group of 
acceptor. 
forms a 1,3 branch linkages with the exogenous dextran. They suggest that 
in the biosynthesis of branched dextran, a separate branching enzyme is not 
required. The synthesis of branch linkages can occur by acceptor reaction. 
However, the synthesis of different types of branches, the 1-2, 1-3, and 1-4 
glucosidic linkages, which are occasionally detected in the same dextran 
molecule, cannot be explained by this mechanism. 
b. Acceptors - When acceptors, other than sucrose, are present in 
reaction mixtures, D-glucopyranosyl residues can be transferred to them (46, 
78, 158, 173). If the acceptor is a low molecular weight sugar, a 
monosaccharide, disaccharide, or trisaccharide, the product is a low 
molecular weight oligosaccharide. The molecular weight increases only by a 
D-glucosyl group (155). Maltose is the most efficient acceptor, followed in 
order by isomaltose and nigerose. High degree of polymerized 
oligosaccharides (d.p. 8 to 13) are found in all reaction digests. This is 
evidence against acceptors as primers of dextran. Rather than acting as 
primers they terminate polymerization. Some acceptor products can also act 
as acceptors resulting in a series of homologous acceptor products. D-
fructopyranose is a poor acceptor (or non acceptor), whereas D-
glucopyranoside, which is composed of an equilibrium mixture of a- and p-
anomers in a ratio of 1: 2 is an effective acceptor (155). Because of their 
structural and conformational differences, D-galactose and D-mannose are 
very poor acceptors. Fu and Robyt reported on the relative effectiveness of 
various acceptor analogs (51). In decreasing order of effectiveness they are 
2-deoxy, the 2-epimer, 3-deoxy, the 3-epimer, the 4-epimer, and 4-deoxy of 
a-methyl-D-glucopyranoside. The hydroxyl group at C2 is not as important 
for acceptor binding as the C3 and C4 hydroxyl groups. The C4 hydroxyl 
group determines the binding orientation of the a-methyl-D-glucopyranoside 
ring (51). Reactions in which glycosyl groups are transferred from one 
saccharide donor to identical, or similar saccharide acceptors, are known as 
disproportionation reactions. For example, two maltose units become 
glucose and maltotriose. This reaction has been observed for cellulase (81), 
amylase (49), glucoamylase (84), transglucosylase (141), glucodextranase 
(83) and isomaltodextranase (161). This reaction is also seen with 
dextransucrase (16, 183). The formation of enzyme-D-glucosyl 
intermediates from the substrate and the subsequent displacement of the D-
glucosyl group by an acceptor produce disproportionation of the substrate 
(16). The transfer of D-glucosyl groups from one dextran chain to another 
can form branch dextrans. 
Tanriseven and Robyt (178) proposed that the acceptor binding site is 
between the two glucosyl (or dextranosyl) groups. The binding of the 
acceptor to its binding site blocks the insertion of the glucosyl residue into 
the growing dextran chain. It causes the inhibition of dextran synthesis and 
the diversion of the glucosyl residue onto on acceptor. Similarly, the 
acceptor can react with the dextranosyl chain releasing it from the active site 
and terminating polymerization. They proposed that the acceptor binding 
site has a minimum of two glucosyl subsites. Maltose, which has two 
glucosyl moieties, is the most effective acceptor (96). 
L. mesenteroides NRRL B-742 produces two extracellular dextran, L 
fraction, which consists of an a-D-(1,6) backbone with a-D-(1,4) branch 
points, and an S fraction, which consists of an a-D-(1,6) backbone with «-D-
(1,3) branch points. Cote and Robyt (33) reported that any change in 
reaction that affects the rate of acceptor reaction relative to chain elongation 
affects the degree of branching in the S fraction. They also found that 
glucansucrase was capable of modifying the L fraction, by transferring D-
glucosyl groups to OH-3 of D-glucosyl residues. Dextran synthesis 
conditions play an important role in structure determination. Calcium is 
required by B-512F dextransucrase and may play a role in branch formation 
by dextransucrases (106, 159). Tsumuraya et al. (186) found the content of 
a-1,6 glucosidic bonds in dextran increased with increased purity of 
dextransucrase. Calcium ion (+2) was to be a powerful branching factor at 
concentrations above 0.03 M. Magnesium ion (+2), Mn2+ ion and Fe2+ ion 
also showed branching activity above concentrations of 0.03 M, 0.1 M and 
0.0005 M, respectively. The mechanism how metal ions act as branching 
factors is not understood. However, it is possible that they alter the 
conformation of the active site so as to preferentially synthesize non a-1,6 
bonds. More dextran with a lower content of a-1,6 bonds were formed at 
between pH's 5.5 and 6.0 (about 85 % a-1,6 linkage) than at pH's between 
4.3 and 5.0 (about 90 to 95 % a-1,6 linkage). These pH's may induce active 
site conformation changes. Both pH and divalent metal concentrations 
influence the degree of branching in dextrans produced by the 
dextransucrase from L. mesenteroides IAM 1046 (186). 
III. Dextran production 
(1) Batch culture 
Commercially, dextran is produced from the fermentation of sucrose 
bv L. mesenteroides. The organism is grown in a medium containing high 
concentrations of sucrose (15 %) along with the other required nutrients, 
salts, vitamins and minerals. The typical commercial growth media 
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composition is ; Yeast Extract 5 (g / L), Peptone (trace amount, detailed 
information is not available), KH2PO4, 5 g / L, pH between 7.0 and 4.8, 15 % 
sucrose (Dr. Patel, Personal communication, Chemdex Inc., FL). Sometimes 
0.002% CaC^isalso added (138). The cells secrete dextransucrase which 
converts sucrose to dextran. Batch processes terminate when all of the 
sucrose has been utilized and the medium pH has dropped to 4.8 - 5.0. 
Although all the sucrose is consumed, the final yield of dextran is only about 
52 % of the theoretical yield. Alsop (5) reported that lower starting sucrose 
concentrations produced higher yields, reducing sucrose costs. However, 
net production (and the concentration) of dextran was lower, reducing plant 
productivity and substantially increasing downstream processing costs. 
Alsop concluded that the most economic sucrose concentration lay between 
170 and 180 g/L for a batch fermentation. The pH has a significant effect on 
dextransucrase production. Otts and Day (134) reported that dextransucrase 
export in L. mesenteroides is dependent on the total proton motive force 
rather than solely on membrane potential (A^orApH. Dextransucrase 
export is more susceptible to dissipators of membrane potential at higher 
pH's (6.4) and more susceptible to dissipators of ApH at lower pH's (5.5). 
The optimum pH for growth of Leuconostoc is between 6.0 and 7.0, where 
the mean doubling time is 31 ±2 min. The doubling time increases when the 
culture pH was outside this range. At pH 5.0 the mean doubling time 
increases to 60 min (135). A decrease in the external pH has little effect on 
the rate of dextransucrase secretion. Cells maintain a constant proton motive 
force of -130 mV when grown within a pH range of 5.8 to 7.0 (135). Ap 
decreases until it reaches a value of -112 mV at pH 5.3. The contribution of -
ZApH to Ap increased from 0 mV at pH 7.0 to -50 mV at pH 5.3 (135). This 
implies that dextransucrase secretion in L. mesenteroides is dependent on 
the presence of a proton gradient across the cytoplasmic membrane. 
Tsuchiya et al. (184) carried out controlled pH, batch fermentations between 
pH 6.1 and 6.9 and demonstrated that maximum enzyme concentration was 
reached at pH 6.7. However, the maximum production rate was observed at 
pH 6.1. At pH 6.0 and below, the enzyme is stable, retaining 100 % of activity 
for five hours at pH 5.4 (101). Above pH 6.0, the enzyme is far less stable, 
retaining only 10 % of its original activity at pH 6.6 (101). 
In commercial, semi-continuous processes (14) of a preculture of L 
mesenteroides is used as an inoculum at a rate of 10-20 % (v/v) for a 
nutrient solution containing a large amount of sucrose (15 % final sucrose 
concentration). This may be repeated ten times without a change in dextran 
quality. Impure dextran, which is nevertheless suitable for technical use, can 
be obtained using final molasses as a substrate instead of sucrose (15, 77). 
(2) Cell free fermentation 
Hehre (69) was the first to synthesize dextran using L. mesenteroides 
cell-free extracts. Since then, different media compositions and fermentation 
conditions have been applied to improve the yield of dextransucrase (88, 
105). The enzyme is produced separately from dextran and then transferred 
to a sucrose. The cells are removed and the filtrate can either be used 
directly to synthesis dextran or can be concentrated by ethanol precipitation 
as a dextransucrase-dextran complex. This can be stored for subsequent 
use (73). Enzymatic synthesis of dextran has advantages over synthesis by 
growing cultures that include a clearer product, better control and the 
production of a more uniform dextran. For dextran production, the purified 
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enzyme (500 units/ liters of sucrose solution) is added to 300 mM sucrose. 
One enzyme unit is the amount necessary to incorporate one micromole of 
glucose from sucrose into dextran in 1 min under specified pH and 
temperature. The yield after 10 hours (one conversion period) is about 45 g 
of dextran/ liter. Yields depend on the amount of enzyme added to the digest 
and the amount of sucrose in the digest (153). This process has never been 
commercialized because of the high cost of producing and purifying 
dextransucrase. 
(3) Immobilization of dextransucrase 
There have been numerous attempts to immobilize dextransucrase in 
order to reduce enzyme costs (122, 123, 137, 156). Generally there are 
large losses of activity upon immobilization (156) and alterations in the 
reaction kinetics of the enzyme(123). Affinity immobilized dextransucrase 
(91, 111) has been used. Abdel-Halim et al. reported increased production 
of both dextransucrase and dextran using L. mesenteroides immobilized in 
calcium alginate beads. Because alginate beads lose mechanical strength 
in the presence of high concentrations of Na+ or K+ions, calcium alginate 
was layered on porous Celite R630 particles (1). 
Monsan et al. found (123) the specific activity of immobilized 
dextransucrase was elevated in the presence of maltose. The Vmax values 
decreased when the larger acceptors, such as maltose, panose, D.P.4, 
D.P.5, and D.P.6 were used. They immobilized their dextransucrase on 
porous silica activated by glutaraldehyde. They found, without acceptors in 
the reaction medium, dextran is released only after it attains a very high 
molecular weight. It then causes plugging of the supports pores. The 
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resulting increase in viscosity induces high resistance to intraparticular mass 
transfer, and in particular, fructose diffusion to the exterior of the support. 
Using maltose as an acceptor, with a sucrose to maltose ratio of 2, they 
could obtain oligodextrans of less than 20,000 M.W. To synthesize clinical 
dextran (M.W. 70,000) this method would require at least two consecutive 
synthesis steps. 
IV. Commercial processes for producing low molecular weight dextrans 
The impetus for commercial production of dextran was the production 
of "plasma volume expander". Native dextran, with a molecular mass of 
about 5 x 108 daltons is unsuitable as a blood-plasma substitute. The 
optimum size for blood-plasma dextran, so called clinical dextran, is 50,000 -
100,000 daltons (62). Clinical dextran requires a product having a weight -
average molecular weight of 75,000 ± 25,000, determined by the light 
scattering method. The distribution of molecular sizes is further specified by 
stating that the 5 to 10 % of the sample having the lowest molecular weight 
shall not have an average molecular weight below 25,000 and the 5 to 10 % 
of the sample having the highest molecular weight shall not have an 
average molecular weight above 200,000. This relatively low molecular 
weight range dextran is produced by controlled acid hydrolysis of native 
dextran, followed by organic solvent fractionation (18, 66). L. mesenteroides 
B-512 is mass cultured as for ordinary dextran production. The cells are 
removed and the dextran is precipitated with organic solvents. The 
precipitated dextran is re-dissolved and hydrolyzed with hydrochloric acid at 
100 - 105° C. The course of the hydrolysis is followed by viscosity change 
until an optimum end point is reached. The hydrolysis is stopped by cooling 
and neutralizing the acid. 
The solution, after hydrolysis, contains dextrans with molecular 
weights ranging from a few hundred to one million. The mixture is 
fractionally precipitated with organic solvents to produce clinical dextran. 
Repeated fractionation produces dextran with the required narrow molecular 
weight range. This solution is then deionized in mixed - bed deionizing 
columns and the volume is reduced by evaporation. Spraying drying 
produces a free - flowing, white powder with an average size of 40 urn and 
an average molecular weight of 75,000 (18). 
(1) Dextran depolymerization 
a. Acid hydrolysis - Generally, a 5 %(w/v) aqueous solution of NRRL 
B-512 dextran is heated to the hydrolysis temperature. The amount of acid 
required to give the desired pH is then added as quickly as possible with 
rapid stirring. The hydrolysis is timed from the moment all of the acid is 
introduced. The relative viscosity of the solution, measured at 25°C, is the 
criterion for judging the extent of hydrolysis. The relative viscosity decreases 
rapidly at first. Typical curves illustrating the change in viscosity with time 
under different conditions of temperature and acidity have been published 
(192). A higher temperature and a lower pH can shorten the hydrolysis time 
to produce clinical dextran. It takes two hours to complete the hydrolysis to 
clinical dextran at 99°C and at pH 1.6. The hydrolysis is stopped by rapid 
cooling of the hydrolyzate and simultaneous neutralization with slightly less 
than the required quantity of sodium hydroxide. The pH after neutralization 
of the solution with dilute alkali, at room temperature, is 6.5 to 7.0. Acid-
hydrolysis is favored over enzymatic hydrolysis because the reaction can be 
25 
carried out in conventional equipment, and can be readily controlled. The 
effect of pH, temperature, time of hydrolysis, acid type, dextran 
concentrations, hydrolysis extent and variation of fractionation condition, on 
the course of dextran degradation and on product obtained have all been 
studied (192). Both, hydrochloric acid and sulfuric acid produce equivalent 
product. Differences that are found are attributable to the differing amounts 
and types of salts present. This can be compensated for a slight shifting of 
alcohol limits on precipitation. The choice of acid in dextran hydrolysis is 
governed by whether or not the nonvolatility and lessened corrosiveness of 
sulfuric acid are considered important and whether the lesser solubility of 
sodium sulfate in aqueous alcohol and its tendency to precipitate with the 
dextran fraction outweigh these advantages. 
b. Thermal depolymerization - When powdered macromolecular 
dextran, dried from solution at pH 7.0, is heated in a vacuum at 100°C, 
depolymerization occurs. This is indicated by a fall in the viscosity of the 
aqueous solution. Further heating at higher temperatures (e.g., 150°C) 
results in discoloration, loss of water and a crisp friable product that contains 
only a small amount of water-soluble material. Under conditions of oxygen 
exclusion, similar heat treatment at neutrality and in a vacuum produces 
water-soluble products of low viscosity. Thermal cleavage appears to take 
place under more conveniently controlled conditions in aqueous phase at 
pH 7.0. The heating of dextran solutions in the presence of reducing agents, 
at different pH's resulted in viscosities indicative of depolymerization. Under 
reducing conditions, at neutrality, depolymerization proceeds smoothly and 
results in the formation of colorless, highly soluble polysaccharides which 
precipitate with the usual organic solvents. The viscosities required for 
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clinical dextrans can be reached in 24 hours at temperatures between 160 
and 170 °C (169). The mechanism of this degradation is different from that of 
acid hydrolysis. The thermally degraded materials have higher 1,6 to non-
1,6 linkage ratios than the original material and have higher optical 
rotations, approaching that of un-degraded dextrans (194). The branched 
nature of heat-degraded dextran is higher than would have been expected 
from the observed viscosities (163). 
c. Depolymerization of dextran by ultrasonics - The depolymerization 
of branched dextrans can be brought about by ultrasonic treatment of these 
macromolecules in aqueous solutions (104). The ultrasonically produced 
fragments, when examined by fractional precipitation methods, show a 
greater homogeneity than the more random acid hydrolytic products (104). 
Unlike with acid degradation, reducing material is not produced. This 
depolymerization is similar to the alkaline depolymerization of dextran 
described by Stacey and Youd (170). They suggested that the mechanism is 
a disrupting of the dextran hydrogen bonds. Ultrasonic dextran was free from 
carboxyl groups (168). Reducing oligosaccharides were not produced and 
generally the molecular size of particles was spread over a much narrower 
range than with acid hydrolysis. Ultrasonically depolymerized dextran was 
neutral in aqueous solutions. They did not cause anaphylaxis on injection 
into guinea pigs and were non-toxic and non immunogenic in rabbits (13). 
d. Enzymatic hydrolysis of dextran - Dextran hydrolyzed by endo 
dextranases produce only a small amount of reducing sugar during the time 
required for the production of molecular weight 75,000 dextran (26). Filtrates 
from Aspergillus sp. cultures on dextran containing media are highly active 
in splitting dextran. Eight liters of a 20 % sucrose media was fermented with 
L. mesenteroides 683, producing 6.1 % (w/v, or 63.5 % of theoretical) 
dextran, 1 % (v/v) of the mold filtrate was added and enzymatic action 
allowed to proceed for 40 min. The action of the enzyme was stopped by 
adding alkali to pH 9. By the alcohol fractionation 400 g of product with an 
average molecular weight of 71,000 was obtained (or 52.8 % of theoretical 
yield). The advantage of this method is that enzyme solutions can be 
allowed to act directly on fermented culture media containing dextran. This 
eliminates a preliminary precipitation of the polysaccharide with alcohol 
(26). 
(2) Dextran fractionation 
Dextran hydrolyzates are fractionated by the graded addition of 
methanol, ethanol or isopropanol. A standard fractionation scheme is 
illustrated diagrammatically in Figure 2. The importance of fractionation 
cannot be over-emphasized. Highly fractionated dextran is used as clinical 
dextran (19), and for hydrodextran (200), dextran sulfate production (150), 
and for various drugs storage forms (180, 199). A 2 % (v/v) error in the 
alcohol content during fractionation seriously affects the molecular 
distribution and, in turn, the yields of desired dextran. The alcohol can be 
removed by boiling the dextran syrup. However, complete removal by this 
method is neither practical nor necessary. The presence of alcohol, up to 16 
% by volume, in the dextran has relatively little effect on the apparent weight 
average (58). 
a. Alcohol fractionation - For equivalent concentrations, methanol 
does not precipitate clinical dextrans as effectively as does 95 % ethanol. 
For example, a 6 % (v/v) ethanol difference yields 26 to 41 % (w/w) of twice 
refractionated clinical dextran, whereas, a 6 % (v/v) methanol difference 
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Figure 2. Fractionation scheme used on dextran hydrolysates (195). 
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produced only 16 % (w/w). Comparisons have been made between 
methanol, ethanol, and isopropanol as precipitants. The precipitation 
efficiency of these solvents is methanol <ethanol cisopropanol. The 
sensitivity of the precipitation to alcohol concentration is in the reverse order. 
Precipitation of 95 % (w/w) of dextran requires a 42.8 % (v/v) methanol, and 
39.4 and 39.1 % (v/v) absolute ethanol and iso-propanol, respectively. 
Generally, relative to methanol the precipitating powers of these alcohols 
does not vary greatly over the entire range for precipitation. The precipitation 
power is related to the molecular weight of the hydrocarbon portion of the 
alcohol and the dielectric constant of the precipitant. The conditions for 
fractionation and hydrolysis for B-512 (F) dextran cannot necessarily be 
applied to other dextrans (193). Because fractionation procedures are 
imperfect, repeated fractionations are necessary to produce dextrans having 
a narrow enough molecular weight range for clinical use. 
b. Other methods - Gel fractionation of low molecular weight dextrans 
(M.W. less than 40,000) has been investigated (60). For this molecular 
weight range fractionation by conventional means, precipitation and 
extraction, often fail (75). Using "Sephadex" (Pharmacia Co.) gel, which has 
water region (Wr) of 7.6 and 100 - 200 mesh, mixture of different size 
dextrans can be separated (M.W. of 3,400 and 41,000). Both of the polymer 
fractionation techniques currently in wide use, fractional precipitation and 
gel permeation chromatography, require skilled operators (10). Fractionation 
of dextran by ultrafiltration, using membranes with sharp molecular weight 
cutoffs, has also been tried (10). Three different techniques have been 
employed. They are batch ultrafiltration, using progressively more retentive 
membranes, continuous ultrafiltration using three similar membranes in 
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series and variable pressure ultrafiltration using a single membrane and 
varying the applied pressure (from 5 to 40 psi). Different intrinsic viscosity 
material has been found for each fractionation. 
V. Dextranases 
Dextranases (E.C. 3.2.1.11) are enzymes that cleave the a-(1-6)-D-
glucopyranosyl linkages in dextrans. They do not cleave either the a 1-4 or 
1-3 linkages. The enzyme is classified catalytically as either exo-acting or 
endo-acting. Both classes exhibit pseudo-first-order kinetics. Some 
dextranases also can carry out transglycosylation reactions (149). Exo-
acting dextranases preferentially attack the dextran polymers at their non-
reducing ends, moving down the chains, liberating glucose and isomaltose. 
The hydrolytic action terminates when they reach either an a 1-3 or a 1-4 
branch point (188). Exo-dextranase produce large limit dextrans and 
therefore have limited commercial importance. Exo-dextranases show the 
same apparent Km for dextran regardless of its size (147). 
Endo-dextranases bind randomly to the substrate and attack the 
internal a-(1-6) linkages. The a-(1-6) linkages near branch points are 
recalcitrant to attack. The products of endo-dextranase action are branched 
and isomalto-oligosaccharides (149, 188). The apparent Km values of these 
enzymes are inversely proportional to the molecular weights of the dextran 
substrates, where affinity for high molecular weight dextran is much larger 
than for low molecular weight dextran. Endo-dextranases are used 
commercially both in sugarcane processing and for dental plaque removal. 
Commercial dextranases are produced by fermentation from either 
Penicillium sp. (Dextranase Novo 25L) or Chaetomium sp. (Dextranex). 
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Lipomvces starkeyi. an ascosporogenous yeast, also produces an 
endo dextranase. This yeast has been used in food related applications and 
is not known to produce antibiotics or toxic metabolites (143). Lipomvces 
dextranase has been demonstrated to be an effective agent for removing 
dextran during sugar processing (93). The dextranase from L starkevi 
ATCC 20825 has been purified and characterized (82, 94, 95). It is a 
glycoprotein and is composed of multiple isozymes. 
Except for a few bacterial dextranases (8, 12), microbial dextranases 
are inducible. Koenig and Day (94, 95) reported on a derepressed mutant of 
Lipomvces starkevi that showed elevated dextranase yields. However, they 
could not obtain derepressed and a constitutive dextranase producing 
mutant. 
VI. Electron microscopy of dextran 
The most thoroughly investigated dextrans are those produced by L 
mesenteroides and S. mutans. Because of their commercial importance 
there is voluminous literature devoted to the production and chemical 
structure of L. mesenteroides dextran. However, there are relatively few 
microscopic studies of this organism and / or of the dextrans it produces. 
Most dextrans studied with electron microscopy are insoluble 
dextrans. All electron microscopy studies used TEM. The exposure of L. 
mesenteroides to sucrose leads to the induction of dextransucrase and the 
initiation of dextran synthesis. These events are accompanied by dramatic 
morphological changes on the surface of the cell wall. These surface 
changes were demonstrated using ruthenium red (107) or reduced osmium 
tetroxide (2) during fixation. The cell wall of MRS (38) media-grown 
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mesenteroides B-512 cell is covered with a layer of material that often has 
the appearance of a mass of tangled filaments. When transferred to media 
containing sucrose, the surface coat (capsule) increases in thickness and 
undergoes internal reorganization. The result is a uniform layer of very fine 
filamentous material in which radically arranged rods are visible. In .L. 
mesenteroides NRRL 1118 grown on sucrose, the major visible component 
is a fibril (9 - 10 nm diameter), whose center is completely electron lucent but 
whose surface is covered with fine, electron dense material. Fibrils are seen 
solid but may be regarded as hollow tubules. These fibrils sometimes 
branch, are randomly oriented and are always associated with filamentous 
material. Although some capsules consist entirely of this fibrillar material, in 
most cases there is a clearly defined zone adjacent to the bacterium in 
which two other dextran components are visible. One of these is refered to 
as globular dextran since it takes the form of spherical aggregates (100 -
110 nm diameter) of tightly packed material. The axis of each globule is 
traversed by a fibril. The other dextran that can be distinguished appears as 
a tightly packed reticulum of filaments and may be regarded as a matrix in 
which the globular and fibrillar dextrans are embedded. 
VII. Mixed culture 
The science of microbiology has developed from the study of pure or 
monospecies culture. Microorganisms in natural environments exist, with 
very few exceptions, as complex, multispecies communities. Traditional 
microbial processes, such as food and beverage fermentations and waste 
treatment, are almost invariably the consequence of mixed microbial action. 
In some fermented foods, the essential microorganisms have been identified 
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and the biochemical transformations that they conduct have been described. 
In most mixed fermentation processes few studies have been conducted 
either at the microbial or the biochemical level (22, 172, 189). The number of 
defined, deliberately constituted mixed cultures deployed in the fermentation 
industry is small but include uses in such diverse areas as the treatment of 
xenobiotic-containing wastes (20, 166), single cell protein production (103), 
biotransformations (198) and food fermentations (40). The advantages of 
using mixed microbial fermentations over monoculture includes a greater 
range of substrate use, increased productivity, improved culture stability to 
adverse operating conditions, resistance to contamination, and a single step 
formation of complex products. Mixed cultures are resistant to contamination. 
In a well-balanced mixed culture, all the ecological niches are occupied; a 
contaminating organism has, therefore, to compete for scarce resources with 
already well-established organisms (160). Many useful products can be 
formed only in mixed culture (132, 133). Various terms are used to denote 
the different interactions, such as, competition, commensalism, mutualism, 
synergism, predation, amensalism, neutralism, symbiosis and parasitism 
(125). 
The demand for controlled size dextrans are increasing. However, the 
traditional process has not changed for over 40 years. This is a batch 
fermentation, acid hydrolysis followed by neutralization and repeated 
alcohol fractionation. This process is time consuming and tedious. In 
addition, yields and productivity are limited. We undertook to develop a new 
process for producing clinical (or controlled size) dextran that would be 
simple and have high productivity. A mixed culture fermentation utilizing 
Lipomvces starkevi and Leuconostoc mesenteroides was designed. L 
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starkevi produces a dextranase and L. mesenteroides produces the 
dextransucrase. By controlling the growth of both organisms and enzyme 
reaction conditions it was possible to control product size. In addition, 
productivity was increased. 
MATERIALS AND METHODS 
I. Organisms and growth conditions 
Lipomvces starkevi ATCC 74054 is a derepressed and dextranase 
constitutive mutant derived from Lipomvces starkevi ATCC 12659 by ethyl 
methane sulfonate mutagenesis. ATCC 12659 was maintained at room 
temperature on WW medium (94) containing 0.1 % yeast extract (WWY), 1% 
dextran as carbon source and 1.2 % agar, pH 4.5. WW salts had the 
following composition per gram per liter of tap water: (NH4)2SC>4, 5.0; 
KH2P04l 1.5; MgS04.7H20, 0.1; NaCI, 0.1; and CaCI2.2H20, 0.1. 
Lipomvces ATCC 74054 was maintained on slants at room temperature on 
LW medium containing 1 % (w/v) soluble starch as a carbon source and 0.5 
g/l (w/v) 2-deoxy-D-glucose. LW medium consists of 3 gram per liter of tap 
water of yeast extract; and 3 gram per liter of tap water of KH2P04- The pH 
of this media was adjusted to 4.5 with HCI. Cultures were transferred 
biweekly. Leuconostoc mesenteroides ATCC 10830 (NRRL B-512) is the 
normal organism for dextran production. Leuconostoc mesenteroides ATCC 
10830 was maintained at room temperature on All Purpose Broth (APT, 
Difco., Detroit, Ml) agar or LW medium containing 2 % (w/v) sucrose as a 
carbon source and pH was adjusted to pH 5.8 with HCI. It was transferred 
biweekly. 
II. Selection of ATCC 74054 
Cells of Lipomyces starkevi ATCC 12659 (approximately 5 x 108 
cells) were collected from slants (5 days old, grown on WWY containing 
dextran) and suspended in 6 ml of sterile sodium phosphate buffer, pH 7.0. 
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Then, 0.7 ml of the cell suspension was added to 3 ml of buffer, and 100 nl 
(1.17 g/ml) of ethyl methane sulfonate (EMS, Sigma Chemical Co.). The 
cells were exposed to EMS for 1.5 hours at 30°C. The treated cell 
suspension (0.2 ml) was then transferred to 8 ml of sterile 10 % sodium 
thiosulfate to quench the EMS. The treated cells were sedimented (x 10,400 
g), washed twice with sodium phosphate buffer and plated onto selection 
plates. 
Selection plates were bi-layer agar plates. The upper layer was 
composed of WWY with 1 % (w/v) agar, 0.05 % (w/v) 2-deoxy-D-glucose, 
and 1 % (w/v) carbon sources. The carbon source was sucrose, glucose, 
fructose or starch. The media was adjusted to pH 4.5 before sterilization. The 
bottom layer was composed of citrate phosphate (0.05 M) buffered blue-
dextran (0.1 %) with agar (1.5 %), pH 5.5. The colonies which formed clear 
zones (110) in the bottom layer were selected and transferred to fresh bi-
layered plates. Confirmation of dextranase constitutive activity was made by 
monitoring enzyme production in shaking flask cultures (WWY medium 
containing 1% starch, glucose, fructose, sucrose or maltose as carbon 
source). 
III. Enzyme production and purification 
Lipomvces starkevi ATCC 74054 dextranase was produced in 1.2 liter 
fermentation in a 2 liter Bio Flo II Batch / Continuous Fermentor (New 
Brunswick Scientific Co.) or in 20 liter batch cultures in a 24 liter Microferm 
Fermenter Model CMF 128S (New Brunswick Scientific Co.) on LW medium 
containing 1 or 2 % carbon sources. The pH was normally maintained at 4.0 
by the automatic addition of 3.0 N NaOH. The aeration rate was set normally 
at 1.0 wm (volume/volume/min), and temperature was maintained at 30 °C. 
The stirring rate for all fermentation was 100 rpm. Inocula were 1.5 % (v/v) 
cultures (shake flask) grown for 48 hrs in LW medium containing 1 % 
glucose or other carbon source. Growth was monitored by absorbance at 
660 nm. 
ATCC 74054 culture supernates were concentrated by ultrafiltration 
from 1.2 L to 50 ml with a 10 KDa cut-off stacked membrane (Diaflo, Amicon 
Co.). A Carboxymethyl-Sepharose column (75 cm x1.5 cm) was prepared 
and equilibrated with 0.02 M potassium phosphate buffer (pH 6.0). The 10 
KDa (kilodalton) concentrate, 1.5 ml (20 mg protein/ml), was applied to the 
column and then eluted with 0.5 M NaCI. The dextranase active fractions 
were pooled and then proteins were further fractionated on a BiO-RAD A-
0.5 m column (70 cm x 2.6 cm) which was prepared and equilibrated with 
0.05 M citrate phosphate buffer (pH 5.5). CM (carboxymethyl)-Sepharose 
concentrate (3 ml) fraction was applied to this column (4 mg protein/ml). The 
fractions with dextranase activity were pooled. This preparation was used for 
the characterization of the dextransucrases. 
Leuconostoc mesenteroides was grown in 1.2 liter batches in a 2 liter 
Bio Flo II Batch / Continuous Fermentor(New Brunswick Scientific Co.) with 
LW medium containing sucrose (1- 3 %). The pH was maintained at 5.8 by 
the addition of 3.0 N NaOH. The aeration rate was set to 0.5 wm, and the 
temperature was maintained at 28 °C. The stirring rate was 100 rpm. Inocula 
were 1 % (v/v) with cultures (shake flask) grown for 24 hrs in LW medium 
containing 1 % glucose or sucrose as carbon source. After removal of the 
cells by centrifugation (20 minutes, x 9,600 g), the extracellular 
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dextransucrase was purified by aqueous two-phase partition with PEG, Mr 
1500, as reported by Otts and Day (134). 
IV. Enzyme assays 
Dextranase activity was determined by incubating the enzyme for 20 
minutes at 50 °C with 2.0 % (wA/) Dextran T-2000 (Sigma Chemical Co.) in 
0.05 M citrate/phosphate buffer, pH 5.5. The level of enzyme activities were 
determined from the rate of increase in amounts of reducing sugars as 
measured by the 3, 5-dinitrosalicylic acid method (174) using a isomaltose 
standard. One unit of dextranase was defined as the amount of enzyme 
which liberates 1 nmole of isomaltose equivalents in one minute under the 
described conditions. Amylase was assayed by the same method except 
that 2 % soluble starch was substituted for the dextran as the enzyme 
substrate. 
Dextransucrase activity was determined from the rate of fructose 
production, detected by HPLC or by ion chromatography (Dionex 
carbohydrate analyzer, Dionex Co.). Dextransucrase reaction mixture was: 
sucrose, 150 mM; CaCi2, 1 mM; sodium acetate pH 5.2, 100 mM. 
Exogenous dextran was not added. One unit is defined as the amount of 
enzyme that catalyses the formation of 1 fimole of fructose per minute at 30 
°C and pH 5.2. For HPLC analysis, a Bio-Rad HPX-87N, 300 x 7.8 mm 
column, was used. The sugars were detected using a Waters 410 differential 
refractometer. The column eluent was 0.004 M sodium sulfate solution was 
used as eluent, pumped at 0.1 ml / min by a Waters chromatographic pump. 
Temperature of the column was maintained at 85 °C with a Waters TCM 
temperature controller. A 20 nl sample was injected either manually, or 
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automatically with a Waters 712 Wisp automatic system. The refractive index 
was recorded and chromatographic integration was by a Spectra - Physics 
SP 4270 integrator. Fructose was determined with a DIONEX carbohydrate 
analyzer (DIONEX Corporation). The column was a Carbopac PA 1, 4 x 250 
mm (DIONEX Corporation). NaOH 100 mM solution was used as eluent and 
pumped at 1.0 ml / min by a Gradient pump. A 50 fil sample was injected 
and signal was detected with a Pulsed Electrochemical Detector. Integration 
was done by a Dionex 4400 Integrator. Total carbohydrate was determined 
by phenol-sulfuric acid assay (41). 
Levansucrase activity was measured by the following the rate of 
reducing sugar produced from raffinose. The dextransucrase assay system 
as determined above was used, with the substitution of 150 mM raffinose for 
the sucrose. Reducing sugar was measured by the DNS (3,5 dinitrosalicylic 
acid) method. 
Protein was determined with a BIO-RAD protein assay kits as 
described by manufacturer (Bio-Rad Co.). 
V. Enzyme characterizations 
The pH optimum for dextranase was determined from reaction 
incubated at 50 °C for 15 minutes. The pH's of the substrate solutions 
ranged from 2.5 to 7.5. The pH of the reaction mixtures was examined both 
before and after incubation, and it was found not to change. 
The dextranase's temperature optimum for activity and stability was 
determined by incubating reactions at various temperatures and then 
measuring residual activity at the optimum temperature. 
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End products of the dextranase reaction were analyzed by using 
dextranase (100 IU) and 10 ml of 2 % dextran T-200Q (Sigma Chemical Co.) 
at 40 °C, pH 5.5. This reactions were complete after 24 hours. Samples 
were then filtered through a 0.22 |xm membrane and assayed by HPLC for 
oligosaccharide composition. The HPLC used was a Varian Vista 5500 with 
a refractive index detector. The column employed for separation was a 
Rainin NH2-Dynamax 60A. The HPLC conditions were: solvent-acetonitrile 
: water (50 : 50), column temperature 25 °C, flow rate 0.5 ml / min, column 
pressure 64 atm, with a 20 [aI sample injection. 
Thin layer chromatography was conducted on either Whatman K5 
0.25 mm silica gel plates, or on E. Merck plates (0.25 mm) of 1:1 silica gel 
60-Kieselguhr. Multiple ascents were made in one of the following solvent-
mixtures : A, 5:2:4:4 (v/v/v/v) n-propanol: nitromethane: acetonitrile: water, B, 
4: 1(v/v) acetonitrile: water and C, 3:1:1 (v/v/v) ethanol: nitroethane: water. 
Detection was with 20 % sulfuric acid in methanol, or with naphthoresorcinol 
sulfuric acid (mixture of equal volumes of 0.2 % naphthoresorcinol 
dissolved in ethanol and 30 % sulfuric acid), heated for 10 - 15 min at 100-
110 °C. D-Glucose, isomaltose, isomaltotriose (Sigma Chemical Co.) and 
isomaltooligosaccharides were used as standards. 
VI. Dextran size and quantity determination 
Dextran sizes and polydispersity indices were determined by 
measurement of multiangle light scattering intensities using a DAWN -
Photometer (Wyatt Technology, Ca). The DAWN GPC detector measures the 
scattering intensities of a sample at 15 discrete angles and transmits the 
data to a computer for digital conversion and subsequent processing under 
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control of the ASTRA™ (or ASTRA 202) software (Wyatt Technology, Ca). 
Cumulative dextran molecular weight distributions were obtained using an 
"Enhanced-analytical-software-inplementation" (EASI™) program (Wyatt 
Technology, Ca). Acetone and cyclohexane were used for instrumental 
calibration. Concentrations were obtained from a Waters model 410 
Differential Refractometer (Millipore Corporation, MA). Dextran sizes were 
based on the GPC calculation and the following external standards; T10, 
T40, T500, and T2000 (Pharmacia Co., Sweden) dextrans. Sample injection 
volumes were 100 \i\ and the GPC column was a Ultrahydrogel Linear 
column (Waters, Millipore Corporation, MA). The running buffer was 0. 1 M 
NaNC>3, and the temperature was 45 °C. 
The total sugar amount was assayed by the phenol - sulfuric acid 
assay (PS) (41). Glucose, fructose and T10 (average M.W. 10,000, 
Pharmacia,Uppsala, Sweden) were used as standards. Saccharimeter 
assays using a saccharimeter (Autopol IIS, Automatic Saccharimeter, 
Rudolph Research, Fairfield, New Jersey) were also used for dextran 
quantification. Dextran T 10, T 40, T 70, T 2000 (Pharmacia, Uppsala, 
Sweden) and T 150 (from Dr. Patel, Chemdex Inc., FL) were used as 
standards. Dry weights were determined by heating samples mixed with 
known amount of pre-determined sand to prevent caking by heating at 110 
°C to constant weight. 
VII. Dextranase addition effect on dextransucrase activity 
L. starkevi ATCC 74054 dextranase (0.1 lU/ml), partially purified, was 
added to dextransucrase preparations (0.32 lU/ml) containing 6 mg/ml of 
carbohydrate. This mixture was incubated for 5 hours or 2 days at room 
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temperature. Then the mixture was dialyzed (5,000 M.W. exclusion 
membrane) for 4 hours against total 12 liters of deionized water at 4 °C. 
Dextransucrase substrate was then added and it was incubated for 1 hour at 
30 °C. 
VIII. Optimization of mixed culture fermentation 
Unless otherwise specified the following conditions were used for all 
mixed culture fermentations : LW 3 media (which composition in the gram 
per liter of tap water is yeast extract; 8.5 and KH2PO4; 5) containing 0.003 % 
antifoam (Dow Corning antifoam 1410, 10 % active industrial defoamer, 
Dow Corning, Ml), pH 5.2, temperature, 28 °C, aeration; 1.0 vvm, agitation; 
100 rpm. Inocula were 1.5 % with ratios of L. mesenteroides to L. starkevi of 
3:1 (or 4 : 1). Sucrose concentration was 15 or 20 % (w/v). Sucrose was 
added by either a discontinuous addition or as a single addition at 
inoculation. Initial sucrose concentration for discontinuous addition was 3 % 
(w/v). 
a. pH - Shake flask cultures were used to screen pHs ranging from 
4.5 to 7.5. Then 1.2 liter fermentations were tested at pH's of 5.2, 5.4, 5.6 and 
6.4. Total dextran yields and clinical dextran yields were determined. Cell 
numbers were estimated using a Petroff-Hauser chamber. Doubling times 
were determined from log phase growth after final sucrose addition. 
b. Temperature - Three temperatures , 26 °C, 29°C, and 32°C, were 
examined by 1.2 L fermentation. 
c. Yeast extract - The effect of yeast extract concentrations ranging 
from 0.3 % to 0.9 %, to dextran production were examined in 1.2 L 
fermentations. 
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d. CaCl2 - CaCl2 effect on dextransucrase and dextranase production 
was examined. CaCfc (0.2 mM) was added to the culture medium before 
final sucrose addition (21 hrs). 
e. Sucrose concentrations - Effect of sucrose concentration (15 %, 20 
%, 25 % or 30 %-w/v) on dextran production and clinical dextran formation 
were studied. Discontinuous addition frequencies depend on the final 
sucrose concentration achieved. The frequencies are followed; 15 % 
sucrose fermentation - 3 %(w/v, at 0 hr) and 12 % sucrose between 12 and 
14 hrs post inoculation, 20 % sucrose fermentation - 3% (at 0 hr), 9 % 
(between 12 and 14 hrs) and 8 % sucrose at 21 hrs; 25 % sucrose 
fermentation - 3 % (at 0 hr), 9 % (between 12 and 14 hrs) and up to 13 % 
sucrose at 21 hrs, 30 % sucrose fermentation - 3 % (at 0 hr), 9 %(at 12 hrs), 
9 % (at 21 hrs) and 9 % sucrose at 29 hrs. A single addition was the addition 
of all the sucrose for the fermentation at inoculation. 
f. Cell number ratios - Different ratios of L. mesenteroides to L. 
starkevi (ranging from 1.4/1 to 48 / 1) in the inoculation were studied for 
their effects on dextran productions. These ratios were achieved by mixing 
different amounts of separate cultures containing a known number of cells to 
provide the mixed culture inoculum. 
IX. Viscosity comparisons of products 
Viscosity was measured with a Brookfield synchro-Lectric viscometer 
model LVT (Brookfield Engineering Lab., Massachusetts) using spindle 
(number 1). The unit was a centipoise (mPa.s). 
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X. Maltose and dextranase addition effects on Leuconostoc fermentations 
Maltose (3 % w/v) was added to Leuconostoc fermentations (sucrose 
12 %) and the dextran size distributions were examined. The maltose was 
added when the residual sucrose was 9 %. 
Dextranase (0.5 lU/ml) was added to Leuconostoc fermentation. The 
dextran size distributions were examined with time. Dextranase was added 
either when the residual sucrose was about 8 % or when all the sucrose had 
been consumed (after 36 hrs). 
XI. Exogenous dextran addition 
Large dextran (average 1.15 x 106) and low molecular weight 
(average 40,000) dextran (1 % - w/v) were added to Leuconostoc grown in 
13 % sucrose when 10 % residual sucrose remained. Dextran size 
distributions and dextransucrase activities were compared to matching 
cultures where exogenous dextran was not added in 15 % sucrose. 
XII. Dextran hydrolysis 
Comparative acid and enzymatic hydrolysis of dextrans produced by 
mixed cultures were conducted. Acid hydrolysis used 1 N HCI and 
enzymatic hydrolysis used ATCC 74054 dextranase. The hydrolysis was 
halted at time intervals and samples were chromatographed on Whatman 
K5 0.25 mm silica gel in solvent A; detection by 20 % sulfuric acid in 
methanol. Acid hydrolysis was 5 % polymer solutions incubated at various 
time in the 110°C oven and enzymatic hydrolysis used dextranase (0.5 
lU/ml) on 0.2 M buffered 3 % polymer solutions. Fermentation final sugar 
concent ra t ion  was  15  % in  case  o f  pure  cu l tu re ,  and  5  % mal tose  was  
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added to 10 % sucrose in case of maltose addition. In case of starch 
containing mixed culture, 3 % was starch and 12 % was sucrose. LW 3 
medium was used. Maltose and starch were added at second sucrose 
addition point. Panose, glucose, and isomaltooligosaccharides were used 
as standards. 
XIII. Dextran precipitation from cultures 
a. Leuconostoc fermentations - At the end of the fermentation 
isopropanol was added, up to 50 % (v/v, usually less than 50 %). After 
decantation the precipitate was dissolved with distilled water and re-
precipitated with isopropanol (50 %). It was then re-dissolved in distilled 
water and boiled it to remove residual solvent. The solution was filtered 
through a 0.45 urn pore size membrane. 
b. Mixed culture fermentation - After harvesting, the culture was 
centrifuged for 20 minutes (x 10,400 g)to remove the cells. Isopropanol was 
used to precipitate the dextran, the concentration depended on the dextran 
size and dextran concentration. Usually the isopropanol was added up to 67 
% (v/v). The precipitate was re-dissolved in distilled water (less than half 
volume of its initial volume) and re-precipitated. Re-dissolved with distilled 
water and boiled to remove solvent. The final dextran solution was filtered 
through a 0.45 urn pore size membrane. 
c. Salt effects on dextran precipitation - Varying amounts of KH2PO4 
and MgS04 were added to the dextran solutions before methanol, ethanol 
or isopropanol precipitations. Dextran solutions were T 2000 (10 % w/v -
Pharmacia, Uppsala, Sweden), industrial grade dextran (5 %, Sigma 
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Chemical Co.) and mixed culture dextran (10 %). The solvents were added 
67 % (or less). The salts concentrations ranged from 0 to 0.4 % (w/v). 
XIV. Residual dextranase activity in the dextran preparation 
Dextran solutions (10 %) were left for 4 days at room temperature and 
then examined by GPC. Dextranase inactivation (by acid) was conducted by 
dropping the pH to 1.7 with concentrated HCI and then incubating at room 
temperature for 1 hr. 
XV. Activated charcoal filtration 
Activated charcoal (Sigma Chemical Co.) was packed in a column 
(150 x 15 mm). Dextranase was mixed with 10 % dextran solutions (2.7 
lU/ml, 52 mg/ml of protein). The dextrans were T 40, T 500 or T 2000 
(Pharmacia,Uppsala, Sweden). The mixture was filtered through the 
activated charcoal column. Samples were also boiled for 5 minutes or 
acidified (pH 1.7) prior to filtration. Residual activity and protein 
concentration of the filtrate were determined. 
XVI. Electron microscopy of dextrans 
Each sample (5 or 10 ml) was loaded into a 13 mm syringe fitted with 
a polycarbonate filter of 0.2 urn pore size. Samples were made 2 % (v/v) with 
glutaraldehyde. The syringe contents were expressed and then 2 ml of 2 % 
glutaraldehyde in 0.1 M cacodylate buffer, pH 7.0 were added to the syringe. 
Total glutaraldehyde fixation time was about 30 minutes. 
The filter is washed with 0.1 M cacodylate buffer about 2 ml through 
the filter over a 15 minute. This was followed by 1 ml of 2 % OSO4 expressed 
over 25 minutes and then distilled water 2 ml over 5 minutes. Then 2 ml of 
0.5 % uranyl acetate was expressed over 20 minutes in the dark and 
washed with 1 ml distilled water over 20 minutes. The filter was then 
removed. 
Ruthenium red (RR) solution composed of 0.15 % (w/v) RR, 0.04 % 
glutaraldehyde, 0.04 % OSO4 and 0.002 M cacodylate buffer was used for 
staining. Then the above fixation procedure was followed. Specimens (yeast 
and/or bacterial culture broths) were dehydrated in successive 5 minutes 
steps with 50 %, 75 %, 87 %, 93 %, 95 % and absolute ethanol. For 
scanning electron microscopy (SEM) each specimen was coated with gold-
palladium in a hummer sputter coater (Technics). The microscopes used 
were either a Cambridge Stereoscan 260 SEM (Cambridge Instrument Co.) 
and a JOEL 100 CX SEM. 
R E S U L T S  
I. Studies on a constitutive dextranases mutant 
(1) Mutant isolation 
A Lipomvces mutant, ATCC 74054, constitutive for dextranase 
production was selected after EMS mutagenesis by zone clearing on blue 
dextran agar plates. The wild type, Lipomvces starkevi ATCC 12659, does 
not produce any clearing on blue dextran selection plates (Figure 3 - A). 
Dextranase activity was not detected under the parental colonies after 
colony removal. The wild type did not show any evidence of clearing blue 
dextran even after 5 days of incubation, however, the mutant (ATCC 74054) 
showed zone clearing after 2 days. The colony sizes of both strains were 
similar at the same time period. Dextranase production by ATCC 74054 on 
various carbon sources (dextran, soluble starch, sucrose and fructose) is 
shown in Figure 3 - B. Clearing was seen with all substrates. 
Dextranase production by ATCC 74054 in liquid culture was assayed 
in shake flasks and in 20 L fermentations cultures (Table 1). Lipomvces 
starkevi ATCC 74054 produced approximately equivalent amounts of 
dextranase when grown on glucose, fructose, maltose and sucrose. When 
grown on starch dextranase production was about 4 fold higher than when 
grown on sucrose. Different starches produced different amounts of 
dextranase, 0.045 lU/mg cells on Soluble Starch versus 0.057 lU/mg on 
Corn Starch. This strain produced more enzyme (0.139 lU/mg cells) than the 
parental strain (0.111 lU/mg cells) on 1 % dextran. 
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Figure 3. Phenotype of L. starkevi and a dextranase mutant on blue 
dextran agar plates. 
A) (1) Wild type (ATCC 12659) and (2) mutant ATCC 74054. 
Arrows indicate the spot where colonies were removed. 
B) ATCC 74054 grown on dextranase selection plates 
containing dextran (1), sucrose (2), starch (3) and fructose (4). 




Growth and dextranase production by Lipomvces 
Strain Carbon Cell Mass Dextranase 
Source (1 %-w/v) (mg/ml) (lU/mg cell) 
ATCC 12659 Starch (SF) 7.4 0.000 
Dextran (20 L) 31.4 0.111 
ATCC 74054 Starch (SF) 12.3 0.041 
Starch (20 L) 30.2 0.086 
Starch (2 %, SF) 17.6 0.045 
Corn Starch 
(2%,  SF)  19 .3  0 .057  
Glucose (SF) 10.1 0.010 
Fructose (SF) 9.5 0.010 
Maltose (SF) 8.0 0.008 
Sucrose (SF) 10.9 0.011 
Dextran (SF) 13.4 0.142 
Dextran (20 L) 29.6 0.139 
Cell mass; Cell dry weight, Carbon source concentration was 1 % (w/v) except indicated, 
Starch; Soluble Starch, SF; Shake flask cultures after 3 days (late-log phase), 20 L; 20 L 
fermentation after 4 days (stationary phase), Dextranase activity standard deviation (s.d.) for 
SF - < ± 0.002 and for 20 L < ± 0.001. 
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(2) Mutant characterization 
The ability of a Lipomvces to grow and produce dextranase in a 
media with sucrose, fructose, and high osmotic pressure is important for use 
in a Leuconostoc mixed culture system. Growth rates of ATCC 74054 on 
g lucose  and  f ruc tose  were  de te rmined  (F igure  4 ) .  ATCC 74054 showed 
similar specific growth rates (1.2164e-4 and 1.2143e-4 [d(mg cells)/dt] at log 
phase) on both glucose and fructose. The rate of disappearance of the sugar 
(glucose or fructose) was also similar (Figure 5). An ability of the Lipomvces 
to grow on fructose is important for mixed fermentations because 52 % of 
sucrose is fructose. In fact, the mutant showed no preference for one carbon 
source over the other as both disappeared from the medium at the same rate 
(Figure 5). Not surprisingly ATCC 74054 grew significantly faster on 15 % 
sucrose than on 30 % sucrose (Figure 6). After the bulk of the sucrose was 
consumed (120 hours) growth differences disappeared. 
(3) Dextranase characterization 
Dextranase production as a function of sucrose concentration is 
shown in Figure 7. Although the growth slowed as sucrose concentration 
increased, dextranase activity increased as sucrose concentration 
increased. At 30 % sucrose, after 148 hours, enzyme activity was 3.1 fold 
greater than on 7.5 % sucrose. 
The pH and temperature optima for ATCC 74054 dextranase are 
shown in Figures 8 and 9. Optimum pH and temperature for the dextranase 
produced on fructose, starch or dextran were the same, a pH optimum of 5.5 
and a temperature optimum of 55° C. The pH optimum was lower than the 




— 0.005  
V> 0 .004  
0 .003  
W 0.002 -
0 . 0 0 1  -
0.000  
O Glucose 
#  Fructose 
Tlme(hr) 
Figure 4. Growth of ATCC 74054 on glucose (open circle) and 
fructose (closed circle). 
LW medium, Initial pH; 4.5, Sugar concentrations; 1 % (wA/). 
Specific growth rate constants [d(mg cells) / dt] at the log 
phase are 1.2164e-4 and 1.2143e-4 on glucose and fructose, 
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Figure 5. Sugar consumption by ATCC 74054 on mixed carbon sources 
(1 % each). 
Open circle; Residual glucose per mg cells in the culture, 
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Figure 6. Growth of ATCC 74054 at various sucrose concentration. 
(A) Growth of ATCC 74054 at times on various sucrose 
concentrations (w/v). 
LW medium, pH 4.5, temperature, 30 °C, shake flask cultures. 
(B) Growth of ATCC 74054 at various sucrose concentration at 
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Figure 7. Dextranase production by ATCC 74054 at various sucrose 
concentrations. 
LW medium, Initial pH 4.5, temperature, 30 °C, shake flask 
culture, Dextranase activity; lU/mg cells, open circle is 
dextranase specific activity after 2 days or closed circle is 
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Figure 8. Optimum pH's for dextranases produced on different 
carbon sources (1 %, w/v). 
Relative activity is the % of dextranase activity at test pH to the 
activity at optimum pH (Medium; WWY). Relative dextranase 
activity on fructose (open circle), starch (closed circle) or 
dextran (open triangle) is shown. 
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Temperature (°C) 
Figure 9. Optimum temperature (°C) for dextranases produced on 
different carbon sources (1 %, w/v). 
Relative activity is the % of dextranase activity at test 
temperatures to activity at optimum temperature. Relative 
dextranase activity on fructose (open circle), starch (closed 
circle) or dextran (open triangle) is shown. 
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whereas the temperature optimum is the same as the parental strain 
enzyme. The temperature stability of the dextranases is shown in Figure 10. 
The dextranase produced on fructose showed higher thermal stability than 
that produced on starch or dextran. At 65 °C, dextranase produced on 
fructose retained 50 % of its original activity after 30 minutes incubation, 
however, the dextranases produced on starch or dextran contained less 
than 20 % of their original activity. It is probable that these dextranases, like 
the parental strain enzyme, are composed of multi-isozymes with different 
properties (82). 
This dextranase gave different end product profiles when produced 
on sucrose rather than dextran (Table 2). When produced by dextran grown 
cu l tu res  the  enzyme produced more  g lucose  and  less  
isomaltooligosaccharides from dextran than the equivalent enzyme 
prepared from sucrose grown cultures. A lower glucose formation is 
preferred for a mixed culture fermentation because isomaltose is a better 
acceptor for dextran production. Glucose is not a dextransucrase substrate 
but it acts to decrease dextran yields. 
(4) Amylase production 
Unlike the parental strain amylase was produced by ATCC 74054 
throughout the growth phase (Figure 11) on sucrose. The specific activities 
o f  bo th  amy lase  and  dex t ranase  were  h ighes t  a t  m id - log  phase  and  then  
decreased with time. Amylase was produced on dextran just as dextranase 
is produced on starch (Table 3). On sucrose ATCC 74054 produced 
amylase at a level about 15 % of the amylase produced on starch. On 































Figure 10. Temperature stability of dextranases produced on different 
carbon sources (1 %). 
Samples were incubated for 30 min at the test temperature. 
The relative activity is the activity remaining after incubation 
upon assay at 50 °C. Relative dextranase activity on fructose 




Hydrolysis products of ATCC 74054 dextranases 
Reaction End Products (%) 
Enzyme source Glucose Isomaltose Higher IMn* 
Sucrose DXase 11.9 62.1 26.0 
Dextran DXase 72.4 0.0 27.6 
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Figure 11. Growth (open circle), dextranase (open triangle), and amylase 
(closed triangle) production by ATCC 74054 on sucrose (2 %). 
LW medium, Initial pH 4.5, temperature, 30 °C, shake flask 
culture, Dextranase activity; lU/mg cells. 
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Table 3. 
Dextranase and amylase production by ATCC 74054 on sucrose, starch or 
dextran 
Carbon Source 



















Cell Mass; Cell dry weight, Samples were measured at maximum dextranase activity (sucrose; 
40 hours, starch and dextran; 72 hours), 1.2 L fermentations. 
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II. Dextransucrase 
(1) Growth and dextransucrase production by L. mesenteroides in 
high sucrose 
Growth and production of dextransucrase bv L. mesenteroides were 
examined (Figure 12) in 15 % and 30 % sucrose. 15 % sucrose is used 
commercially for dextran production, and 30 % sucrose where dextran yields 
are reported to decrease significantly (5). Dextransucrase enzyme 
production also followed exponential growth; its activity was highest in the 
late log phase. More dextransucrase activity was found in 30 % (1.18 lU/ml) 
than in 15 % (0.73 lU/ml) sucrose. Dextransucrase activity was also more 
stable when grown in a 30 % culture than in a 15 % culture. 
(2) Effect of dextranase on dextransucrase activity 
The effect of ATCC 74054 dextranase on dextransucrase activity was 
examined by adding dextranase (final activity of 0.1 Ill/ml) to partially 
purified dextransucrase preparations. The controls were samples containing 
only dextransucrase. After incubation (5 hours and 48 hours at room 
temperature) in the absence of substrate, preparations were analyzed for 
total carbohydrate and then dextransucrase activity was determined (Table 
4). Dextransucrase activity initially increased 2.6 fold upon dextranase 
treatment. This increase disappeared after 48 hours, and total carbohydrate 
decreased to 10 % of the control value. Control activity decreased after 48 
hours 78 % of its original. There was no detectable dextransucrase 
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D8«m (15 % - Ill/ml) 
D8aaa (30 % • ID/ml) 
Figure 12. Growth (circle) and extransucrase production (triangles) 
ot L. mesenteroides at 15 (open) and 30 % (closed) sucrose. 
Organisms were grown in LW 3 media with sucrose 15 or 30 % 
(wA/) as carbon source. DSase (dextransucrase) activity (lU/mg 
cells) was determined by measuring the fructose released from 
sucrose by the reaction. 
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Table 4. 









5 hrs 0.32 0.83 6.0 3.0 
(±0.02)** (±0.03) (±0.2) (±0.1) 
48 hrs 0.25 0.27 6.0 0.6 
(±0.02) (±0.02) (±0.2) (±0.1) 
Treated; Dextransucrase preparation added with dextranase, ** Standard deviation. 
I 
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III. Optimization of mixed culture fermentation 
A mixed culture fermentation system was designed to produce 
controlled size dextrans. This process requires the establishment of a 
microbial consortia of Lipomvces starkevi ATCC 74054 and Leuconostoc 
mesenteroides ATCC 10830 (Figure 13). By controlling growth and enzyme 
production of both organisms, product size can be controlled. Parameters, 
especially those which affect growth and enzyme activity, must be optimized 
to produce clinical size dextrans. For this process, both strains are initially 
grown independently on sucrose to prepare an inoculum and then mixed. 
Dextran fermentation is then allowed to proceed normally. At the desired 
time (and molecular size) the fermentation is harvested. 
(1) Media requirements - yeast extract and CaCl2 
Both total and clinical dextran yields depended on the concentration 
of yeast extract in the medium (Table 5). Differences were detected between 
pure and mixed cultures. For yeast extract concentrations between 0.3 % to 
0.9 %, L, mesenteroides pure cultures produced from 52 to 74 % of the 
theoretical yield of dextran (most of it was high molecular weight dextran). 
The highest yields were obtained with 0.9 % yeast extract. 100 % of the 
theoretical yield of dextran is about 48 % of sucrose used. The total dextran 
yields in mixed culture fermentations were comparable to pure culture. On 
0.9 % yeast extract media the dextran productivity (75.3 %) of mixed culture 
was similar to or higher than that of pure culture (73.6 %). Mixed culture 
fermentations also produced more dextran than pure culture on both 0.3 and 
0.75 % yeast extract media, respectively. L. mesenteroides cell numbers 
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Figure 13. Phase-contrast micrograph of mixed culture broth. 
Twenty one hours after co-inoculation showing mixed culture 
aggregation. Ruthenium red treated (x 1,050), bar = 10 jim. 
Table 5 
Effect of yeast extract on dextran yield 
Pure Culture Mixed Culture 
0.3 %1 0.75 % 0.9 % 0.3 % 0.75 % 0.9 % 
Total Dextran 
Yield (%) 51.8 66.1 73.6 70.4 71.9 75.3 
Clinical 
Dextran (%) NA NA NA 82.0 94.0 93.0 
Lm cell # 
(x107) 48 80 81 40 64 74 
Ls cell # 
(x107) NA NA NA 9.0 8.0 7.4 
DSase (lU/ml) 0.24 0.45 0.54 1.01 0.86 0.87 
DXase (lU/ml) NA NA NA 0.77 0.57 0.60 
Total dextran (%); Average total dextran % of theoretical yield, standard deviation; (±2.2) and (± 1.5) for pure and mixed culture, respectively, 
(average of GPC*, PS*, and Saccharimeter * assay - * GPC; Gel Permeation Chromatography, PS; Phenol-sulfuric acid assay), Clinical dextran 
%; In mixed culture fermentation, clinical dextran portion of the total dextran produced (±1.5),Lm #; L. mesenteroides cell number in pure and 
mixed culture fermentations (±0.05), DSase; Dextransucrase activity (Ill/ml) of pure and mixed culture fermentations (±0.02), Ls cell #; L 
starkevi number in mixed culture (±0.04), DXase; Dextranase (lU/ml) activity in the mixed culture fermentation (±0.02), 1; % - w/v, NA; Not 
appliable. 




were similar in mixed culture and in pure culture. However, dextransucrase 
activities were higher in mixed culture. L. starkevi cell numbers also did not 
show higher changes with changing yeast extract levels. Between 0.3 and 
0.75 % yeast extract, dextranase activity decreased slightly. At the 0.75 and 
0.9 % yeast extract, clinical dextran yields (%) were 94 and 93 % of 
theoretical, respectively. Despite high dextranase and dextransucrase 
activities with 0.3 % yeast extract, clinical dextran production was lower. It 
appears that dextran was degraded when dextranase levels were in excess 
over that necessary to produce acceptors. HPLC analysis showed an 
increase in the amount of small oligosaccharides in 0.3 % yeast extract 
mixed culture broths (83). A level of 0.85 % yeast extract was used in all 
further mixed culture fermentations. 
The production of dextransucrase by L. mesenteroides B-512(F) has 
been reported to be stimulated (about 2 fold) by the addition of CaCl2 (0.005 
%) (88, 159). The addition of up to 0.2 mM CaCl2 to the mixed culture 
fermentation medium (21 hrs post-inoculation) produced no increase in 
dextransucrase activity (after 26 hrs) (Table 6). Dextransucrase was more 
stable at the end of fermentation (after 38 hrs) in the presence of CaCl2. 
However, elevated dextransucrase activity is not a critical factor for the 
mixed culture fermentations because all the sucrose is consumed. In the 
absence of sucrose, dextransucrase will produce branched dextrans (126, 
159). It has been reported that Ca++ and other divalent metal ions can also 
act as branching factors (186). Toward the end of the mixed culture 
fermentation, dextranase is required for low molecular weight (LMW) dextran 
production. CaCl2 inhibits dextranase activity (Table 6, 93). 
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Table 6. 
Effect of CaCl2 on the production of dextransucrase and dextranase in 
mixed culture 
Time from DSase Activity 
























1. Dextransucrase activity, 2. Dextranase activity, 3. Without CaCl2 addition.Standard 
deviations; * ± 0.02; ** ± 0.03, ND • Not determined. 
(2) Effect of pH on the production of clinical dextran 
The effect of pH on the production of dextran and clinical dextran was 
examined in order to reconcile growth and reaction conditions for 
dextransucrase and dextranase. L. mesenteroides grows and produces 
dextransucrase best between pH 6.5 to 7.0 (51). L. starkevi grows well at pH 
4.5 or below (93). Dextransucrase is produced throughout the growth phase 
of L. mesenteroides (Figure 12) and ATCC 74054 dextranase is produced 
from mid - log phase to early stationary phase (Figure 11). Both enzymes 
have similar optimum pH's for activity and stability. The optimum pH for 
dextransucrase is 5.2 and for ATCC 74054 dextranase is 5.5. To maximize 
dextran production, growth and substrate consumption must be limited. The 
effects of pH controlling on dextran productivity are shown in Figure 14. At 
pH 5.4 the dextransucrase activity was highest (1.3 Ill/ml). A comparison 
dextransucrase activities in pure and mixed cultures at pH 5.6 showed the 
activity of dextransucrase in mixed culture was about 1.6 times higher. The 
higher dextransucrase activity is probably due to the small oligosaccharides 
produced by dextranase and/or by acceptor reactions. It was reported that 
maltose and small dextrans can act as acceptors removing dextran from 
enzyme active sites, increasing dextransucrase activity (138, 139, 152). 
Total dextran yield ranged between 74 to 80 % of theoretical (Figure 15). 
Theoretical yield is based on the total weight % of glucose available in 
sucrose that can be added to a dextran chains. It is 48 % of the weight of 
sucrose. At pH 5.4 the yield was the highest, 80 % of theoretical. Clinical 
dextran was 90 to 93 % of the total dextran over the pH range 5.2 to 5.6. The 
peak in LMW dextran corresponds to the peak pH activity range for both 
73 
1 . 4  n  
1 . 2  
1  . 0  
0 . 8  H  
0 . 6  
0 . 4  
0 . 2  H  
0 . 0  
"»D 
* 
0 . 7  
h o . 6  ™  
IS 
V 
- 0 . 5  r t  
<D 
i _  .  «  - 0 . 4  c  




• i • • i • • i * • i ' • i • • i • '  
4 . 4  4 . 6  4 . 8  5 . 0  5 . 2  5 . 4  5 . 6  5 . 8  
0 . 2  
PH 
Figure 14. Comparison of activity of dextransucrase (open circle) and 
dextranase (closed circle) at various pH's in mixed culture. 
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Figure 15. Effect of pH on dextran productivity. 
pH; ± 0.05, Total dextran (%) - Total dextran portion of 
theoretical yield (open triangle, s.d.; < ± 2.0), Clinical dextran % 
of total dextran produced were 93, 91, 90 and 78 % in pH 5.2, 
5.4, 5.6 and 6.4. HMW - High molecular dextran (open circle, > 
107 MW), LMW - Low molecular dextran (closed circle, clinical 
dextran) - dextran which size ranged 75,000 ± 25,000. 
% 
enzymes in mixed culture. Based on total clinical dextran yields, a pH range 
between 5.1 and 5.4 was selected for the mixed culture fermentations. 
(3) Effect of temperature on the production of clinical dextran 
Dextran yields were monitored as a function of growth temperature on 
15 % sucrose fermentations (Figure 16). The total dextran yield was the 
highest at 26 °C. The highest production of clinical dextran was at 29 °C, 
where 92 % of the total dextran was clinical dextran. The doubling time of L 
mesenteroides did not change between 26 and 29 °C (Table 7). However, 
the doubling time for L. starkevi decreased 48 % between 26 and 29 °C, 
then stabilized. It has been reported that at temperatures above 30°C, 
dextransucrase is inactivated (43, 85, 159). The dextransucrase activity was 
0.21 IU/108 cells (66 % of the activity at 26 ° C) at 32 °C. The mixed system 
may act to stabilize this enzyme because of the presence of dextran. The 
ATCC 74054 dextranase optimum temperature is near 55°C and it is very 
stable below 30°C (Figure 9 & 10). A temperature of 28 (± 0.5) °C was 
chosen as the optimum working temperature for the mixed fermentation 
process. 
(4) Sucrose concentrations 
Because of the high levels of sucrose required in this fermentation, 
the method of sucrose addition must be considered, i.e. discontinuous or 
single addition. Discontinuous addition is the addition of the carbon source 
in segments such that the total available carbon in the fermentor is always 
portion of the total. The relative advantages for discontinuous vs single 
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Figure 16. Effect of fermentation temperature on dextran yields. 
Temperature; ± 0.5°C, Total dextran % of theoretical yield; 
(open circle, ± 2.0), Clinical dextran % of total dextran 
produced; (closed circle, ± 1.5), Clinical dextran % of 
theoretical yield (open square). 
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Table 7. 
Temperature effect on the cell growth in mixed culture 
Growth Temperature 
26°C 29°C 32°C 
Doubling Time (hr) 
L. mesenteroides 9.3 9.6 12.8 
L. starkevi 28.8 14.7 13.5 
Specific activity of 
dextransucrase o.32 0.29 0.21 
* Dextransucrase specific activity (IU/10® L. mesenteroides cells) 
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Table 8. 





































Dextran (%) 94 79 94 73 
* Clinical dextran yield % of theoretical dextran production, 1.Standard deviation 
sucrose (Table 8). Based on total yield, a single addition was better than 
discontinuous additions for 15 % sucrose level. However, the clinical 
dextran portion was higher using discontinuous (94 %) rather than a single 
addition (79 %). At 15 % sucrose the clinical dextran yield was 68.2 % (w/w) 
for discontinuous addition versus 65.6 % (w/w) for single step addition. For 
30 % sucrose the total dextran yield by discontinuous addition was similar to 
that of a single addition, 85.6 % versus 84.5 %, respectively. The advantage 
of discontinuous addition is obvious for clinical dextran production. Clinical 
dextran yields were 80.5 % (w/w) for discontinuous and 61.7 % for a single 
addition. This correlated with the growth ratio of L. mesenteroides to L. 
starkevi. The growth ratios for discontinuous addition was about 51 /1 for 15 
% sucrose and 22 /1 for 30 % sucrose. The single addition showed about 
300 / 1 ratio for 15 % sucrose and as 100/1 for 30 % sucrose of JL. 
mesenteroides to L. starkevi. Balanced cell growth is necessary to obtain 
high yields of clinical dextran. The additional dextran obtained from the 
second 15 % sucrose on a 30 % fermentation was almost 100 % of 
theoretical yield. Little of the extra sucrose was used for cell growth. 
Discontinuous addition is favored if high levels of sucroses are used. Total 
and clinical dextran yields were independent of inoculum ratios of L^. 
mesenteroides / L. starkevi. as long as they were at least 1 : 1 (up to 48 : 1) 
(83 ) .  The  ce l l s  s tab i l i zed  a t  a  ra t i o  a round  25  :  1  a f te r  i n i t i a l  suc rose  
consumed. 
Dextran yield depend on the total amount of sucrose (Figure 17). As 
sucrose concentration increases from 15 to 30 %, the clinical dextran yield 
increases. With high levels of sucrose a small portion of the sucrose will be 
required for cell growth. Growth does not increase proportionally to the 
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Sucrose Concentration (%) 
Figure 17. Clinical dextran productivity as a function of sucrose 
concentration. 
Open circle; Clinical dextran % of theoretical, Closed circle; 
Specific productivity (gram of clinical dextran / 108 L 
mesenteroides and L starkevi cells). 
% 
sucrose increase (Figure 17). The specific productivity varied from 1.45 gram 
/108 cells to 3.80 gram /108 cells as sucrose varied from 15 to 30 %. 
When the initial sucrose is consumed, L. starkevi cell numbers are 
about 2 x 106 cfu / ml (Table 9), and L. mesenteroides cell numbers are 
about 4 x 107 cfu / ml. Final cell numbers in 15 % sucrose fermentation were 
7.9 x 108 cfu / ml Leuconostoc and 2 x 107 cfu / ml Lipomvces. As higher 
sucrose levels are used L. mesenteroides cell number retained about the 
same, however, some increase was seen in L. starkevi cell numbers. When 
growth stopped the cell number ratios of L. mesenteroides to starkevi 
ranged from 20 to 40. 
A comparison of dextransucrase activities at various sucrose 
concentrations is shown in Figure 18. The dextransucrase activities (lU/ml) 
were highest in 20 % sucrose fermentations. Dextransucrase activities at 25 
and 30 % were lower than the values at 15 and 20 %, however, the 
dextransucrase specific activity increased as sucrose concentration 
increased. 
IV. Mixed culture fermentation 
The proposed optimized mixed culture fermentation process is as 
follows. The first step is the the co-inoculation of L. starkevi ATCC 74054 and 
L. mesenteroides ATCC 10830 into the production vessel. L. starkevi ATCC 
74054 and L. mesenteroides ATCC 10830 seed cultures are grown 
separately on LW media containing 2 %(w/v) sucrose. The dextran polymers 
are not visible in the Leuconostoc culture at this stage except as viscous 
material which surrounds the cell (Figure 19). L. starkevi ATCC 74054 
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Table 9. 
Effect of the final sucrose concentration on final L. mesenteroides and L 
starkevi cell numbers 
Sucrose L. mesenteroides L. starkevi Lm#/Ls# 
(%)* cfu/ml (x 107) cfu/ml (x 107) Ratio 
3 4 0.2 20.0 
15 79 2.0 39.5 
20 71 2.1 33.8 
25 66 2.3 28.7 
30 64 3.0 21.3 
* Fermentation time (hours); 3 % - Initial sucrose, Samples were taken at the end of 
fermentations where 12.5, 32, 36, 49 and 52 hrs, respectively, Lm #; L. mesenteroides cell 
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Figure 18. Dextransucrase productivity as a function of sucrose 
concentration. 
Samples were taken at the end of the fermentation; for 15 and 
20 % - at 32 and 36 hours, for 25 and 30 % - at 49 and 52 
hours, Dextransucrase activity (open circle), Specific activity -
IU/108 cells (closed circle), Initial sucrose concentration was 3 
% in LW 3 medium. 
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Figure 19. SEM micrographs of L. mesenteroides ATCC 10830. 
(A) Grown in LW medium containing 2 % sucrose, ruthenium 
red treated (x 17,200), bar = 1 urn, (B) Grown in LW medium 
containing 10 % sucrose, ruthenium red treated (x 6,450), bar 
= 5 f-im. 
The specimen was coated with gold-palladium in the hummer 
sputter coater then it was viewed on the JOEL 100CX SEM (A) 
or on the Cambridge Stereoscan 260 SEM (B) at 15 KV. 
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shows no evidence of any polymer in the inoculum (Figure 20). The 
inoculation volume is 1.5 % (v/v) at a rate 0.3 % (v/v) L. mesenteroides to 1.2 
%(v/v) L. starkevi. The pH is controlled at 5.2, and the temperature is 
controlled at 28 °C. Aeration is required at 1.0 wm for L. starkevi growth and 
agitation is 100 rpm. 
For efficient enzyme production and control of dextran synthesis, 
discontinuous sucrose addition is favored. Based on final volumes for a 30 
% sucrose fermentation, the starting level of sucrose is 3 %(w/v). After 12 
hours 9.5 % of the sucrose is added and then after a further 9 hours, the 
remainder (16.5 % or 9.5 % and 7 % in batches) is added. The fermentation 
is then allowed to proceed to completion; between 20 and 40 hours after the 
final sucrose addition. After 12 hours from inoculation, the cell number ratio 
is 24 to 1 (L. mesenteroides to L. starkevi). The dextran size distribution 
changes with time are shown in Figure 21 and 22. Initially, medium size 
(M.W. 150,000 - 1,000,000) dextrans are produced. With increasing time, the 
amount of medium size dextran decreases and the amount of clinical 
dex t ran  i nc reases .  The  inc rease  o f  med ium s i ze  dex t rans  seen  a t  30  hou rs  
is a result of the sucrose addition at 21 hours. When 20 to 30 % sucrose is 
used to produce clinical dextran, the fermentation takes between 30 and 60 
hours to complete. Micrographs of the mixed culture at 21 hours are shown 
in Figure 23. The dextran polymers, except for some thread-like material, are 
not visible without specific staining. These thread-like materials may be high 
molecular weight dextrans (Figure 24). Many bud scars were visible on the 
L. starkevi indicating the growing state of the culture. With ruthenium red 
treatment dextran polymers were visible (Figure 23 B). Half of the dextran is 
clinical size dextran at this point (Figure 21 and 22). When the fermentation 
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Figure 20. SEM micrographs of L. starkeyi ATCC 74054 (grown in LW 
medium containing 2 % sucrose). 
(A) Without Ruthenium red treatment (x 13,000), bar = 1 nm, 
(B) Ruthenium red treated (x 9,650), bar = 1 ^m. 
The specimen was coated with gold-palladium in the hummer 
sputter coater then it was viewed on the JOEL 100CX SEM (A) 
or on the Cambridge Stereoscan 260 SEM (B) at 15 KV. 
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Figure 21. GPC chromatograms of dextrans from a 30 % sucrose mixed 
culture fermentation. 
(A) 12 hours, (B) 21 hours, (C) 50 hours. The solid line shows 
size of polymers and the broken lines show dextran 
concentrations. Intergration was done using a DAWN GPC 
detector. Size decreases with increasing volume. 
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Figure 22. Dextran distribution with time. 
Final sucrose concentration was 30 %, M.W. of LMW, MMW 
and HMW are less than 150,000, between 150, 000 and 106, 
and greater than 10®, respectively. 
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Figure 23. SEM micrographs of L. starkevi and L. mesenteroides in mixed 
culture. 
(A) Without Ruthenium red treatment (sample at 21 hours after 
inoculation), 1; Photographed at a magnification of 2,150 x, bar 
= 5 urn, 2; Photographed at a magnification of 7,820 x, bar = 1 
nm. No dextran visible except some thread-like materials. 
(B) Ruthenium red treated (samples at 21 hours after 
inoculation), Photographed at a magnification of 3,940 x, bar = 




Figure 24. SEM micrographs of pure and mixed culture. 
(A) Micrograph of L. mesenteroides grown on 4 % sucrose for 
24 hours, without Ruthenium red treated, Photographed at a 
magnification of 9,190 x, bar = 2 jim. 
(B) Micrograph of mixed culture grown on 26 % sucrose for 15 
hours, Ruthenium red treated, Photographed at a 
magnification of 4,490 x, bar = 4 urn. 
Arrows indicate the thread-like materials. 
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is stopped more than 90 % of the dextran was clinical size dextran (Figure 
25). Figure 26 shows the mixed culture sample at this point. Changes in 
glucose, fructose, leucrose, mannitol and higher oligosaccharides during 
fermentation are shown in Figure 27. At the end of fermentation remaining 
fructose was about 9 % (w/v), both leucrose and mannitol were 2 % (w/v) 
and glucose and higher oligosaccharides were less than 1 % (w/v). 
It was possible to distinguish between high molecular weight dextran 
and low molecular weight dextran using ruthenium red staining. Figure 19 B 
shows a Leuconostoc pure culture containing high molecular weight dextran 
(4 %). The dextran showed a net like structure. Most dextran had greater 
than 107 M.W. (Figure 25). In contrast, the dextran polymers seen in the 
mixed cultures were smooth (Figure 26). Although L. mesenteroides cells 
were surrounded by net like dextran in the mixed culture, the degree of net 
structure was less than in L. mesenteroides pure cultures. 
V. Product characterization 
(1) Viscosity comparisons of products 
Viscosity of the product varied depending on the dextran 
concentration and size distribution (Table 10). A standard T 40 solution has 
a lower viscosity than equivalent weights of industrial grade dextran (M.W. 
5,000,000 to 40,000,000, Sigma Chemical Co.) material. Clinical dextran 
(M.W. 20,000) has also a low viscosity. It has a 50 fold lower viscosity than 
high molecular weight dextran produced by L. mesenteroides pure culture. 
Because of lowered viscosities observed in mixed culture permit pH and 
temperature to be controlled more efficiently. The substrate distribution 
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Figure 25. Cumulative dextran molecular weight distributions. 
Molecular weight distributions were obtained using EASI 
program after processing GPC data with ASTRA ™ software. 
A; Mixed culture dextran, B; pure culture dextran. 
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Figure 26. SEM micrographs of L. starkevi and L. mesenteroides in mixed 
culture. 
Ruthenium red treated (samples at 50 hours after inoculation), 
(A) ;Photographed at a magnification of 1,250 x, bar = 20 jim, 
(B) ;Photographed at a magnification of 3,230 x, bar = 10 ^m. 
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Figure 27. Sugar changes during mixed culture fermentation. 
LW 3 medium containg 30 % sucrose was used. Open circle; 
glucose, closed circle; fructose, closed square; 




Viscosity comparisons of products 
Dextrans (5 % w/v) Viscosity (cps) 
Industrial grade dextran 48.7 
Dextran T 40 1.3 
Dextran T 500 2.6 
Mixed culture dextran 1.2 
L. mesenteroides culture dextran 58.5 
•Industrial grade dextran (Sigma Chemical Co., M.W. 5,000,000 to 40,000,000), T 40 K 
(Sigma Chemical Co., M.W. 35,600), T 500 K (Sigma Chemical Co., M.W. 507,000), Mixed 
culture fermentation dextran (M.W. 20,000), L. mesenteroides pure culture dextran (M.W. 
over 4 x 107), *" Viscosity; unit; Centipoise (mPa.s) 
103 
within the fermentor probably is also better. Moreover, higher sucrose 
concentrations (over 30 %) can be used giving higher yield. 
(2) A comparison of clinical dextran yield as a function of sucrose 
concentration in mixed culture 
Comparisons of the yields of dextran produced by mixed and pure 
cultures are shown in Table 11 for 15 and 30 % sucrose. Total yields were 
similar for both fermentations. At 15 % sucrose, pure culture produced 78 % 
of the theoretical dextran and mixed culture produced 74 %. At 30 % sucrose 
pure culture produced 72 % of theoretical and mixed culture produced 87 %. 
The average M.W. of dextrans from 15 % pure culture was 2.2 x 107. 
Production of clinical dextran by hydrolysis normally yields about 66 % of 
theoretical (based on 85 % clinical dextran recovery after acid hydrolysis 
and alcohol fractionation). The yield of clinical dextran for the mixed culture 
(15 %) was 68.8 %. With the 30 % sucrose fermentation the yield differences 
become apparent. Clinical dextran can be produced at 66 % and 61 % of 
theoretical yield from 15 and 30 % pure cultures, respectively (Dr. Patel, 
Chemdex Inc., FL, personal communication). The mixed culture (with 
discontinuous addition) yielded 84 % of theoretical. The average 
polydispersity index of the product of mixed fermentation was between 1.2 
and 1.5. Commercial clinical dextran has a polydispersity index of 1.5 to 2.0. 
VI. Mechanism of clinical dextran formation 
(1) Maltose and dextran addition 
Surprisingly, in the supernatants of mixed culture fermentations 
significant amounts of isomaltose, isomaltotriose and other small 
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Table 11. 
Dextran yields with pure and mixed culture 
Yield (% of theoretical) 
Type- Pure-15% Mixed-15% Pure - 30 % Mixed - 30 % 
Sucrose % 
Total Dextran 78 74 72 87 
Clinical 
Dextran appr. 66* 68.8 appr. 61* 84 
Mixed- Mixed fermentation with discontinuous sucrose addition, 3 % initial sucrose, Pure - L 
mesenteroides pure culture fermentation, 15 and 30 - sucrose concentration (%), Total 
dextran yield; % of theoretical - w/v (± 2.0), Clinical dextran yield; % of theoretical - w/v, * 
Expected value based on 85 % clinical dextran recovery after acid hydrolysis and alcohol 
fractionation, Yield was calculated by GPC assay. 
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isomaltooligosaccharides (or small dextran hydrolyzates) were not detected 
(Figure 28). In L. mesenteroides pure culture supernatants significant 
amounts of oligosaccharides in addition to fructose were detected. To test for 
isomaltose and isooligosaccharide incorporation into dextran, maltose (3 %-
w/v) was added to Leuconostoc fermentations (12 % sucrose) when the 
sucrose level was 9 %. It has been reported that maltose and isomaltose are 
good acceptors with similar efficiencies (32, 155). Molecular weight 
distributions after the addition of maltose are shown in Figure 29. Prior to the 
addition of maltose to the L. mesenteroides culture, high molecular weight 
dextran (molecular weight greater than 10 million) composed greater than 
90 % of the product. Most of the dextran was of molecular weight 1.3 x 107 
(Dextran A), however, there was a small second fraction of 4.3 x 106 
(Dextran B) (Table 12). After the addition of maltose, smaller size dextrans 
were detected in increasing amounts with time. The average molecular 
weight of each fraction decreased by 1/2 after 5 hours. A further 20 % 
decrease in molecular weight was observed in Dextran B in the next 5 
hours. Before the addition of maltose the mass ratio of large to small dextran 
was 16.2. After the addition of maltose the ratio decreased to 4.3 after 10 
hours. 
Dextransucrase specific activity decreased with time after the addition 
of maltose (Figure 30). However the activity 5 hours after the addition of 
maltose was higher than that observed in the control. After 10 hours, the 
dextransucrase levels were similar. It has been reported that maltose 
addition stimulates the dextransucrase activity over a short period by the 
removing of dextran from the active sites (138, 139, 152). 
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Figure 28. Thin layer chromatogram of supernatants from mixed culture 
and pure culture fermentations. 
Supernatants of mixed culture (20 % sucrose) (A) and pure 
culture (20 % sucrose) (B) were loaded on Thin-Layer 
chromatogram on Whatman K5 0.25 mm silica gel in solvent C; 
detection by 20 % sulfuric acid in methanol; Mixed Culture 
Supernatants, G; Glucose, F; Fructose, S; Sucrose, P; Panose, 
IMn; Isomaltooligosaccharides, 1,2,3; supernatant at 12, 15 
and 21 hrs, respectively, 4,5,6; supernatants at 28, 32, and 40 
hrs, respectively ; Leuconostoc mesenteroides Culture 
Supernatants, 5-7; Dilution of 2 - 4 supernatants at 24, 32, 
and 40 hrs, respectively. 
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Figure 29. Cumulative dextran molecular weight distribution after the 
addition of maltose. Molecular weight distributions were 
obtained using EASI program after processing GPC data with 
ASTRA™ software. 
12 % sucrose L. mesenteroides pure culture in LW medium, 
(A) Before the addition of maltose (3 %), (B) 5 hours after the 
addition of maltose, (C) 10 hours after the addition of maltose. 
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Table 12. 
Effect of maltose addition on dextran size distribution 





% (w/v) M.W.* 
(x 106) 
% (w/v) M.W.* 
(x 106) 















* M.W. ; (x 106, < ± 2x 105), Time; Time passed after the addition of maltose, Dextran A; 
Dextran of M.W.> 107, Dextran B; Dextran of M.W. <107, Control; L. mesenteroides pure 
culture on 15 % sucrose, 0; Before the addition of maltose, 5; After 5 hours from maltose 
addition, 10; After 10 hours from the addition of maltose (3 %), At 0 hour and control, there 
were two fractions, dextran A and Dextran B. At 5 and 10 hours, there was only one fraction, 
Dextran A, in control. 
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Figure 30. Effect of maltose addition on dextransucrase activity in the 
L. mesenteroides pure culture. 
Dextransucrase activity (lU/mg L. mesenteroides). 0; Before the 
addition of maltose, 5; After 5 hours from maltose addition, 10; 
After 10 hours from the addition of maltose, open circle; 
dextransucrase activity after maltose addition, closed triangle; 
dextransucrase activity of control pure culture. 
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Isomaltose is an end product of dextranase action. Maltose mimics 
the action of isomaltose. To test the possible maltose incorporation into 
dextran, two sets of cultures were prepared. A Leuconostoc pure culture 
fermentation containing various maltose concentrations in addition to 
sucrose and a mixed culture containing starch in addition to sucrose. Starch 
was used in mixed culture because the L. starkevi will produce amylase, 
producing maltose, rather than utilizing maltose for growth (Table 3). The 
molecular weight of the dextran from maltose containing pure culture 
fermentations was 4,000. The molecular weight of dextran from starch 
containing mixed culture was about 40,000. Acid and dextranase 
hydrolyzates of the dextrans are shown in Figure 31. Panose (a-D-Glc(1-6)-
a-D-Glu(1-4)-D-Glu) is seen in hydrolysates from both fermentations as well 
a s  i s o m a l t o s e  a n d  i s o m a l t o o l i g o s a c c h a r i d e s .  M a l t o s e  a n d  
maltooligosaccharides were incorporated in dextran from the starch 
containing mixed culture fermentations because ATCC 74054 produces 
amylase. Amylase hydrolysates were incorporated into the dextran. 
Therefore it is probable that dextran hydrolysates, isomaltose or 
isomaltooligosaccharides, may also be incorporated into the dextran in 
mixed culture acting as acceptors for clinical dextran. This would explain the 
absence of small isomaltooligosaccharides in the mixed culture 
supernatants. 
Exogenous dextran (larger or low molecular weight dextran) was 
added to L. mesenteroides fermentations and dextransucrase activities were 
compared (Table 13). The addition of larger size dextran (1.15 x 106 M.W., 
LD) to the fermentation decreased growth of Leuconostoc. Dextransucrase 
activity doubled upon addition of LD dextran. The change in molecular 
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Figure 31. Acid and enzyme hydrolysates of dextrans (or polymers). 
Acid and enzyme hydrolysates of dextrans (or polymers) from 
maltose containing L. mesenteroides pure culture (A) and 
starch containing mixed culture (B). Thin layer chromatogram 
on Whatman K5 0.25 mm silica gel in solution A; detection by 
20 % sulfuric acid in methanol, G; Glucose, P; Panose, IM2; 
Isomaltose, M2; Maltose, M3; Maltotriose and IMn; 
Isomaltooligosaccharides, (A)Partial acid hydrolysis of dextran 
produced by Leuconostoc mesenteroides on maltose (5%) and 
sucrose(10%) 1 - 5; Acid partial hydrolysis; 20, 30, 40, 60 and 
90 min, respectively, 6-10; Dextranase partial hydrolysis using 
ATCC 74054 dextranase (0.5 lU/ml); 30, 45, 60, 90 and 120 
min, respectively, (B) Acid and dextranase partial hydrolysis of 
dextran from mixed culture on soluble starch(3%) and 
sucrose(12%)1 - 4; Acid partial hydrolysis; 30, 40, 60 and 90 
min, respectively, 5 - 8; Dextranase partial hydrolysis using 
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Table 13. 















* Cell mass : cell dry weight - mg/ml, < ± 0.1, ** Dextransucrase : lU/mg at the end of 
termentation (about 24 hours from start), < ± 0.01, *** Control; L. mesenteroides pure culture 
on 15 % sucrose, LD; Larger size dextran (average 1.15 x 106). LMW ; Low molecular weight 
(average M.W. of 40,000), Dextran was added after 12 hours from start. 
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weight distributions after the addition of dextran is shown in Figure 32. After 
the addition of LD dextran, the molecular weight distribution shifted toward 
smaller sized dextrans. Without the addition of exogenous LD dextran, the 
dextran size distribution was typical of a L. mesenteroides pure culture. After 
the addition of exogenous dextran, the product size distribution shifted 
toward smaller size dextrans, emphasizing the need for acceptors for 
controlling dextran size. 
(2) Effect of dextranase on dextran size in L. mesenteroides pure 
culture 
The effect of the dextranase addition to L. mesenteroides pure culture 
was also examined. ATCC 74054 dextranase (0.5 lU/ml) was added to a 
Leuconostoc fermentation and dextran size was monitered with time (Table 
14). Two hours after the addition of dextranase, the average molecular 
weight of the larger fraction was essentially unchanged. However, as with 
dextranase addition, size decreased significantly compared to the control. 
The average molecular weight of the smaller fraction decreased from 1.3 x 
106 to 0.8 x 106 after 20 hours. The mass ratio of larger fraction to smaller 
fraction changed from 14.9 to 0.36 after 20 hours. 
The dextransucrase activity increased from 1.18 to 1.42 (lU/mg) after 
two hours, but after 20 hours, dextransucrase activity decreased to 0.08 
lU/mg cells (Figure 33). The dextransucrase activity increase (2 hours post 
dextranase addition) may be caused by dextranase removal of the dextran 
from the dextransucrase active sites (138, 139, 152). The control value for 
dextransucrase, 20 hours post dextranase addition, was 0.09 lU/mg. 
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Figure 32. Cumulative dextran molecular weight distributions after the 
addition of exogenous dextrans. 
Molecular weight distributions were obtained using EASI 
program after processing GPC data with ASTRA™ software. 
Comparison among LD (1.15 x 106 m.W. dextran 1 %-w/v), 
LMW dextran additions (M.W. 40,000 dextran, 1 %) and without 
(N) addition of exogenous dextran. 
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Table 14. 
Effect of dextranase addition on L. mesenteroides pure culture 





% (w/v) M.W.* 
(x 106) 
% (w/v) M.W.* 
(x 106) 















* M.W. ; (x 10®, < ± 2x 105), Time; Time passed after the addition of maltose, Dextran A; 
Dextran of M.W.> 107, Dextran B; Dextran of M.W. <107, Control; L. mesenteroides pure 
culture on 15 % sucrose, 0; Before the addition of dextranase (18 hours from fermentation 




























Figure 33. Effect of dextranase addition on dextransucrase activity in 
theL. mesenteroides pure culture. 
Dextransucrase activity (lU/mg L. mesenteroides). 0; Before the 
addition of dextranase (18 hours from fermentation start), 2; 
After 2 hours from dextranase addition, 20; After 20 hours from 
the addition of dextranase, open circle; dextransucrase activity 
after dextranasee addition, closed triangle; dextransucrase 
activity of control pure culture. 
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At the end of pure culture fermentations (20 % sucrose) dextranase 
was added and changes in dextran polymer size and amounts were 
examined (Figure 34). Before the addition of dextranase, dextran size was 
greater than 10 million M.W. and the yields were 76 % of theoretical. After 
the addition of dextranase, both dextran size and amounts changed. The 10 
million size dextran was degraded to smaller dextrans. After 4 hours, the 
amount of isopropanol (67 %-v/v) precipitable dextran had decreased to 
23.3 % of theoretical or 30.6 % of original dextran in the culture. After 6 
hours, the differences due to dextranase addition was even clearer, 8.8 % of 
the theoretical yield of dextran was precipitated, or 11.6 % of the initial 
dextran was recovered. Although the dextran size decreased, no significant 
amount of clinical dextran was produced. Dextranase addition during 
fermentations, which had residual sucrose (8 %), resulted in different 
dextran sizes and amounts (Figure 35). The high molecular size dextran 
portion did not change. Clinical dextran was produced, and it consisted of 
about 23 % of the total precipitable dextran. The total precipitable dextran 
was 27.6 % of theoretical. This compares to the 8.8 % for total dextran yield 
when sucrose was absent. When sucrose was present, only a small amount 
of isomaltooligosaccharide was detected. When a sucrose was depleted, the 
amount of isomaltooligosaccharides increased sharply (Figure 36). In the 
presence of sucrose, isomaltose and isomaltooligosaccharides can act as 
acceptors for smaller size dextrans. When the sucrose is absence, the 
concentration of isomaltooligosaccharides increases due to dextran 
cleavage. 
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Figure 34. Effect of dexranase addition on fermentations containing 
no residual sucrose. 
Time (hr); Time passed after the addition of dextranase (0.3 
lU/ml), 0; 36 hours from fermentation start, Distribution (%) of 
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Figure 35. Effect of dextranase addition on fermentations containing 
residual sucrose. 
Time (hr); Time passed after the addition of dextranse (0.3 
lU/ml), 0; 21 hours from fermentation start - 8 % residual 
sucrose, 20 hours is similar period of fermentation at 6 hours 
of Figure 34, at this time most sucrose has been used, 
Values are the istribution (%) of the total dextran, LW 3 
medium, pH 5.2 control, temperature 30 °C control. 
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Tlme(hr) 
Figure 36. Change in amount of sucrose and isomaltooiigosacharide with 
time. 
Open circle is residual sucrose % (w/v) and closed circle is 
isomalto oligosaccharide % (w/v) in culture. LW 3 medium, pH 
5.2 control, temperature 30 °C control 
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VII. Product recovery 
(1) Alcohol precipitation 
Dextran is fractionated commercially by alcohol precipitation with 
either ethanol or isopropanol. Dextran precipitation efficiency with 
isopropanol is related to dextran size (Figure 37). High molecular weight 
dextran precipitates at low concentrations of isopropanol. Above 106 M.W. 
dextrans from mixed cultures precipitate with 40 % (v/v) isopropanol. 
Smaller size dextrans require up to 67 % (v/v) isopropanol. With 60 % 
isopropanol most dextran greater than 104 precipitates. High and low 
molecular weight dextrans can be separated by alcohol fractionation. 
The size distributions of precipitated dextrans by isopropanol and 
ethanol (95 %) are shown in Table 15. An increase in ethanol concentration 
(from 40 % to 55 % - v/v) resulted in increased precipitation of dextrans of 
the size range 5 x "lO^o 105. When ethanol concentration is increased to 67 
% (v/v), dextrans smaller than 104 M.W. precipitated. An increase in 
isopropanol concentration from 40 to 55 % increased the precipitation of 
dextran of sizes 10^0 5 x 104. Isopropanol (67 %) precipitated smaller size 
(less than 104 M.W.) dextrans. The amount of dextran precipitated at 
different alcohol concentrations were comparable for both alcohols. At the 
same concentration isopropanol was more efficient than ethanol in total and 
clinical dextran recovery. 
(2) Salt effects on solvent precipitation 
The addition of KH2PO4 and/or MgS04 to the samples increased the 
recovery of dextran on alcohol precipitation (Table 16). At 67 % ethanol, 
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Figure 37. The precipitation pattern of mixed culture dextrans by 
isopropanol. 
Dextran precipitation with various concentrations of 
isopropanol, ** M.W. of 20 % of sample dextran was 10,000, 
70 % was 30,000 and 10 % was greater than 5 x 106. y - axis is 
the cumulative % of dextran recovered. 
125 
Table 15. 
Comparison of dextran recoveries by ethanol or isopropanol precipitation 
Size of Product 
Alcohol Recovery >5 x 10£ > 105- > 5 x 104 > 1Ql > 5 x 103. 
(%-v/v) (%V 
Ethanol 
40 8 10" 8 8 72 0 
55 51 6 6 16 72 0 
67 80 6 2 2 52 38 
Isopropanol 
40 14 7 5 10 78 0 
55 63 7 5 4 84 0 
67 83 4 5 3 24 64 
' Total Recovery (%); (Precipitated dextran amount/ Original dextran amount) x 100, *' % of 
Total Recovered; Data were re-organized from GPC and EASI analyses, and data are % of 




Effect of salts on dextran precipitation by ethanol 
Relative Recovery of Dextran (%) 
Dextran* A B C D E 
I 94.1 96.8 100" 97.2 92.5 
II 95.9 97 98.9 100 94.6 
III 92.7 97.6 100 99.7 89.2 
*l - Industrial grade dextran (Sigma Chemical Co.): 5%, II - T 2000 (Pharmacia Co.): 10 %, III -
Mixed culture fermentation sample (approximate M.W. - 40,000) : 10 %, Solvent - 95% 
ethanol, final solvent concentration was about 67%, ** 100 % means the highest recovery of 
each dextran sample , Those values were obtained by saccarimeter, A; 0.4 % KH2PO4 and 
0.05 % MgS04l B; 0.4 % KH2P04 and 0.1 % MgS04l C; 0.4 % KH2P04 and 0.15 % 
MgS04, D; 0.4 % KH2P04 and 0.18 % MgS04l and E;Control - No salt addition. 
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salts are not precipitated. At the equivalent ethanol concentration, salt 
containing sample precipitated better than controls. An examination of the 
effect of salt concentrations on isopropanol, ethanol and methanol 
precipitation are shown in Table 17. With methanol, 77 % of the dextran was 
recovered without salt addition. Recovery increased upon the addition of 
KH2PO4. Ethanol precipitation produced greater recovery of dextran upon 
the addition of KH2PO4 and MgS04. Isopropanol recovery was better than 
methanol without or with MgSCU. 
It is reported that neutral hydrolysates of a 5 % commercial dextran 
solution contain approximately 2 % sodium chloride (200). The effect of the 
addition of NaCI and MgSC>4 upon dextran recovery are compared in Table 
18. MgSC>4 addition increased recovery about 2 % with isopropanol 
precipitation over NaCI addition. Since acid hydrolysis and neutralization 
steps are not required for mixed culture fermentation, the addition of salt can 
be considered to increase dextran recovery (i.e. 0.36 % MgSC>4 in case of 
isopropanol precipitation). 
VIII. Protein (residual dextranase) removal 
Dextran samples from mixed culture fermentations contain less than 2 
ng per ml protein in 10 % dextran solutions. However, residual dextranase 
activity was present in the samples. A 10 % dextran solution (dextran was 
vacuum dried at 30 °C) kept at room temperature 4 days showed 
degradation (Table 19). Without acid treatment, after 4 days of incubation, 
dextran size decreased. However, by dropping the pH to 1.7 with acid, 
changes in dextran size were stopped. Since during industrial production, 
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Table 17. 
Effect of salts on dextran precipitation by methanol, ethanol or isopropanol 
% Recovery* 
Salt Ratio Isopropanol Ethanol Methanol 
A 83 85 85 
B 88 87 82 
C 83 91 84 
D 83 85 77 
* % recovery; Recovered dextran (%) of original dextran, ** Ethanol - 200 proofs, The values 
were % of initial dextran concentration and were measured by Saccharimeter and, Dextran 
used is T40 (Pharmacia, Sweden) : 5 % solution, pH 5.6, Solvent concentration was 53 %, 
Data were obtained after twice solvent precipitation of T40 dextran. A; 0.36 % KH2PO4, B; 
0.36 % MgS04, C; 0.18 % KH2PO4 and 0.18 % MgS04, D;Control - No salt addition. 
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Table 18. 
Effect of NaCI or MgS04 addition on dextran recovery 
Salt (% - w/v) Recovery (% of original dextran) 
NaCI (1 %) 86 (± 0.2) 
NaCI (2 %) 86 (± 0.3) 
MgS04 (0.36 %) 88 (± 0.3) 
* Control dextran sample was 5 % T150 (average M.W. of 150,000; kindly supplied by Dr. 




Effect of residual dextranase activity on dextran prepared from mixed culture 
HCI addition (pH 1.7) 
No HCI addition (pH 5.5) 
Mass Ratio 
(Control1 fT reatment2) 
1.0 
1.0 




1. Control - The amount of dextran before incubation at 30°C, 2. Treatment (T) - The amount 
of dextran after incubation at 30°C for 4 days, 3. Clinical Dextran - Low molecular weight 
dextran in sample (average M.W. of 32,000). 
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dextran solutions are heated to remove solvent, dextranase should be 
inactivated during practical process. 
Commercial practice uses activated charcoal to remove color from 
dextran solutions (Dr. Patel, personal communication). To determine 
whether the residual dextranase (protein) can be removed by activated 
charcoal, a 10 % (w/v) dextran solution of average M.W. 500,000 was mixed 
with crude ATCC 74054 dextranase and filtered through an activated 
charcoal column (150 x 15 mm). The column removed 31.5 % (16.3 mg/ml) 
of protein (Table 20). A heated sample was also filtered through this column. 
The removal of protein from this sample was lower; 26.1 % (13.6 mg/ml). 
After acid treatment removal increased to 71.4 % (37.1 mg/ml). It is possible 
that pH changes the protein charges and improves its binding to activated 
charcoal. A filtered dextran sample, without heat inactivation, was found to 
undergo no change in size after 7 days. 
It is known that dextranase binds to different size dextrans with 
different affinities (93). The ability of the activated charcoal to remove 
dextranase was dependent on the size of the dextran in mixed with the 
protein. Only 16.4 % mixed with T2000 was removed, whereas 36.5 % of the 
protein mixed with T40 dextran was removed. Since mixed culture broth 
contains smaller size dextran, the residual protein (or dextranase) probably 
can be easily removed. 
IX. Identification of HMW dextran present in mixed fermentations 
A small proportion of high molecular weight polymer is always found 
in the mixed culture process. To eliminate the possibility that this material is 
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Table 20. 




Heat inactived sample 
Acid inactived sample 









Active T2000 sample 
Active T 500 sample 






* Preparations of dextran and dextranase mixture with various treatments, ** Enzyme - ATCC 
74054 Dextranase concentrate from sucrose grown (520 mg/ml & 27 lU/ml), Active sample; 
dextran T500 (10 %) solution containing ATCC 74054 dextranase (final 52mg/ml) and filtered 
through activated charchol column, Remained and removed protein (%) - protein % remained 
and removed after Alteration with activated charchol, Heat - Boiling for 5 min, Acid - Addition of 
HCI to pH 1.7, 100 % means 52 mg/ml protein, T2000, T500 and T40; Dextrans M.W. of 
2,000,000, 500,000 and 40,000, respectively, Active T2000 sample was active sample 
containing T2000 (10 %) instead of T500. 
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a polymer other than dextran, its composition was determined. Polymer was 
acid hydrolyzed and analyzed (Table 21). The acid hydrolyzate contained 
only glucose. The polymer was also treated with ATCC 74054 dextranase 
concentrate (0.5 lU/ml). After hydrolysis 5.8 % of sample was unhydrolyzed. 
This unhydrolyzed remaining material may consist of non a 1,6 linked 
dextrans that are resistant to ATCC 74054 dextranase (endo-type). It has 
been reported that L. mesenteroides NRRL B-512 produces 94 - 95 % a 1,6 
linked dextran and 5 - 6 % a 1,3 linked dextrans, which is endo dextranase 
resistant (187). 
1 3 4  
Table 21. 























Control dextran was prepared using 20 % sucrose, Acid hydrolysis was done tor 4 hours at 
110 °C and enzyme hydrolysis was done with 0.5 Ill/ml ATCC 74054 dextranases for 2 days at 
room temperature. 
DISCUSSION 
Low molecular weight dextrans have their largest application in the 
pharmaceutical industry. Commercially, dextran is produced from sucrose 
fermentations by Leuconostoc mesenteroides ATCC 10830. The bacteria 
are grown in a medium containing 15 % (w/v) sucrose along with other 
required nutrients. Native dextran has a molecular mass of about 5 x 108 
daltons. This size is unsuitable as a blood plasma substitute. Relatively low 
molecular weight dextrans (a few hundred to a million) are produced by 
controlled acid hydrolysis of native dextran, followed by organic solvent 
fractionation. The process has drawbacks. It requires multi-steps, i.e. alcohol 
precipitation, acid hydrolysis, cooling, and neutralization. The yields are 
relatively low due to losses during repeated fractionation and the inherent 
viscosity of the fermentation because of the high levels of large polymers. A 
new fermentation process was developed to overcome these limitations in 
the production of clinical dextran. It involves use of a mixed culture 
fermentation with a dextranase producing strain (Lipomvces starkevi) and a 
dextransucrase producing strain (Leuconostoc mesenteroides). 
The requirement of this process for the L. starkevi is an ability to 
produce dextranase in the presence of fructose, which exists in high 
concentrations in dextran fermentation broths. The organism of choice is a 
mutant of L. starkevi ATCC 12659, an ascosporogenous yeast, which has 
been used in food related applications and produces dextranase (82, 93). It 
was selected after chemical mutagenesis (ethyl methane sulfonate) on 
double layered plates containing blue dextran as a dextranase indicator. 
The selected mutant, L. starkevi ATCC 74054, produces dextranase on all 
carbon sources. Its specific dextranase productivity on dextran, 0.14 lU/mg 
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cell, is as good or better than the dextranase productivity of the parental 
type, 0.11 lU/mg cell. It produces dextranase on glucose, sucrose and/or 
fructose. On soluble starch, ATCC 74054 produces 4 fold more dextranase 
than on maltose, sucrose, glucose or fructose. It produces greater than 60 % 
of the amount of enzyme produced on dextran. Different starches (soluble 
starch vs corn starch) gave different dextranase productivities. The parental 
strain does not produce dextranase when grown on starch. Dextranase 
production in Lipomvces is an example of a repressible - inducible system 
(99). However, ATCC 74054 is not only a derepressed but also a constitutive 
mutant for dextranase production. It is possible that repression by glucose, 
and dextranase inducibility in Lipomyces is controlled by different 
mechanisms. Some Saccharomvces cerevisiae mutants produce maltase, 
invertase, and/or galactokinase constitutively on galactose (6, 7, 201) or 
raffinose (47, 48, 65, 201) in the presence of 2-deoxy-D-glucose. This 
situation may be similar for Lipomyces. 
Dextranase (group of dextranase isozyme) from ATCC 74054 has a 
pH optimum of 5.5 and a temperature optimum of 55 °C. The optimum pH 
value is lower than that of the dextranase from the parental strain, pH 6.5. 
The thermal stability of the enzyme depended on the carbon source on 
which it was produced. Dextranase produced by ATCC 74054 on fructose 
had a higher thermal stability than the enzyme produced on dextran or 
starch, or than the parental enzyme (82). The optimum pH and the higher 
thermal stability make this strain useful for this mixed culture system. The 
dextranase pH optimum is close to the optimum for dextransucrare and 
highest stable pH of dextransucrase, pH 5.2 (5). At pH 5.2, dextranase 
activity is over 90 % of that at pH 5.5. The dextran hydrolysis products of 
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sucrose grown ATCC 74054 dextranase contain less glucose (12 %-w/w) 
and more small isomaltooligosaccharides (82 % - w/w) than those of the 
dextran grown enzyme. Isomaltose, isomaltotriose and other 
isomaltooligosaccharides are better acceptors for clinical dextran formation 
than is glucose. An enzyme that produces isomalto series oligosaccharides 
from dextran, is preferred for producing acceptors for clinical dextran 
production. The broths of 30 % sucrose mixed culture fermentations contain 
less than 1 % (w/v) glucose at the conclusion of the fermentation (Figure 27). 
It is probable that this dextranase, as with the parental strain enzyme, is 
composed of multi-isozymes, each with different properties (82). 
Sucrose concentration is an important parameter in determining 
dextran yields. Commercially, 15 % sucrose is used for dextran production. 
The ability of an organism to grow in high sucrose is a function of the 
osmotic stability of the organism. ATCC 74054 grew well in 15 % sucrose 
compared to its parental strain (83). In the mixed culture system, a 
discontinuous sucrose addition is used to maintain the sucrose 
concentration at less than 10 % (w/v) at any given time. 
Since the co-production of strains and two different enzymes are 
required to make this mixed culture fermentation work, conditions for cell 
growth, enzyme production, and enzyme reactions had to be optimized. The 
goal of the process is the production, in high yields, of clinical or controlled 
size dextrans. The fermentation was optimized for yield of clinical dextran. A 
pH ranging between 5.1 and 5.4 is optimum for clinical dextran formation in 
mixed culture. At pH 5.4, 72.7 % of theoretical yield of clinical dextran was 
produced. At pH 5.2, 70.1 % was produced. The optimum temperature for 
mixed culture fermentation was between 28 and 29 °C based on the clinical 
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dextran yield. As the growth temperature increased from 26 to 32 °C 
mesenteroides growth rate did not change, however, L. starkevi doubling 
time decreased. The total dextran productivity followed dextransucrase 
activity. The highest dextransucrase activity was 0.32 IU/108 cells at 26 °C. 
Interestingly, at 32 °C, there was still over 0.2 IU/108 cells. It was reported 
that at temperatures above 30 °C, dextransucrase activity decreased sharply 
(43, 85). Apparently the mixed culture system acts to stabilize this enzyme. 
Willemot et al. reported that thermally inactivated dextran-free 
dextransucrase could be reactivated by the addition of exogenous dextran 
(190). The presence of dextran in the mixed system may help stabilize this 
enzyme (159). 
The media were optimized for yeast extract concentrations. The 
highest yield of clinical dextran was obtained with 0.9 % yeast extract, 70 % 
of theoretical, in mixed culture fermentation. At the lower yeast extract 
concentrations (0.3 %), dextransucrase and dextranase activities were 
higher, however, clinical dextran production was lower. It appears that the 
decrease was caused by excess dextranase which produced high 
concentrations of oligosaccharides. The oligosaccharides may act as 
acceptors producing shorter dextran chains, to the point where the polymers 
are too small to be useful. HPLC analysis confirmed the presence of high 
concentrations of small oligosaccharides in the low yeast extract 
fermentations (83). These small oligosaccharides do not readily alcohol 
precipitate and may cause decreased yields. It appears that a balance 
between dextranase and dextransucrase activity is essential for the success 
of the mixed fermentation. 
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Calcium has been reported to stimulate dextransucrase production 
and is normally added commercial production schemes (138). No significant 
increase in dextransucrase activity was seen in mixed fermentations with the 
addition of calcium. Additionally, high dextransucrase activity, in the 
absence of residual sucrose, is not necessary for clinical dextran formation. 
Rather branched dextran formation is favored with the addition of calcium 
when sucrose is absent (106, 159). Calcium and other divalent metal ions 
have been reported to act as branching factors, though the reason is not 
clear (186). Calcium was found to inhibit dextranase activity (Table 6, 93). 
Because dextranase activity is required for the formation of small size 
dextrans, calcium was not added to mixed culture fermentation. 
Clinical dextran formation in the mixed culture system appears to be 
the result of both dextranase action and acceptor reactions. It is logical that 
the balance of sucrose to acceptor would be important. Dextranase addition 
to bacterial pure culture fermentations resulted in high amounts of isomalto-
oligosaccharides only when there was no sucrose present (Figure 36). Few 
oligosaccharides were found in the broth when sucrose was present. This is 
an indication that the growth of the dextran was faster than the action of 
dextranase. Fragments were immediately incorporated into new polymer 
chains. A ratio of less than 4 to 1 sucrose to acceptor in mixed culture 
resulted in high clinical dextran levels (83). Practically this means that the 
sucrose concentration at any given period should be less than 4 times the 
available acceptor concentration. Operationally less than 10 % (w/v) sucrose 
was maintained at any given period. This minimized growth inhibition due to 
high osmosity. Discontinuous sucrose addition was utilized. A single 
sucrose addition (15 %) produces more total dextran, 83 % of theoretical 
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(w/v), than a discontinuous addition, 74 %. However, the picture reverses 
with regard to clinical dextran yields. Single sucrose addition produces 65.6 
% of theoretical clinical dextran versus 68.8 % for discontinuous sucrose 
addition. With 30 % sucrose the advantage of discontinuous addition 
becomes apparent. The total dextran yield by single addition was 84.5 % of 
theoretical and the yield by discontinuous addition was 87 % of theoretical. 
The differences between clinical dextran yields were more apparent, 80.5 % 
of theoretical for discontinuous addition and 61.7 % for single addition. The 
higher productivity of discontinuous sucrose addition is reflected in the cell 
number ratios of the mixed culture. The ratio of L. mesenteroides to L. 
starkevi for discontinuous addition was 51 / 1 (15 % sucrose) and 22 /1 (30 
% sucrose), and in case of single addition 306 /1 (15 % sucrose) and 100 / 
1 (30 % sucrose). Balanced cell numbers means the appropriate ratios 
between dextranase and dextransucrase are maintained for high yields of 
clinical dextran. The sucrose consumption for cell growth did not increase 
proportionally to sucrose concentration. At concentration higher than 15 %, 
most of the additional sucrose was converted into dextran. Thus the specific 
productivity (grams clinical dextran / 108 cells) increased as sucrose 
concentrations were raised above 15 % (Figure 17). Dextransucrase 
production, based on the cell numbers showed that residual activity at the 
end of fermentation increased as sucrose concentration increased. 
The inoculum ratio of L. mesenteroides to L. starkevi turned out not to 
affect significantly either the final cell ratios or clinical dextran production as 
long as the two cultures were co-inoculated over a broad range (1 /1 to 48 / 
1 of L. mesenteroides to L. starkeyi). When the initial sucrose (3 %-w/v) was 
consumed, cell numbers were generally balanced at 20 /1. The ratio of 4 /1 
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was chosen as the optimum inoculum ratio. Under optimized condition, the 
final cell number ratio of L. mesenteroides to L. starkevi ranged from 20 /1 to 
40/1. 
Several factors are known to affect dextran yields (5). They are 
requirements for substrate dispersion, dextransucrase activity maintenance 
by control of pH and temperature, viscosities control and by-product, i.e., 
fructose, levels. Fructose is a poor acceptor for dextran formation. When 
fructose concentrations are high, glucose is transferred from sucrose to 
fructose molecules with formation of a 1-5 linkage. The compound is 
leucrose (a-D-Glu (1-5) p-D-Fru). Leucrose is not an acceptor for 
dextransucrase. Mixed culture fermentation overcomes some of these 
problems by maintaining a lower viscosities in the fermentation broth (less 
than 50 times as viscous as pure culture broths). The concentrations of 
isomaltose, isomaltotriose and other isomaltooligosaccharides are higher, 
displacing fructose as an acceptor. These isomalto series oligosaccharides 
are incorporated into dextran and show up as increased yield. 
The lack of significant amounts of small oligosaccharides in the mixed 
culture broth gave some insight into the mechanism of dextran production in 
this system. The dextranase reaction produces small oligosaccharides 
which are good acceptors for dextran formation. To confirm the incorporation 
of small molecules into small dextran (by acceptor mechanisms), maltose 
was added into bacterial pure culture fermentations. After polymer 
precipitation, using isopropanol, small size dextrans (not the high molecular 
s i ze  dex t ran  wh ich  i s  usua l l y  p roduced  f rom L .  mesen te ro ides  
fermentations) were obtained. Acid partial hydrolysis produced panose (a-
D-Glc(1-6)-a-D-Glu(1-4)-D-Glu). This confirmed maltose incorporation into 
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small size dextrans. Mixed culture fermentations containing starch and 
sucrose were also tested. L. starkevi ATCC 74054 produces an amylase as 
well as dextranase (Table 3) on sucrose. This amylase produces similar 
amounts of glucose, maltose, maltotriose and maltopentaose from starch 
(soluble starch, pH 5.5, 83). A mixed fermentation containing starch and 
sucrose produced primarily small molecular weight dextran (average M.W. 
of 40,000). After the polymer precipitation, and acid or dextranase 
hydrolysis, panose as well as other oligosaccharides were found in the 
hydrolyzates. Thus starch hydrolyzates are incorporated into polymers 
limiting the size of polymers. Presently, dextran hydrolysates, isomaltose 
and/ or isomaltooligosaccharides, are incorporated into the dextran in mixed 
culture in a similar manner, acting as acceptors for clinical dextran. This also 
explains the absence of small isomaltooligosaccharides in mixed culture 
fermentations. 
Incubation of the partially purified dextranase with dextransucrase for 
5 hours stimulated dextransucrase activity. It has been reported that the 
displacement of a dextranosyl chain from the enzyme provides a nascent 
enzyme that reacts more rapidly with sucrose (152). During mixed culture 
fermentation it is possible that both dextranase and isomalto­
oligosaccharides produced by dextranase, continuously regenerate the 
active site. This appears as a stimulation of the enzyme activity. It has been 
reported that dextransucrase activity decreases upon long term dextran 
removal (190). However, since high amounts of dextran exist in the mixed 
culture fermentation there was no dextransucrase inactivation upon the 
addition of dextranase. 
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Dextransucrase activity increased after exogenous dextran addition 
during fermentation. LD (large size dextran, 1.15 x 106) stimulated 
dextransucrase activity. The size of dextran produced was smaller than 
native dextran. This is similar to an other report on the LMW dextran addition 
e f fec t  t o  pu r i f i ed  dex t ransuc rase  so lu t ions  (190) .  They  found  tha t  l ow  
molecular weight (LMW) dextrans obtained from acidic hydrolysis of native 
dextrans acted as acceptors. Those LMW dextran have a higher acceptor 
efficiency than maltose or glucose (113). It is probable that in the mixed 
culture fermentation, when the concentration of oligosaccharides is high, 
they act as acceptors. This gives rise to the next higher homolog, etc., until a 
specific size is reached. 
Depending on the sucrose concentrations varying proportions of high 
molecular weight dextrans (HMW, 2 - 8 %-w/w) and low molecular weight 
dextrans (LMW, 92 - 98 %-w/w) were found in the final product. Using both 
dextranase and acid hydrolysis, it was detected that the HMW dextran was 
not levan and only a portion contained non 1,6 linkages. The total non 1,6 
linked portions were 5 - 6 % of the total dextrans. The dextran produced by 
mixed culture fermentation has the same or similar structural composition to 
the dextran produced by bacterial pure culture fermentation (187). 
The new process for the production of clinical dextrans differs in 
several steps from the traditional process. This process requires co-
inoculation and establishment of a co-culture. Discontinuous sucrose 
addition is required. Because of higher sucrose concentrations (over 30 %), 
the fermentation time is longer than traditional processes. When 30 % 
sucrose is used to produce clinical dextran the time required is about 52 
hours. For traditional fermentations, 24 hrs are required for 15 % sucrose. 
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However, a further 24 hrs is needed for acid hydrolysis and subsequent 
steps (Dr. Patel, personal communication). In addition, an extra 48 hr is 
required to produce same amount of clinical dextran. One of the most 
expensive steps in the traditional process, having the highest dextran loss, is 
acid hydrolysis. The new process does not require acid hydrolysis. Because 
acid hydrolysis is not required, deionization is not required. The clinical 
dextran produced in mixed culture broth has a small polydispersity index. 
The dextran size can be readily controlled simply by stopping the 
fermentation at the desired size. The dextran produced by this new process 
also needs less fractionation. This process produces small dextrans which 
have lower viscosity, making cell removal easier. 
There are many studies on clinical dextran production using purified 
dextransucrase. Hydrolysis of sucrose provides the energy required for the 
condensation of D-glucopyranosyl units. Thus dextran synthesis can be 
carried out in vitro, using only purified enzyme and sucrose. A popular idea 
for making clinical dextran with enzyme has been to use maltose as an 
acceptor. Maltose can be used as an acceptor for the first reaction step. The 
purified product obtained is used for the next reaction step. Dextrans of 
molecular weights ranging from 1,000 to 100,000 have been made using 
this method with 80 % of theoretical yield. (148). This process has 
drawbacks. For separate enzyme production and enzyme purification steps, 
more than a 5 fold larger amount of nutrients are required (4, 142, 184). The 
a 1,4 linkage present in this dextran is readily degraded in humans (152). 
Since about half of the clinical dextran produced contains maltose, this is a 
structural drawback. In order to obtain suitable sized dextrans a multi-step 
synthesis is required, i.e. a 4 step-process (148). The dextransucrase 
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reaction theoretically converts 52 % of the sucrose to fructose. The fructose 
concentration increases with every reaction step because it is not 
consumed. When fructose concentration is high, it acts as an acceptor. The 
end product of the reaction is leucrose which is not an acceptor. 
Dextransucrase product sizes are controlled by controlling the ratio of 
sucrose to maltose. To make controlled size dextran with dextransucrase the 
ratio of sucrose and acceptor should be low (close to a 1: 1 ratio of sucrose 
to maltose is required). Every reaction step in this multi-step process has to 
be followed by polymer precipitation to prepare the acceptor for the next 
stage. This is not a practical procedure for industrial scale fermentation. 
An enzymatic hydrolysis method for clinical dextran has been 
patented (129, 130). The advantage of this method is that the enzyme 
solution can be allowed to act directly on a culture broth containing dextran. 
This eliminates the preliminary precipitation of the dextran with alcohol. The 
dextranase must be prepared separately and there is no way to recover the 
dextranase for re-utilization. The product is generally of very small size 
unless the dextranase is properly inactivating or being purified. This process 
has not achieved commercialization. 
Commercial fermentation media consists of 5 g / L yeast extract, 5 g / 
L KH2PO4, an 15 % (w/v) sucrose, and trace amounts of peptone (Dr. Patel, 
personal communication). Mixed culture system requires yeast extract (8.5 g 
/ L) and same amount of KH2PO4 (5 g / L), 30 % sucrose, and no peptone. 
The medium cost $ 3.1 per Kg of clinical dextran produced for traditional 
methods. With its higher yields and productivities, the media cost for mixed 
fermentation $ 2.1 per Kg of clinical dextran. The dextran market is several 
billion Kg a year world wide. The dextran price depends on the quality. 
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Crude dextran sells for about $ 3 / Kg whereas clinical dextran sells for over 
$ 50 / Kg (D,r. Patel, Personal communication). Not including production 
simplification, this new process has the advantage in lower production cost. 
Dextran precipitation by alcohol concentrations is related to dextran 
size. The precipitation efficiency of alcohol for clinical dextran is methanol < 
ethanol < isopropanol. A commercial neutral hydrolyzate of 5 % dextran 
contains approximately 2 % sodium chloride (199). When dextran is 
precipitated from the acid hydrolyzate, practically all of the sodium chloride 
remains behind. The new process does not include acid hydrolysis or 
neutralization step, thus the fermentation broth does not contain sodium 
chloride. Dextran recovery by precipitation increased upon the addition of 
some salts (Ms. Sarkar, D., personal communication, Audubon Sugar Inst., 
LSU). KH2PO4 and/or MgS04 improved the recovery more than NaCI. The 
optimum salt concentrations depended on the dextran concentration (and 
size). Ions are known to affect water activity by reducing the water available 
for dextran hydration. Ion addition also increases specific gravity (199). The 
addition of salts helps to diminish solvent usage. The modest product value 
of dextran requires efficient recovery and solvent re-uses, as well as good 
solvent removal from food and pharmaceutical grade products. The addition 
of 0.6 % salts (KH2PO4 or MgS04) to 5 % dextran solution showed "salt in" 
effect on isopropanol precipitation (83). It has been reported that high salt 
concentrations (about 15 %-w/v) increase the ionic strength of dextran 
solutions and inhibit the precipitation of dextran (198). Additional studies for 
optimum salts' concentrations for various dextran level is needed. Proteins 
(or residual dextranase) in dextran can be removed by activated charcoal. 
Since commercial practice uses activated charcoal to remove color from 
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dextran solutions, the dextranase does not require an additional process for 
removal. 
Using ruthenium red addition in conjunction with osmium tetroxide, it 
was  poss ib le  to  examine  dex t ran  p roduced  in  m ixed  and  bac te r ia l  pu re  
culture fermentations. The morphologies of high molecular weight and low 
molecular weight dextrans were different. High molecular weight dextran 
prepared from bacterial pure culture fermentations showed a net like 
structure. However, mixed culture fermentation polymers showed up as 
smooth surfaces, although the bacterial cells were surrounded by net like 
materials. Since dextran is a neutral polysaccharide, the interaction of the 
dextran with ruthenium red is interesting. It has been suggested that the role 
of ruthenium red is the formation of an electron dense deposit with OSO4 at 
the location of the polysaccharide (107). The ruthenium red must then be 
making insoluble dextran polymer which reacts with OSO4. The formation of 
ruthenium red complex may occur via free hydroxyl groups. The intense 
electron density of dextran is probably due to the formation of an osmium 
black complex with the dextran. The net like appearance of high molecular 
weight materials vs the smooth appearance of low molecular weight 
materials may become a useful diagnostic tool for polymer size and should 
be investigated further. 
BIBLIOGRAPHY 
1. Abdel-Halim, M.M. El-Sayed, Wafaa M. Mahmound, and R.W. 
Coughlin (1990). Comparative study of production of dextransucrase 
and dextran by cells of L. mesenteroides on celite and in calcium 
alginate beads. Biotechnology and Bioenginering. 36: 83 - 91. 
2. Ainsworth, S.K. (1977). An ultrastructural method for the use of 
polyvinylpyrrolidone and dextrans as electron opaque tracers. J. of 
Histochemistry and Cytochemistry. 25: 1254 - 1259. 
3. Aitkeldieva, S.A. (1982). Extraction of copper from Dzhezkazgan ore 
by an association of heterotrophic bacteria. Izv. Akad. Nauk. SSSR, 
Ser .  B io l .  4 :  46 -51 .  
4. Ajongwen Numfor, N.J. (1988). The production of the enzyme 
dextransucrase by batch and continuous fermentation techniques, 
PhD. Thesis, Aston University. 
5. Alsop, R.M. (1983). "Industrial production of dextrans" In Progress in 
Industrial Microbiology, vol. 1, ed. by M.E. Bushell. 18: 1 - 44. 
Elsevier, Amsterdam. 
6. Bailey, R.B., T. Benitez, and A. Woodward (1982). S. cerevisiae 
mutants resistant to catabolite repression: use in cheese whey 
hydrolysate fermentation. Appl. Environ. Microbiol. 44: 631 - 639. 
7. Bailey, R.B. and A. Woodward (1984). Isolation and characterization 
of a pleiotropic glucose repression resistant mutant of S. cerevisiae. 
Mol. Gen. Genet. 193: 507 - 512. 
8. Bailey, R.W. and A. Clarke (1959). A bacterial dextranase. Biochem. J. 
72 :49. 
9. Bakan, J.A. (1966). Methyl - cellulose dextran microcapsules. Fr. 
Patent 1,453,745; Chem. Abstract. 69: 3890a (1968). 
10. Baker, R.W. (1969). Methods of fractionating polymers by 
ultrafiltration. J. Appl. Poly. Sci. 13: 369 - 376. 
11. Barker, P.E. and N.J. Ajongwen (1991). The production of the enzyme 
dextransucrase using nonaerated fermentation techniques. 
Biotechnol. Bioeng. 37: 703 - 707. 
12. Barrett,J.F., T.A.Barrett and R.Curtiss III (1987). Purification and 
partial characterization of the multicomponent dextranase complex of 
Streptococcus sorbis and the cloning of the dextranase gene. Infect. 
Immun. 55: 729-802. 
148 
149 
13. Basedow, A.M. and K.H. Ebert (1975). Zum Mechanisms des abbaus 
von polymeren in Losung durch ultraschall. Die Makromolekulare 
Chemie. 176: 745 - 757. 
14. Behrens, U. (1965). Semicontinuous method for making dextran. 
Chem. Abstract. 63: 7624 (1965). 
15. Behrens, U. and L. Wuensche (1965). Utilization of final molasses in 
dextran production. Sobre Deriv, Cana Azucar 3: 39, Chem Abstract. 
73: 57413y (1970). 
16. Binder, TP., G.L. Cote, and J.F. Robyt (1983). Disproportionate 
reactions catalyzed by Leuconostoc and Streptococcus 
glucansucrases. Carbohydr. Res. 124: 275 - 286. 
17. Binder, T.P. and J.F. Robyt (1983). p-Nitrophenyl a-D-
Glucopyranoside, A new substrate for glucansucrases. Carbohydr. 
Res. 124: 287 - 299. 
18. Bixler, G.H., G.E. Hines, R.M. McGee and R.A. Shurter (1953). 
Dextran. Ind. Eng. Chem. 45: 692 - 709. 
19. Boyd, A.M., F. Fletcher, and A.H. Ratcliffe (1953). Supportive Therapy: 
An improved type of dextran. Lancet. 264: 59 - 63. 
20. Brooker, B.E. (1979). "Electron microscopy of the dextrans produced 
by lactic acid bacteria". In Microbial Polysaccharides and 
Polysaccharase. eds by Berkeley, R.L.W., G.W. Gooday and D.C. 
Ellwood, pp. 85 -115. Society for General Microbiology, Academic 
Press, London. 
21. Bull, A.T. and C.M. Brown (1979). "Continuous culture applications to 
microbial biochemistry". In International Review of Biochemistry, ed. 
Quayle, J.R., Vol. 21, pp. 177 - 226. University Park Press, Baltimore, 
MD. 
22. Bull, A.T. (1985). "Mixed culture and mixed substrate systems" In 
Comprehensive biotechnology. Vol. 1, The principles, applications 
and regulations of biotechnology in industry, agriculture and 
medicine, eds. by M. Moo-Young, A.T. Bull and H. Dalton. pp 281 -
299. Pergamon Press. 
23. Bungay, H.R. and M.L. Bungay (1968). Microbial interactions in 
continuous culture. Adv. Appl. Microbiol. 10: 269 - 290. 
24. Carlson, W.V. and W.W. Carlson (1949). The vitamin requirements of 
Leuconostoc for dextranase synthesis. J. Bacteriol. 58: 135- 141. 
150 
25. Carlson, W.V. and C.L. Rosano (1951). The nutritional requirements 
of Leuconostocdextranicum for growth and dextran synthesis. J. 
Bacteriology. 62: 583 - 589. 
26. Carlson, V.W. and W.W. Carlson (1952). Enzymatic hydrolysis of 
dextran. Science. 115: 43. 
27. Chemicals Inc. (1966). Iron dextran complex. Brit. Patent 1,025,735; 
Chem. Abstract. 64: 10808. 
28. Ciardi, J.E. (1983). "Dextransucrase" In Glucosyltransferases, 
glucans, sucrose and dental caries" eds. by Doyle, R.J. and J.E. 
Ciardi. Spec. Suppl. p. 51. IRL Press, Arlington, Virginia. 
29. Cohen, A.B. and C.D. Shacklett (1965). Photographic emulsions. U.S. 
Patent 3,203,804. 
30. Cori, G.T. and C.F. Cori (1939). The activating effect of glycogen on 
the enzymatic synthesis of glycogen from glucose - 1 - phosphate. J. 
Biol. Chem. 131: 397 - 398. 
31. Cote, G.L. and J.F. Robyt (1982). Isolation and partial characterization 
of an extracellular glucansucrase from L. mesenteroides NRRL B-
1355 synthesize an alternating (1-6), (1-3)-a-D-glucan. Carbohydr. 
Res .  101 :57-74 .  
32. Cote, G.L. and J.F. Robyt (1982). Acceptor reactions of 
alternansucrase from L. mesenteroides NRRL - B-1355. Carbohydr. 
Res. 111: 127 - 142. 
33. Cote, G.L. and J.F. Robyt (1983). The formation of a-D- (1-3) branch 
linkages by an exocellular glucansucrase from L. mesenteroides 
NRRL B-742. Carbohydr. Res. 119: 141 -156. 
34. Curds, C. (1982). The ecology and protozoa in aerobic sewage 
treatement processes. Ann. Rev. Microbiol. 36: 27 - 46. 
35. Cypert, J.D. and J.T.Patton (1963). Stabilized dextran solutions. U.S. 
Patent 3,084,122; Chem. Abstract. 59: 1422 (1963). 
36. Cybulska, J. and R. Pakula (1963). Streptococcal polyglucosidase. II. 
Effect of some factors on enzymatic synthesis of dextran in cell free 
media. Exp. Med. Microbiol. 15: 285 - 296. 
151 
37. Deibel, R.H. and C.F. Niven, Jr. (1959). Microbiology of meat curing. 
II. Characteristics of a Lactobacillus during in Ham curing brines 
which synthesizes a polysaccharide from sucrose. Appl. Microbiol. 7: 
138 - 141. 
38. DeMan, J.C. and M.E. Sharpe (1960). A medium for the cultivation of 
Lactobacilli. J. Appl. Bacteriol. 23: 130 - 135. 
39. Ditson, S.L. and R.M. Mayer (1984). Dextransucrase : The direction of 
chain growth during autopolymerization. Carbohydr. Res. 126: 170 -
175. 
40. Drissen, M.F. (1981). "Protocooperation of yoghurt bacteria in 
continuous culture". In Mixed Culture Fermentations, eds. by Bushell, 
M.E. and J.H. Slater, pp. 99 - 120, Academic Press, London. 
41. Dubois, M., K.A. Gilles, J.K. Hamilton, P.A. Rebers, and F. Smith 
(1956). Colorimetric method for determination of sugars and related 
substances. Anal. Chem. 28: 350 - 356. 
42. Dunican, L.K. and H.W. Seeley (1963). Temperature-sensitive 
dextransucrase synthesis by a Lactobacillus. J. Bacteriol. 86: 1079 -
1083. 
43. Dunican, L.K. and H.W. Seeley (1965). Extracellular polysaccharide 
synthesis by members of the genus Lactobacillus : Conditions for 
formation and accumulation. J. Gen. Microbiol. 40: 297 - 308. 
44. Dunn, G.M. and A.T. Bull (1983). Bioaccumulation of copper by a 
defined community of activated sludge bacteria. Eur. J. Appl. 
Microbiol. Biotechnol. 17: 30 - 34. 
45. Ebert, K.H. and G. Schenk (1962). Enzymatic polymerization III. 
Preparation, purification, and characterization of dextransucrase from 
L. mesenteroides B-512 (F). Z. Naturforsch. 17: 732 - 741. 
46. Ebert, K.H. and G. Schenk (1968). Mechanisms of biopolymers 
growth : The formation of dextran and levan. Adv. Enzymol. 30: 179 -
219. 
47. Entian, K.D. and F.K. Zimmermann (1980). Glycolytic enzymes and 
intermediates in carbon catabolite repression mutants of 
Saccharomvces cerevisiae. Mol. Gen. Genet. 177: 345 - 350. 
48. Entian, K.D., F.K. Zimmermann and I. Scheel (1977). A partial defect 
in carbon catabolite repression in mutants of Saccharomvces 
cerevisiae with reduced hexose phosphorylation. Mol. Gen. Genet. 
156: 99 - 105. 
152 
49. French, D. (1962). Cyclodextrin transglycosylase (Bacillus macerans 
amylase) Methods in Enzymol. 5: 148 - 155. 
50. Fu, D. and J.F. Robyt (1988). Essential histidine residues in 
dextransucrase : chemical modification by diethyl pyrocarbonate and 
dye photooxidation. Carbohydr. Res. 183: 97 - 109. 
51. Fu, D and J.F. Robyt (1990). Specificity of acceptor binding to L 
mesenteroides B-512F dextransucrase : Binding and acceptor-
Product structure of a-methyl-D-glucopyranoside analogs modified at 
C-2, C-3, and C-4 by inversion of the hydroxyl and by replacement of 
the hydroxyl with hydrogen. Arch. Biochem. Biophys. 276: 460 - 465. 
52. Fu, D. and J.F. Robyt (1990). A facile purification of L. mesenteroides 
B- 512 FM dextransucrase. Preparative Biochemistry. 20: 93 - 106. 
53. Gancedo, J.M. and C. Gancedo (1986). Catabolite repression mutants 
of yeast. FEMS Microbiology Reviews. 32: 179 - 187. 
54. Germaine, G., A. M. Chludzinski, and C.F. Schachtele (1974). 
Streptococcus mutans dextransucrase : Requirement for primer 
dextran. J. Bacteriol. 120: 287 - 294. 
55. Germaine, G.R. and C.F. Schachtele (1976). Streptococcus mutans 
dextransucrase : Mode of interaction with high - molecular - weight 
dextran and role in cellular aggregation. Infect. Immun. 13: 365 -
372. 
56. Gibbons, R.J. and S.B.Banghart (1967). Synthesis of extracellular 
dextran by carcinogenic bacteria and its presence in human dental 
plaque. Arch. Oral Biol. 12: 11 - 24. 
57. Gibbons, R.J. and S.B. Banghart (1968). Variation in extracellular 
polysaccharide synthesis by cariogenic Streptococcus. Arch. Oral 
Biol. 13: 697 -701. 
58. Graham, W.D., Patry, O., and E.H. Jackman (1956). Influence of 
methanol on viscosity and light scattering properties of dextran 
solution. Can. J. Chem. 34: 445 - 450. 
59. Grahame, D.A. and R.M. Mayer (1984). The origin and composition of 
multiple forms of dextransucrase from Streptococcus sanguis. 
Biochim. Biophys. Acta. 786: 42 - 48. 
60. Granath, K.A. and P. Flodin (1961). Fractionation of dextran by the gel 
filtration method. Makromol. Chem. 48: 160 - 171. 
153 
61. Grier, T.J. and R.M. Mayer (1981). Dextransucrase : Studies on donor 
substrate specificity. Arch. Biochem. Biophys. 212: 651 - 659. 
62. Groenwall, A. (1957). Dextran and its use in colloidal infusion 
solutions, pp 91 - 98. Academic Press, Inc., New York. 
63. Groenwall, A.J.T. and B.G.A. Ingleman (1944). Untersuchunger uber 
dextran und sein verhalten bei parenteraler zufuhr. I. Acta Physiol. 
Scand. 7: 97 - 107. 
64. Groenwall, A.J.T. and B.G.A. Ingleman (1945). Untersuchunger uber 
dextran und sein verhalten bei parenteraler zufuhr. II. Acta Physiol. 
Scand. 9: 1 - 27. 
65. Hackel, R.A. and N.A. Khan (1978). Genetic control of invertase 
formation in S. cerevisiae. Mol. Gen. Genet. 164: 295 - 302. 
66. Hammond, B.F. (1969). Dextran production by human oral strain of 
Lactobacillus casei. Arch. Oral Biol. 14: 879 - 890. 
67. Hanada, N. and T. Takehara. (1987). (1-3) a-D-glucan synthase from 
Streptococcus mutans AHT (serotype g) does not synthesize glucan 
without transferase. Carbohydr. Res. 168: 120 - 124. 
68. Hanada, N., T. Takehara, and E. Saeki (1987). Purification and 
characterization of a third glucosyltransferase from Streptococcus 
mutans serotype g. J. Gen. Microbiol. 133: 1351 - 1358. 
69. Hehre, E.J. (1941). Production from sucrose of a serologically reactive 
polysaccharide by a sterile bacterial extract. Science. 93: 237. 
70. Hehre, E.J. (1952). An unusual Streptococcus that yields low 
molecular weight (clinical type) dextran directly. Bacteriol. Proc. p. 23. 
71. Hobson, P.N. (1981). "Microbial pathways and interactions in the 
anaerobic treatment processes". In Mixed culture fermentations, eds. 
by Bushell, M.E. and J.H. Slater, pp. 53 - 79. Academic Press, 
London. 
72. lyata, K. and T. Yamamoto (1975). Dextransucrase as an enzyme 
associating with alkaline earth metal ions. Agri. Biol. Chem. 39: 1187 
- 1192. 
73. Jeanes, A (1965). Preparation of a water soluble dextran by 
enzymatic synthesis. Methods Carbohydr. Chem. 5: 127 - 132. 
154 
74. Jeanes, A., W.C. Haynes, C.A. Wilham, J.C. Rankin, E.H. Melvin, M.J. 
Austin, J.E. Cluskey, B.E. Fisher, H.M. Tsuchiya and C.E. Rist (1954). 
Characterization and classification of dextran from ninety-six strains of 
bacteria. J. Amer. Chem. Soc. 76: 5041-5055. 
75. Jeanes, A., N. Schieltz and C. Wilham (1948). Molecular association 
in dextran and in branched amylaceous carbohydrates. J. Biol. Chem. 
176: 617 - 627. 
76. Jellum, E., J. Aaseth and L. Eldjarn (1973). Mercaptodextran, a 
methal-chelating and disulfide - reducing polythiol of high molecular 
weight. Biochem. Pharmacol. 22: 1179 - 1188. 
77. Jiricek, V. (1967). Dextran production bv Leuconostoc fermentation. 
Czech. Patent 124,853; Chem. Abstract. 69: 34684r (1968) 
78. Jones, R.W., A. Jeanes, C.S. Stringer and H.M. Tsuchiya (1956). 
Crystalline methyl a-isomaltoside and its homologs obtained by 
synthetic action of dextransucrase. J. Amer. Chem. Soc. 78: 2499 -
2502. 
79. Jung, S.M. and R.M. Mayer (1981). Dextranase; Donor substrate 
reaction. Arch. Biochem. Biophys. 208: 288 - 295. 
80. Kamochi, M. M. Ogata, S. Yoshida, Y. Mizuguchi and A. Shigematsu 
(1992). Priming effect of dextran sulfates on lipopolysaccharide-
induced tumour necrosis factor production in mice FEMS Microbiol. 
Immunol. 89: 175 - 182. 
81. Kanda, T. I. Noda, K. Wakabayashi and K. Nisizawa (1983). 
Transglycosylation activities of exo - and endo type cellulases from 
Irpex lacteus. J. Biochem. (Tokyo). 93: 787 - 794. 
82. Kim, D. (1990). The dextranase isozymes from Lipomvces starkevi. 
MSc. Thesis, Louisiana State University. 
83. Kim, D. Unpublished data. 
84. Kitihata, S. (1981). Scope and mechanism of carbohydrase 
action - stereocomplementary hydrolytic and glucosyl - transferring 
action of glucoamylase and glucodextranase with a and 0 - D -
glucosyl fluoride. J. Biol. Chem. 256: 6017 - 6026. 
85. Kobayashi, M. and K. Matsuda (1980). Characterization of the 
multiple forms and main component of dextransucrase from L. 
mesenteroides NRRL B-512F. Biochim. Biophys. Acta. 614: 46 - 62. 
155 
86. Kobayashi, M., K. Mihara and K. Matsuda (1986). Dextransucrase 
from L. mesenteroides NRRL B-512 F: Characterization of the enzyme 
bound to sephadex gel. Agric. Biol. Chem. 50: 551 - 556. 
87. Kobayashi, M. and K. Matsuda (1986). Electrophoretic analysis of the 
multiple forms of dextransucrase from L. mesenteroides. J. Biochem. 
100: 615 - 621. 
88. Kobayashi, M., I. Yokoyama and K. Matsuda (1985). Effectors 
differently modulating the dextransucrase activity of L. mesenteroides. 
Agric. Biol. Chem. 49: 3189 - 3195. 
89. Kobayashi, M., I. Yokoyama and K. Matsuda (1986). Substrate 
binding sites of Leuconostoc dextransucrase evaluated by inhibition 
kinetics. Agric. Biol. Chem. 50: 2585 - 2590. 
90. Kobayashi, T. (1944). Mucous fermentation of sucrose by 
Lactobacillus musicus isolated from tobacco leaves. J. Agri. Chem. 
Soc. Japan. 20: 60 - 64. 
91. Kobs, S.F. (1991). Acceptor activity of affinity-immobilized 
dextransucrase from Steptococcus sanguis ATCC 10558. 
Carbohydr. Res. 211: 337 - 342. 
92. Kobs, S.F. and R.M. Mayer (1991). Photolabeling of dextransucrase 
from Streptococcus sanguis with p-azidophenyl a-D-
glucopyranoside. Carbohydr. Res. 211: 317 - 326. 
93. Koenig, D.W. (1988). The dextranase of Lipomvces starkevi and its 
use in sugar cane process. Ph.D. Thesis, Louisiana State University. 
94. Koenig,D.W. and Day.D.F. (1988). Dextranase production by a 
derepressed mutant. Ann.N.Y. Acad. Sci. 542: 111-114. 
95. Koenig,D.W. and Day.D.F. (1989). Induction of Lipomvces 
starkevi dextranase. Appl. Environ. Microbiol. 55: 2079-2081. 
96. Koepsell, H.J. and Tsuchya, H.M. (1951). Enzymatic synthesis of 
dextran, J. Bacteriol. 63: 293 - 295. 
97. Kuznetsova, G., S. Sel'tsovskaya, and M.E. Preobrazhenskaya 
(1967). The effect of various native dextrans on nonspecific resistance 
to infection. Dokl. Akad. Nauk SSSR. 175: 495 - 497. 
98. Lacko, L. J. Malek and J. Dvorakova (1959). Dextran III. Collection 
Czechoslov. Chem. Commun. 24: 2954 - 2958. 
156 
99. Laires, A., I. Spencer-Martins and N. Van-Uden (1983). Use of D-
glucosamine and 2-deoxyglucose in the selective isolation of mutants 
of the yeast Lipomvces starkevi derepressed for the production of 
extracellular endodextranase. Z. Allg. Mikrobiol. 23 (9): 601 - 603. 
100. Langston, G.W. and C. Bouma (1960). A study of the 
microorganisms from grass silage. II. The Lactobacilli. Appl. 
Microbiol. 8: 223 - 234. 
101. Landon, R.S. and C. Webb (1990). Separating enzyme 
(dextransucrase) production and product (dextran) synthesis within a 
traditional fermentation process. Process Biochem. February 
1990, 19 -23. 
102. LE, M.S. and J. A. Howell (1985). "Ultrafiltration" In The 
principles, applications and regulations of biotechnology in industry, 
agriculture and medicine. " eds. by M. Moo-Young, A.T. Bull and H. 
Dalton, Vol. 2. pp 383 - 409. Pergamon Press. 
103. Linton, J.D. and J.W. Drozd (1982). "Microbial interactions and 
communities in biotechnology". In Microbial Interactions and 
Communitie. eds. by Bull, A.T. and J.H. Slater, vol. 1. pp. 357 - 406. 
Academic Press, London. 
104. Lockwood, A.R., A.E. James and F.G. Pautard (1951). Studies on the 
breakdown product of dextran formed by ultrasonic vibration. 
Research. 4: 46 - 48. 
105. Lopez, A. and P. Monsan (1981). On the production of dextran by free 
and immobilized dextransucrase. Adv. Biotechnol. 1: 679. 
106. Lowford, G.R., A. Kligerman and T. Williams (1979). Dextran 
biosynthesis and dextransucrase production by continuous culture of 
L. mesenteroides. Biotechnol. Bioeng. 21: 1121 - 1131. 
107. Luft, J.H. (1971). Ruthenium red and violet. I. Chemistry, purification, 
methods of use for electron microscopy and mechanism of action. 
Anatomical Record. 171: 347 - 368. 
108. MaCabe, M.M. and R.M. Hamelic (1983). An enzyme from Strep. 
mutans forms branches on dextran in the absence of sucrose. 
Biochem. Biophys. Res. Commun. 115: 287 - 294. 
109. Mah, R.A. (1982). Methanogenesis and methanogenic partnerships. 
Philos. Trands. R. Soc. London, Ser. B, 297: 153 - 170. 
110. Makinen, K.K. and I.K. Paunio (1971). Exploitation of blue dextran as 














Mattiasson, B. (1988). Affinity immobilization. Methods in Enzymol. 
137: 647 - 656. 
Mayer, R.M. (1987). Dextransucrase : A glucosyltransferase from 
Streptococcus sanguis. Methods in Enzymol. 138: 649 - 661. 
Mayer, R.M., M.M. Matthews, C.L. Futerman (1981). Dextransucrase: 
acceptor substrate reactions. Arch. Biochem. Biophys. 208: 278 -
287. 
Mazza, J.C., A. Akgerman and J.R. Edwards (1975). Synthesis of a-D-
glucopyranosyl a-L-sorbofuranoside and its use as a D-glucosyl 
donor. Carbohydr. Res. 40: 402 - 406. 
Mbemba, E., V. Cham, J.C. Gluckman, D. Klatzmann, and L. Gattegno 
(1992). Molecular interaction between HIV - 1 major envelope 
glycoprotein and dextran sulfate, Biochim. Biophys. Acta. 1138: 62 -
67. 
McCabe, M.M. (1985). Purification and characterization of a primer -
independent glucosyltransferase from Streptococcus mutans 6715 - B 
mutant 27. Infect. Immun. 50: 771 - 777. 
Michiels, A.G. (1991). Inhibition of dextransucrase by a-D-glucose 
derivatives. Appl. Biochem. Biotechnol. 31: 237 - 246. 
Midland Chemical Corp. (1959). Nitroparaffin - base explosives. 
Germ. Patent 1,106,659; Chem. Abstract. 56: 622 (1962). 
Miller, A.W., Eklund, S.H. and J.F. Robyt (1986). Milligram to gram 
scale purification and characterization of dextransucrase from L 
mesenteroides B-512F. Carbohydr. Res. 147: 119 - 133. 
Miller, A.W. and J.F. Robyt (1986). Functional molecular size and 
structure of dextransucrase by radiation inactivation and gel 
electrophoresis. Biochim. Biophys. Acta. 870: 198 - 203. 
Mitsuya, H., D. Looney, S. Kuno, R. Ueno, F. Wong - Staal and S. 
Broder (1988). Dextran sulfate suppression of viruses in the HIV 
family : Inhibition of virion binding to CD4+ cells: Science. 240: 646 -
649. 
Monsan, P. and A. Lopez (1981). On the production of dextran by free 
and immobilized dextransucrase. Biotechnol. Bioeng. 23: 2027 -
2037. 
158 
123. Monsan, P. F. Paul, D. Auriol and A. Lopez (1987). Dextran synthesis 
using immobilized Leuconostoc mesenteroides dextransucrase. 
Methods in Enzymol.136: 239 - 254. 
124. Morsen, A. and H.-J. Rehm (1990). Degradation of phenol by a 
defined mixed culture immobilized by adsorption on activated carbon 
and sintered glass., Appl. Microbiol. Biotechnol. 33: 206 - 212. 
125. Moser, A. (1985). Special cultivation Techniques in "Biotechnology" 
eds. by H.-J. Rehm and G. Reed. Vol. 2 ed. by H. Brauer, VCH 
Verlagsgesellschaft, Weinheim (Federal Republic of Germany) 
pp. 1334 - 1347. 
126. Neely, W.B. and J. Nott (1962). Dextransucrase, an induced enzyme 
from Leuconostoc mesenteroides. Biochemistry. 1: 1136 - 1140. 
127. Norris, P.R. and D.P. Kelly (1982). "The use of mixed microbial 
cultures in metal recovery". In Microbial Interactions and 
Communities", eds. by Bull, A.T. and J.H. Slater, vol. 1 pp. 443 - 474. 
Academic Press, London. 
128. Novak, L.J. (1960). Gelled nitroparaffin propellants. U.S. Patent 
2,921,846; Chem. Abstract. 54: 7150 (1960). 
129. Novak, L.J. and G.S. Stoycos (1958). Method for producing clinical 
dextran. U.S. Patent 2,841,578, Julyl. 
130. Novak, L.J. and E.C. Witt (1961). Method of producing clinical dextran. 
U.S. Patent 2,972,567. Feb. 21. 
131. Novak, L.J. and E.E. Witt (1958). Soil conditioning and fertilizing. U.S. 
Patent 2,826,002 ; Chem. Abstract. 52: 8437 (1958). 
132. Ohshima, M., N. Ishizaki, A. Handa and Y. Tonooka (1983). Cultural 
conditions for production of neopurpuratin, a purplish-red pigment, by 
mixed cultures of Streptomvces propurpuratus with Bacillus sp. J. 
Ferm. Technol. 61: 31 - 36. 
133. Ohshima, M., N. Ishizaki, A. Handa, Y. Tonooka and N. Kanda (1981). 
Formation of purplish-red pigment by mixed culture of Streptomvces 
propurpuratus with other microorganisms. J. Ferm. Technol. 59: 
209 - 213. 
134. Otts, D.R. and D.F. Day (1987). The effect of ionophores on the 
production of exocellular dextransucrase by L. mesenteroides. FEMS 
Microbiol. Lett. 42: 179 - 183. 
159 
135. Otts, D.R. and D.F. Day (1988). Dextransucrase secretion in L. 
mesenteroides depends on the prescence of a transmembrane 
protein gradient. J. Bacterid. 170: 5006 - 5011. 
136. Owen, W.I. (1959). Drilling fluids containing sealing agents. U.S. 
Patent 2,868,725; Chem. Abstract. 53: 7571 (1959). 
137. Parnaik, V.K.(1983). A D-glucosylated form of dextransucrase : 
preparation and charcteristics. Carbohydr. Res. 121: 257 - 268. 
138. Paul, F. D. Auriol, E. Oriol, and P. Monsan (1984). Production and 
purification of dextransucrase, NRRL B512(F). New York Academy of 
Science. 434: 267 - 270. 
139. Paul, F. (1986). Acceptor reaction of a highly purified dextransucrase 
with maltose and oligosaccharides : Application to the synthesis of 
controlled molecular weight dextrans. Carbohydr. Res. 149: 433 -
441. 
140. Paul, F. (1986). Process for the purification of dextransucrase. U.S. 
Patent 4,591,563. 
141. Pazur, J.H., Budovich, T. and C.L.Tipton (1957). The enzymatic 
synthesis and disproportionation of 3-O-a-glucopyranosyl-D-glucose. 
J. Am. Chem. Soc. 79: 625 - 628. 
142. Pennel, R.D. and P.E. Barker (1992). The production of the enzyme 
dextransucrase using unaerated continuous fermentation. J. Chem. 
Tech. Biotechnol. 53: 21 - 27. 
143. Phaff.H.J. and C.P. Kortzman (1984). "Genus 14. Lipomvces Lodder 
et Kreger-van Rij". In The yeast a taxonomic study, ed. by Kreger-van 
Rij. pp. 252 - 262. Elsevier, Amsterdam. 
144. Philipson, L. and M. Kaufman (1964). The efficiency of ribonuclease 
inhibitors tested with viral ribonucleic acid as substrate. Biochim. 
Biophys. Acta. 80: 151- 154. 
145. Planas R., Gines P. and V. Arroyo (1990). Dextran - 70 versus 
albumin as plasma expanders in cirrhotic patients with tense ascites 
treated with total paracentesis. Results of a randomized study. 
Gastroenterology. 99: 1736 - 1744. 
146. Preobrazhenskaya, E. and L. Rozenfel'd (1968). Reaction of native 
dextrans of different structures with concanavalin A. Biokhimiya. 33: 
784 - 791. 
160 
147. Ramos,A. and I.Spencer-Martins (1983). Extracellular glucose-
producing exodextranase of the yeast Lipomvces lipofer. Antonie Van 
Leeuwenhoek. 49: 183-190. 
148. Remaud, M., F. Paul, P. Monsan, A. Heyraud, M. Rinaudo (1991). 
Molecular weight characterization and structural properties of 
controlled molecular weight dextrans synthesized by acceptor 
reaction using highly purified dextransucrase. J. Carbohydr. 
Chem. 10: 861 - 876. 
149. Richards,G.N. and M.Streamer (1974). Studies on dextranases. Part 
IV. Mode of action of dextranase D1 on Oligosaccharides. Carbohydr. 
Res. 32: 251-260. 
150. Ricketts, C.R. (1959). Dextran sulfate - A synthetic analogue of 
heparin. Biochem. J. 51: 129 - 133. 
151. Ricketts, C.R., L. Lorenz and W. D'A. Maycock (1950). Molecular 
composition of dextran solutions for intravenous use. Nature. 165: 
770 - 771. 
152. Robyt, J.F. (1980). Mechanism of action of dextransucrase. Proc. 
Symp. Mechanisms of saccharide polymerization and 
depolymerization - Miami Beach 1978. Publ. pp 43 - 54, Academic 
Press. 
153. Robyt, J.F. (1986). "Dextran". In Encyclopedia of polymer science 
and technology, vol. 4. pp. 752 - 767, John Wiley & Sons, Inc., New 
York. 
154. Robyt, J.F. and A.J. Corrigan (1977). The mechanism of 
dextransucrase action - Activation of dextransucrase from S. mutans 
OMZ 176 by dextran and modified dextran and the nonexistence of 
the primer requirement for the synthesis of dextran. Arch. Biochem. 
Biophys. 183: 726 - 731. 
155. Robyt, J.F. and S.H. Ekland (1983). Relative, quantitative effects of 
acceptors in the reaction of L. mesenteroides B-512F dextransucrase. 
Carbohydr. Res. 121: 279 - 286. 
156. Robyt, J.F., B.K. Kimble and T.F. Walseth (1974). The mechanism of 
dextransucrase action; Direction of dextran biosynthesis. Arch. 
Biochem. Biophys. 165: 634 - 640. 
157. Robyt, J.F. and H. Taniguchi (1976). The mechanism of 
dextransucrase action; Biosynthesis of branch linkages by acceptor 
reactions with dextran. Arch. Biochem. Biophys. 174:129 - 135. 
161 
158. Robyt, J.F. and T.F. Walseth (1978). The mechanism of acceptor 
reactions of L. mesenteroides B-512 F dextransucrase. Carbohydr. 
Res. 61: 433 - 445. 
159. Robyt, J.F. and T.F. Walseth (1979). Production, purification, and 
properties of dextransucrase from L. mesenteroides NRRL B-512F. 
Carbohydr. Res. 68: 95 - 111. 
160. Rokem, J.S., I. Goldberg and R.I. Mateles (1980). Growth of mixed 
cultures of bacteria on methanol. J. Gen. Microbiol. 116: 225 - 232. 
161. Sawai, T. and Y. Niwa (1975). Transisomaltosylation activity of a 
bacterial isomalto-dextranase. Agric. Biol. Chem. 39: 1077 - 1083. 
162. Schneider, M., C. Guillot and A. Ayerbe (1982). Preparation and 
purification process. UK Patent 2,079,290. 
163. Schneider,M., C. Guillot and A. Ayerbe (1984). Preparation and 
purification of a polysaccharide-producing enzyme, UK Patent 
2.079.292B. 
164. Senti, F.R. and N.N. Hellman (1955). Viscosity, sedimentation, and 
light-scattering properties of fractions of an acid-hydrolyzed dextran. 
J. Poly. Sci. 17: 527 - 546. 
165. Shimamura, A., H. Tsumori and H. Mukasa (1982). Purification and 
properties of S. mutans extracellular glucosyltransferase. Biochim. 
Biophys. Acta. 702: 72 - 80. 
166. Slater, J.H. and A.T. Bull (1982). Microbial communities : 
Biodegradation. Philos. Trans. R. Soc. London, Ser. B. 297: 575 -
597. 
167. Staat.R.H. and C.F.Schachtel (1974). Evaluation of dextranase 
production by the cariogenic bacterium Streptococcus mutans. Infect. 
Immun. 9: 467-469. 
168. Stacey, M. (1951). Degradation of dextran by ultrasonic waves. 
Research. 4: 48. 
169. Stacey, M. and F.G. Pautard (1952). Thermal degration of dextran. 
Chem. Ind. 43: 1058 - 1059. 
170. Stacey, M. and F.R. Youd (1943). A note on the dextran produced 
from sucrose by Betacoccus arabinosaceus haemolvticus. Biochem. 
J. 32: 1943 - 1945. 
162 
171. Starling, E.H. (1896). On the absorption of fluids from the connective 
tissue spaces. J. Physiol. (London). 19: 312 - 366. 
172. Steinkraus, K.H. (1982). "Fermented foods and beverages: the role of 
mixed cultures". In Microbial Interactions and Communities", eds. by 
Bull, A.T. and J.H. Slater, vol. 1. pp. 407 - 442. Academic Press, 
London. 
173. Stodola, F.H., E.S. Sharpe and H.J. Koepsell (1956). The preparation, 
properties and structure of disaccharide leucrose. J. Amer. Chem. 
Soc. 78: 2514. 
174. Sumner, J.B. (1924). A method for the measure of reducing sugars in 
urine. J. Biol. Chem. 62: 287 - 290. 
175. Taeufel, K., W. Krause, H. Ruttloff, and R. Maune (1967). Intestinal 
splitting of oligosaccharides. Z. Gestamte Exp. Med. Exp. Chir. 144: 
54 - 66. 
176. Takemoto, K.K. and H. Liebharber (1962). Virus - polysaccharide 
interactions, II. Enhancement of plaque formation and the detection of 
variants of poliovirus with dextran sulfate. Virology. 17: 499 - 501. 
177. Tam, S.C, T. Blumenstein, and T.F. Wong (1976). Soluble dextran -
hemoglobin complex as a potential blood substitute. Proc. Natl. Acad. 
Sci. USA. 73: 2128 - 2131. 
178. Tanriseven A. and J. F. Robyt (1992). Inhibition of dextran synthesis 
by acceptor reactions of dextransucrase, and the demonstration of a 
separate acceptor binding - site. Carbohydr. Res. 225: 321 - 329. 
179. Thiery, J.P. and H. Kumon, H. Ichikawa and J. Tawara (1974). 
Cytochimie des polysaccharides. J. de Microscopie. 21: 225 - 232. 
180. Thulin, K.E. (1948). Way of making stable penicillin solutions with 
prolonged effectiveness. Swed. Patent 121,752 (April 1). 
181. Toulmin, H.A., Jr. (1960). Stabilizers for icing compositions for bakery 
products. U.S. Patent 2,938,797; Chem. Abstract. 54: 20009 (1960). 
182. Toulmin, H.A., Jr. (1960). Gum confections. U.S. Patent 2,938,798; 
Chem. Abstract. 54: 20009 (1960). 
183. Tsuchiya, H.M. (1960). Dextransucrase. Bull. Soc. Chim. Biol. 42: 
1777 - 1788. 
163 
184. Tsuchiya, H.M., M.J. Koepsell and J. Corman (1952). The effect of 
certain cultural factors on production of dextransucrase by L 
mesenteroides. J. Bacteriol. 63: 521 - 526. . 
185. Tsuchiya, H.M., N.C. Trivedi and M.L. Schuler (1974). Microbial 
mutualism in ore leaching. Biotechnol. Bioeng. 16: 991 - 995. 
186. Tsumuraya, Y. N., Nakamura and T. Kobayashi (1976). 
Dextransucrase, and the role of metallic ions in the formation of 
branch links in dextran synthesis. Agric. Biol. Chem. 40: 1471 - 1477. 
187. VanCleve, J.W., W.C. Schaefer and C.E. Rist (1956). The structure of 
NRRL B-512 dextran. Methylation Studies. J. Am. Chem. Soc. 78: 
4435 - 4438. 
188. Walker,G.J. and A.Pulkownik. (1974). Action of a-1,6-glucan 
glucohydrolase on oligosaccharides derived from dextran. 
Carbohydr. Res. 36: 53-66. 
189. Wang, H.L. and C.W. Hesseltine (1982). Oriental fermented foods. In " 
Prescott and Dunn's Industrial Microbiology", ed. Reed, G., 4th 
eddition., pp. 492 - 538. Avi Publishing, Westport, CT. 
190. Willemot, R.M., P. Monsan and G.Durand (1988). Effects of dextran on 
the activity and stability of dextransucrase from L. mesenteroides. 
Annals New York Academy of Science. 542: 169 - 172. 
191. Witt, E.E. and L.J. Novak (1958). Low molecular weight dextran as a 
soil conditioner. U.S. Patent 2,822,643; Chem. Abstract. 52: 7601. 
192. Wolff, I.A., C.L. Mehltretter, R.L. Mellies, P.R. Watson, B.T. Hofreiter, 
P.L. Patrick, and C.E. Rist (1954). Production of clinical dextran. 
Industrial and Engineering Chemistry. 46: 370 - 377. 
193. Wolff, I.A., R.L. Mellies, R.L. Lohmar, N.N. Hellman, S.P. Rogovin, P.R. 
Watson, J.W. Sloan, B.T. Hofreiter, B.E. Fisher, and C.E. Rist (1954). 
Production of clinical-type dextran. Industrial and Engineering 
Chemistry. 46: 2605 - 2610. 
194. Wolff, I.A., P.R. Watson, J.W. Sloan, and C.E. Rist (1953). Controlled 
thermal depolymerization of dextran. Ind. Eng. Chem. 45: 755 - 759. 
195. Wolff, I.A. (1954). Production of clinical-type dextran; Partial 
hydrolytic depolymerization and fractionation of the dextran from L. 
mesenteroides strain NRRL B-512. Ind. Eng. Chem. 46: 370 - 377. 
196. Yamashita, Y., N. Hanada, and T. Takehara (1988). A novel 
glucosyltransferase from Streptococcus mutans produces oligo-
164 
isomaltosaccharides. Biochem. Biophys. Res. Commun. 150: 687 -
693. 
197. Yamashita, Y., N. Hanada, and T. Takehara (1989). Purification of a 
fourth glucosyltransferase from Streptococcus sobrinus. J. Bacteriol. 
171: 6265 - 6270. 
198. Yoshida, T.M., M. Sueki, H. Taguchi, S. Kulprecha and N. Nilubol 
(1981). Modelling and optimization of steroid transformation in a 
mixed culture. Ann. Rep. ICME, Osaka. 4: 1-13. 
199. Zief, M., G. Brunner, and J. Metzendorf (1956). Fractionation of 
par t i a l l y  hyd ro lyzed  dex t ran .  Ind .  Eng .  Chem.  48 :119-121 .  
200. Zief, M. and J.R. Stevens (1952). Hydrodextran. J. Am. Chem. Soc. 
74: 2126. 
201. Zimmermann, F.K. and I. Scheel (1977). Mutants of S. cerevisiae 
resistant to carbon catabolite repression. Mol. Gen. Genet. 154: 75 -
82. 
VITA 
Doman Kim was born in Seoul, Republic of Korea, on March 8, 1962. 
After graduating from Hong IK University High School he attended the Seoul 
National University where he obtained his Master and Bachelor of Science 
degrees in Food Science and Technology in 1987 and 1985, respectively. In 
August 1988, he began his graduate training at Louisiana State University in 
Baton Rouge and obtained Master degree in Microbiology in 1990. 
165 
DOCTORAL EXAMINATION AND DISSERTATION REPORT 
Candidate: Doman Kim 
Major Field: Microbiology 
Title of Dissertation: a Novel Process for the Production of Clinical Dextran 
Approved: 
3 .  Q-
Major Professor and /Chairman 
\ 
\ W- -..0 \~~oc/r 




Date of Examination: 
September 15, 1992 
